<div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Long-term degenerative neurological disorder</div>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">"Parkinson's" redirects here. For the medical journal, see <a href="/wiki/Parkinson%27s_Disease_(journal)" title="Parkinson&#39;s Disease (journal)">Parkinson's Disease (journal)</a>. For other uses, see <a href="/wiki/Parkinson%27s_(disambiguation)" class="mw-disambig" title="Parkinson&#39;s (disambiguation)">Parkinson's (disambiguation)</a>.</div>
<p class="mw-empty-elt">
</p>
<table class="box-Update plainlinks metadata ambox ambox-content ambox-Update" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="Ambox current red Americas.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/42px-Ambox_current_red_Americas.svg.png" decoding="async" width="42" height="34" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/63px-Ambox_current_red_Americas.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/84px-Ambox_current_red_Americas.svg.png 2x" data-file-width="360" data-file-height="290" /></div></td><td class="mbox-text"><div class="mbox-text-span">This article needs to be <b>updated</b>. The reason given is: see <a href="/wiki/Wikipedia:Featured_article_review/Parkinson%27s_disease/archive1" title="Wikipedia:Featured article review/Parkinson&#39;s disease/archive1">Wikipedia:Featured article review/Parkinson's disease/archive1</a>.<span class="hide-when-compact"> Please help update this article to reflect recent events or newly available information.</span>  <span class="date-container"><i>(<span class="date">April 2021</span>)</i></span></div></td></tr></tbody></table>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medical condition</div><style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Parkinson's disease</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">Parkinson disease, idiopathic or primary parkinsonism, hypokinetic rigid syndrome, paralysis agitans, shaking palsy</td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/File:Paralysis_agitans_(1907,_after_St._Leger).png" class="image"><img alt="Two sketches (one from the front and one from the right side) of a man, with an expressionless face. He is stooped forward and is presumably having difficulty walking." src="//upload.wikimedia.org/wikipedia/en/thumb/5/5d/Paralysis_agitans_%281907%2C_after_St._Leger%29.png/300px-Paralysis_agitans_%281907%2C_after_St._Leger%29.png" decoding="async" width="300" height="316" srcset="//upload.wikimedia.org/wikipedia/en/thumb/5/5d/Paralysis_agitans_%281907%2C_after_St._Leger%29.png/450px-Paralysis_agitans_%281907%2C_after_St._Leger%29.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/5/5d/Paralysis_agitans_%281907%2C_after_St._Leger%29.png/600px-Paralysis_agitans_%281907%2C_after_St._Leger%29.png 2x" data-file-width="1500" data-file-height="1580" /></a></td></tr><tr><td colspan="2" class="infobox-full-data">Illustration of Parkinson's disease by <a href="/wiki/William_Gowers_(neurologist)" title="William Gowers (neurologist)">William Richard Gowers</a>, first published in <i>A Manual of Diseases of the Nervous System</i> (1886)</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Neurology" title="Neurology">Neurology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data"><a href="/wiki/Tremor" title="Tremor">Tremor</a>, <a href="/wiki/Spasticity" title="Spasticity">rigidity</a>, <a href="/wiki/Hypokinesia#Bradykinesia" title="Hypokinesia">slowness of movement</a>, <a href="/wiki/Gait_abnormality" title="Gait abnormality">difficulty walking</a><sup id="cite_ref-NIH2016_1-0" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Complication_(medicine)" title="Complication (medicine)">Complications</a></th><td class="infobox-data"><a href="/wiki/Parkinson%27s_disease_dementia" title="Parkinson&#39;s disease dementia">Dementia</a>, <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">depression</a>, anxiety<sup id="cite_ref-Sv2016_2-0" class="reference"><a href="#cite_note-Sv2016-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Usual onset</th><td class="infobox-data">Age over 60<sup id="cite_ref-NIH2016_1-1" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-Car2016_3-0" class="reference"><a href="#cite_note-Car2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Causes</th><td class="infobox-data">Unknown<sup id="cite_ref-Lancet2015_4-0" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Risk_factor" title="Risk factor">Risk factors</a></th><td class="infobox-data"><a href="/wiki/Pesticide" title="Pesticide">Pesticide</a> exposure, <a href="/wiki/Head_injuries" class="mw-redirect" title="Head injuries">head injuries</a><sup id="cite_ref-Lancet2015_4-1" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data">Based on symptoms<sup id="cite_ref-NIH2016_1-2" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Differential_diagnosis" title="Differential diagnosis">Differential diagnosis</a></th><td class="infobox-data"><a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a>, <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a>, <a href="/wiki/Essential_tremor" title="Essential tremor">essential tremor</a>, <a href="/wiki/Antipsychotic" title="Antipsychotic">antipsychotic</a> use<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">&#91;5&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data">Medications, surgery<sup id="cite_ref-NIH2016_1-3" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medication" title="Medication">Medication</a></th><td class="infobox-data"><a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>, <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a><sup id="cite_ref-Sv2016_2-1" class="reference"><a href="#cite_note-Sv2016-2">&#91;2&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Prognosis" title="Prognosis">Prognosis</a></th><td class="infobox-data"><a href="/wiki/Life_expectancy" title="Life expectancy">Life expectancy</a> about 7–15 years<sup id="cite_ref-Macleod2014_6-0" class="reference"><a href="#cite_note-Macleod2014-6">&#91;6&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">6.2 million (2015)<sup id="cite_ref-GBD2015Pre_7-0" class="reference"><a href="#cite_note-GBD2015Pre-7">&#91;7&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Deaths</th><td class="infobox-data">117,400 (2015)<sup id="cite_ref-GBD2015De_8-0" class="reference"><a href="#cite_note-GBD2015De-8">&#91;8&#93;</a></sup></td></tr></tbody></table>
<p><b>Parkinson's disease</b> (<b>PD</b>), or simply <b>Parkinson's</b>,<sup id="cite_ref-PF_9-0" class="reference"><a href="#cite_note-PF-9">&#91;9&#93;</a></sup> is a <a href="/wiki/Chronic_condition" title="Chronic condition">long-term</a> <a href="/wiki/Neurodegeneration" class="mw-redirect" title="Neurodegeneration">degenerative disorder</a> of the <a href="/wiki/Central_nervous_system" title="Central nervous system">central nervous system</a> that mainly affects the <a href="/wiki/Motor_system" title="Motor system">motor system</a>. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common.<sup id="cite_ref-NIH2016_1-4" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-Lancet2015_4-2" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> The most obvious early symptoms are <a href="/wiki/Tremor" title="Tremor">tremor</a>, <a href="/wiki/Spasticity" title="Spasticity">rigidity</a>, <a href="/wiki/Hypokinesia#Bradykinesia" title="Hypokinesia">slowness of movement</a>, and <a href="/wiki/Gait_abnormality" title="Gait abnormality">difficulty with walking</a>.<sup id="cite_ref-NIH2016_1-5" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup> <a href="/wiki/Cognition" title="Cognition">Cognitive</a> and behavioral problems may also occur with <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a>, <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>, and <a href="/wiki/Apathy" title="Apathy">apathy</a> occurring in many people with PD.<sup id="cite_ref-:5_10-0" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup> <a href="/wiki/Parkinson%27s_disease_dementia" title="Parkinson&#39;s disease dementia">Parkinson's disease dementia</a> becomes common in the advanced stages of the disease. Those with Parkinson's can also have problems with their <a href="/wiki/Sleep" title="Sleep">sleep</a> and <a href="/wiki/Sensory_systems" class="mw-redirect" title="Sensory systems">sensory systems</a>.<sup id="cite_ref-NIH2016_1-6" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-Sv2016_2-2" class="reference"><a href="#cite_note-Sv2016-2">&#91;2&#93;</a></sup> The motor symptoms of the disease result from the <a href="/wiki/Death_of_cells" class="mw-redirect" title="Death of cells">death of cells</a> in the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a>, a region of the <a href="/wiki/Midbrain" title="Midbrain">midbrain</a>, leading to a <a href="/wiki/Dopamine" title="Dopamine">dopamine</a> deficit.<sup id="cite_ref-NIH2016_1-7" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup> The cause of this cell death is poorly understood, but involves the build-up of <a href="/wiki/Protein" title="Protein">misfolded proteins</a> into <a href="/wiki/Lewy_bodies" class="mw-redirect" title="Lewy bodies">Lewy bodies</a> in the <a href="/wiki/Neuron" title="Neuron">neurons</a>.<sup id="cite_ref-:9_11-0" class="reference"><a href="#cite_note-:9-11">&#91;11&#93;</a></sup><sup id="cite_ref-Lancet2015_4-3" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> Collectively, the main motor symptoms are also known as <a href="/wiki/Parkinsonism" title="Parkinsonism">parkinsonism</a> or a parkinsonian syndrome.<sup id="cite_ref-Lancet2015_4-4" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup>
</p><p>The cause of PD is <a href="/wiki/Idiopathy" class="mw-redirect" title="Idiopathy">unknown</a>, with both <a href="/wiki/Heredity" title="Heredity">inherited</a> and environmental factors believed to play a role.<sup id="cite_ref-Lancet2015_4-5" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> Those with an affected family member are at an increased risk of getting the disease, with certain genes known to be inheritable risk factors.<sup id="cite_ref-Quadri2018_12-0" class="reference"><a href="#cite_note-Quadri2018-12">&#91;12&#93;</a></sup> Other risk factors are those who have been exposed to certain <a href="/wiki/Pesticide" title="Pesticide">pesticides</a> and who have prior <a href="/wiki/Head_injury" title="Head injury">head injuries</a>. <a href="/wiki/Coffee" title="Coffee">Coffee</a> drinkers, <a href="/wiki/Tea" title="Tea">tea</a> drinkers, and <a href="/wiki/Tobacco_smoking" title="Tobacco smoking">tobacco smokers</a> are at a reduced risk.<sup id="cite_ref-Lancet2015_4-6" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup><sup id="cite_ref-nutri2009_13-0" class="reference"><a href="#cite_note-nutri2009-13">&#91;13&#93;</a></sup> 
</p><p>Diagnosis of typical cases is mainly based on symptoms, with motor symptoms being the chief complaint. Tests such as <a href="/wiki/Neuroimaging" title="Neuroimaging">neuroimaging</a> (<a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">magnetic resonance imaging</a> or imaging to look at dopamine neuronal dysfunction known as <a href="/wiki/DaT_scan" title="DaT scan">DaT scan</a>) can be used to help rule out other diseases.<sup id="cite_ref-:1_14-0" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup><sup id="cite_ref-NIH2016_1-8" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup> Parkinson's disease typically occurs in people over the age of 60, of whom about one percent are affected.<sup id="cite_ref-NIH2016_1-9" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-Car2016_3-1" class="reference"><a href="#cite_note-Car2016-3">&#91;3&#93;</a></sup> Males are more often affected than females at a ratio of around 3:2.<sup id="cite_ref-Lancet2015_4-7" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> When it is seen in people before the age of 50, it is called early-onset PD.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> By 2015, PD affected 6.2 million people and resulted in about 117,400 deaths globally.<sup id="cite_ref-GBD2015Pre_7-1" class="reference"><a href="#cite_note-GBD2015Pre-7">&#91;7&#93;</a></sup><sup id="cite_ref-GBD2015De_8-1" class="reference"><a href="#cite_note-GBD2015De-8">&#91;8&#93;</a></sup> The average <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> following diagnosis is between 7 and 15 years.<sup id="cite_ref-Sv2016_2-3" class="reference"><a href="#cite_note-Sv2016-2">&#91;2&#93;</a></sup>
</p><p>No cure for PD is known; treatment aims to reduce the effects of the symptoms.<sup id="cite_ref-NIH2016_1-10" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid15172778_16-0" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup> <a href="/wiki/Management_of_Parkinson%27s_disease#Medication" title="Management of Parkinson&#39;s disease">Initial treatment</a> is typically with the medications levodopa (<a href="/wiki/L-DOPA" title="L-DOPA">L-DOPA</a>), <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAO-B inhibitors</a>, or <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a>.<sup id="cite_ref-:1_14-1" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup> As the disease progresses, these medications become less effective, while at the same time producing a <a href="/wiki/Side_effect" title="Side effect">side effect</a> marked by <a href="/wiki/Dyskinesia" title="Dyskinesia">involuntary muscle movements</a>.<sup id="cite_ref-Sv2016_2-4" class="reference"><a href="#cite_note-Sv2016-2">&#91;2&#93;</a></sup> At that time, medications may be used in combination and doses may be increased.<sup id="cite_ref-:1_14-2" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup> Diet and certain forms of rehabilitation have shown some effectiveness at improving symptoms.<sup id="cite_ref-pmid19691125_17-0" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup><sup id="cite_ref-Neuro2011_18-0" class="reference"><a href="#cite_note-Neuro2011-18">&#91;18&#93;</a></sup> <a href="/wiki/Neurosurgery" title="Neurosurgery">Surgery</a> to place <a href="/wiki/Microelectrode" title="Microelectrode">microelectrodes</a> for <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a> has been used to reduce motor symptoms in severe cases where drugs are ineffective.<sup id="cite_ref-NIH2016_1-11" class="reference"><a href="#cite_note-NIH2016-1">&#91;1&#93;</a></sup> Evidence for treatments for the nonmovement-related symptoms of PD, such as sleep disturbances and emotional problems, is less strong.<sup id="cite_ref-Lancet2015_4-8" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup>
</p><p>The disease is named after English doctor <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a>, who published the first detailed description in <i>An Essay on the Shaking Palsy</i>, in 1817.<sup id="cite_ref-ParkinsonJEssay_19-0" class="reference"><a href="#cite_note-ParkinsonJEssay-19">&#91;19&#93;</a></sup><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">&#91;20&#93;</a></sup> Public awareness campaigns include <a href="/wiki/World_Parkinson%27s_Day" class="mw-redirect" title="World Parkinson&#39;s Day">World Parkinson's Day</a> (on the birthday of James Parkinson, 11 April) and the use of a red <a href="/wiki/Tulip" title="Tulip">tulip</a> as the symbol of the disease.<sup id="cite_ref-pmid18175393_21-0" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> People with PD who have increased the public's awareness of the condition include boxer <a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a>, comedian <a href="/wiki/Billy_Connolly" title="Billy Connolly">Billy Connolly</a>, actor <a href="/wiki/Michael_J._Fox" title="Michael J. Fox">Michael J. Fox</a>, Olympic cyclist <a href="/wiki/Davis_Phinney" title="Davis Phinney">Davis Phinney</a>, and actor <a href="/wiki/Alan_Alda" title="Alan Alda">Alan Alda</a>.<sup id="cite_ref-MJF_TIME_22-0" class="reference"><a href="#cite_note-MJF_TIME-22">&#91;22&#93;</a></sup><sup id="cite_ref-Mac2008_23-0" class="reference"><a href="#cite_note-Mac2008-23">&#91;23&#93;</a></sup><sup id="cite_ref-Ali_NN_comment_24-0" class="reference"><a href="#cite_note-Ali_NN_comment-24">&#91;24&#93;</a></sup><sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Motor"><span class="tocnumber">2.1</span> <span class="toctext">Motor</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Neuropsychiatric"><span class="tocnumber">2.2</span> <span class="toctext">Neuropsychiatric</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Psychosis"><span class="tocnumber">2.3</span> <span class="toctext">Psychosis</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Behavior_and_mood"><span class="tocnumber">2.4</span> <span class="toctext">Behavior and mood</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Other"><span class="tocnumber">2.5</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Genetic"><span class="tocnumber">3.1</span> <span class="toctext">Genetic</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Non-genetic"><span class="tocnumber">3.2</span> <span class="toctext">Non-genetic</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-11"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-12"><a href="#Brain_cell_death"><span class="tocnumber">4.1</span> <span class="toctext">Brain cell death</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-14"><a href="#Imaging"><span class="tocnumber">5.1</span> <span class="toctext">Imaging</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Differential_diagnosis"><span class="tocnumber">5.2</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Prevention"><span class="tocnumber">6</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#Management"><span class="tocnumber">7</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#Medications"><span class="tocnumber">7.1</span> <span class="toctext">Medications</span></a>
<ul>
<li class="toclevel-3 tocsection-19"><a href="#Levodopa"><span class="tocnumber">7.1.1</span> <span class="toctext">Levodopa</span></a></li>
<li class="toclevel-3 tocsection-20"><a href="#COMT_inhibitors"><span class="tocnumber">7.1.2</span> <span class="toctext">COMT inhibitors</span></a></li>
<li class="toclevel-3 tocsection-21"><a href="#Dopamine_agonists"><span class="tocnumber">7.1.3</span> <span class="toctext">Dopamine agonists</span></a></li>
<li class="toclevel-3 tocsection-22"><a href="#MAO-B_inhibitors"><span class="tocnumber">7.1.4</span> <span class="toctext">MAO-B inhibitors</span></a></li>
<li class="toclevel-3 tocsection-23"><a href="#Other_drugs"><span class="tocnumber">7.1.5</span> <span class="toctext">Other drugs</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-24"><a href="#Surgery"><span class="tocnumber">7.2</span> <span class="toctext">Surgery</span></a></li>
<li class="toclevel-2 tocsection-25"><a href="#Rehabilitation"><span class="tocnumber">7.3</span> <span class="toctext">Rehabilitation</span></a></li>
<li class="toclevel-2 tocsection-26"><a href="#Palliative_care"><span class="tocnumber">7.4</span> <span class="toctext">Palliative care</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-27"><a href="#Prognosis"><span class="tocnumber">8</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-28"><a href="#Epidemiology"><span class="tocnumber">9</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-29"><a href="#History"><span class="tocnumber">10</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-30"><a href="#Society_and_culture"><span class="tocnumber">11</span> <span class="toctext">Society and culture</span></a>
<ul>
<li class="toclevel-2 tocsection-31"><a href="#Cost"><span class="tocnumber">11.1</span> <span class="toctext">Cost</span></a></li>
<li class="toclevel-2 tocsection-32"><a href="#Advocacy"><span class="tocnumber">11.2</span> <span class="toctext">Advocacy</span></a></li>
<li class="toclevel-2 tocsection-33"><a href="#Notable_cases"><span class="tocnumber">11.3</span> <span class="toctext">Notable cases</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-34"><a href="#Research"><span class="tocnumber">12</span> <span class="toctext">Research</span></a>
<ul>
<li class="toclevel-2 tocsection-35"><a href="#Animal_models"><span class="tocnumber">12.1</span> <span class="toctext">Animal models</span></a></li>
<li class="toclevel-2 tocsection-36"><a href="#Gene_therapy"><span class="tocnumber">12.2</span> <span class="toctext">Gene therapy</span></a></li>
<li class="toclevel-2 tocsection-37"><a href="#Neuroprotective_treatments"><span class="tocnumber">12.3</span> <span class="toctext">Neuroprotective treatments</span></a></li>
<li class="toclevel-2 tocsection-38"><a href="#Cell-based_therapies"><span class="tocnumber">12.4</span> <span class="toctext">Cell-based therapies</span></a></li>
<li class="toclevel-2 tocsection-39"><a href="#Other_2"><span class="tocnumber">12.5</span> <span class="toctext">Other</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-40"><a href="#References"><span class="tocnumber">13</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-41"><a href="#External_links"><span class="tocnumber">14</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
</div>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Parkinson's disease is the most common form of parkinsonism and is sometimes called "<a href="/wiki/Idiopathic" class="mw-redirect" title="Idiopathic">idiopathic</a> parkinsonism", meaning parkinsonism with no identifiable cause.<sup id="cite_ref-pmid15172778_16-1" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup><sup id="cite_ref-Jankovic_book-Epidemiology2_26-0" class="reference"><a href="#cite_note-Jankovic_book-Epidemiology2-26">&#91;26&#93;</a></sup> It is sometimes referred to as a type of <a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">neurodegenerative disease</a> called <a href="/wiki/Synucleinopathy" title="Synucleinopathy">synucleinopathy</a> due to an abnormal accumulation of the protein <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> in the brain.<sup id="cite_ref-pmid164896092_27-0" class="reference"><a href="#cite_note-pmid164896092-27">&#91;27&#93;</a></sup> The synucleinopathy classification distinguishes it from neurodegenerative diseases such as <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a> where the brain accumulates a different protein known as the <a href="/wiki/Tau_protein" title="Tau protein">tau protein</a>.<sup id="cite_ref-pmid164896092_27-1" class="reference"><a href="#cite_note-pmid164896092-27">&#91;27&#93;</a></sup>
</p><p>Considerable clinical and pathological overlap exists between <a href="/wiki/Tauopathy" title="Tauopathy">tauopathies</a> and synucleinopathies, but differences exist. In contrast to PD, people with Alzheimer's most commonly experience memory loss. The cardinal signs of PD (slowness, tremor, stiffness, and postural instability) are not normal features of Alzheimer's.
</p><p>Attempts to classify PD into different subtypes have been made, with focus put on age at onset, progression of symptoms and dominance of tremor, but none have been adopted.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=2" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg" class="image"><img alt="Black and white picture of a male with PD stooping forward as he walks. He is viewed from the left side with a chair behind him." src="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg/220px-Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg" decoding="async" width="220" height="325" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/88/Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg/330px-Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/88/Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg/440px-Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg 2x" data-file-width="991" data-file-height="1464" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Paralysis_agitans-Male_Parkinson%27s_victim-1892.jpg" class="internal" title="Enlarge"></a></div>A man with PD displaying a flexed walking posture pictured in 1892<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup></div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Writing_by_a_Parkinson%27s_disease_patient.png" class="image"><img alt="French signature reads &quot;Catherine Metzger 13 Octobre 1869&quot;" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Writing_by_a_Parkinson%27s_disease_patient.png/220px-Writing_by_a_Parkinson%27s_disease_patient.png" decoding="async" width="220" height="85" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Writing_by_a_Parkinson%27s_disease_patient.png/330px-Writing_by_a_Parkinson%27s_disease_patient.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/Writing_by_a_Parkinson%27s_disease_patient.png/440px-Writing_by_a_Parkinson%27s_disease_patient.png 2x" data-file-width="2175" data-file-height="845" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Writing_by_a_Parkinson%27s_disease_patient.png" class="internal" title="Enlarge"></a></div>Handwriting of a person affected by PD<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup></div></div></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Signs_and_symptoms_of_Parkinson%27s_disease" title="Signs and symptoms of Parkinson&#39;s disease">Signs and symptoms of Parkinson's disease</a></div>
<p>The most recognizable early symptoms are movement ("motor") related.<sup id="cite_ref-Jankovic2008_31-0" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> Non-motor symptoms, including <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">autonomic</a> dysfunction (<a href="/wiki/Dysautonomia" title="Dysautonomia">dysautonomia</a>), <a href="/wiki/Neuropsychiatry" title="Neuropsychiatry">neuropsychiatric</a> problems (mood, cognition, behavior or thought alterations), and sensory (especially altered sense of smell) and sleep difficulties, are usually associated with later stages, but may present at the time of diagnosis.<sup id="cite_ref-Jankovic2008_31-1" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Motor">Motor</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=3" title="Edit section: Motor">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a></div>
<p>Four motor symptoms are considered as <a href="/wiki/Signs_and_symptoms_of_Parkinson%27s_disease#Cardinal_signs" title="Signs and symptoms of Parkinson&#39;s disease">cardinal signs</a> in PD: tremor, slowness of movement (bradykinesia), rigidity, and postural instability.<sup id="cite_ref-Jankovic2008_31-2" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup>
</p><p>The most common presenting sign is a coarse, slow <a href="/wiki/Tremor" title="Tremor">tremor</a> of the hand at rest, which disappears during voluntary movement of the affected arm and in the deeper stages of sleep.<sup id="cite_ref-Jankovic2008_31-3" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> It typically appears in only one hand, eventually affecting both hands as the disease progresses.<sup id="cite_ref-Jankovic2008_31-4" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> Frequency of PD tremor is between 4 and 6 <a href="/wiki/Hertz" title="Hertz">hertz</a> (cycles per second). A feature of tremor is "pill-rolling", the tendency of the index finger and thumb to touch and perform together with a circular movement.<sup id="cite_ref-Jankovic2008_31-5" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup><sup id="cite_ref-Cooper_32-0" class="reference"><a href="#cite_note-Cooper-32">&#91;32&#93;</a></sup> The term derives from the similarity between the movement of people with PD and the early pharmaceutical technique of manually making pills.<sup id="cite_ref-Cooper_32-1" class="reference"><a href="#cite_note-Cooper-32">&#91;32&#93;</a></sup>
</p><p><a href="/wiki/Bradykinesia" class="mw-redirect" title="Bradykinesia">Bradykinesia</a> is found in every case of PD, and is due to disturbances in <a href="/wiki/Motor_planning" title="Motor planning">motor planning</a> of movement initiation, and associated with difficulties along the whole course of the movement process, from planning to initiation to execution of a movement. Performance of sequential and simultaneous movement is impaired. Bradykinesia is the most handicapping symptom of Parkinson’s disease, leading to difficulties with everyday tasks such as dressing, feeding, and bathing. It leads to particular difficulty in carrying out two independent motor activities at the same time, and can be made worse by emotional stress or concurrent illnesses. Paradoxically, people with PD can often ride a bicycle or climb stairs more easily than walk on the level. While most physicians may readily notice bradykinesia, formal assessment requires  persons to do repetitive movements with their fingers and feet.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup>
</p><p><a href="/wiki/Hypokinesia" title="Hypokinesia">Rigidity</a> is stiffness and resistance to limb movement caused by increased <a href="/wiki/Muscle_tone" title="Muscle tone">muscle tone</a>, an excessive and continuous contraction of muscles.<sup id="cite_ref-Jankovic2008_31-6" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> In parkinsonism, the rigidity can be uniform, known as 'lead-pipe rigidity', or ratchet-y, known as 'cogwheel rigidity'.<sup id="cite_ref-pmid15172778_16-2" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup><sup id="cite_ref-Jankovic2008_31-7" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup><sup id="cite_ref-Banich_34-0" class="reference"><a href="#cite_note-Banich-34">&#91;34&#93;</a></sup><sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup> The combination of tremor and increased tone is considered to be at the origin of cogwheel rigidity.<sup id="cite_ref-Jankovic_book-Rigidity_36-0" class="reference"><a href="#cite_note-Jankovic_book-Rigidity-36">&#91;36&#93;</a></sup> Rigidity may be associated with joint pain; such pain being a frequent initial manifestation of the disease.<sup id="cite_ref-Jankovic2008_31-8" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> In early stages of PD, rigidity is often asymmetrical and tends to affect the neck and shoulder muscles prior to the muscles of the face and extremities.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup> With the progression of the disease, rigidity typically affects the whole body and reduces the ability to move.
</p><p><a href="/wiki/Balance_disorder" title="Balance disorder">Postural instability</a> is typical in the later stages of the disease, leading to impaired balance and frequent falls,<sup id="cite_ref-OFP_38-0" class="reference"><a href="#cite_note-OFP-38">&#91;38&#93;</a></sup> and secondarily to <a href="/wiki/Bone_fracture" title="Bone fracture">bone fractures</a>, loss of confidence, and reduced mobility.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;39&#93;</a></sup> Instability is often absent in the initial stages, especially in younger people, especially prior to the development of bilateral symptoms.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup> Up to 40% of people diagnosed with PD may experience falls, and around 10% may have falls weekly, with the number of falls being related to the severity of PD.<sup id="cite_ref-Jankovic2008_31-9" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup>
</p><p>Other recognized motor signs and symptoms include gait and posture disturbances such as <a href="/wiki/Parkinsonian_gait" title="Parkinsonian gait">festination</a> (rapid shuffling steps and a <a href="/wiki/Camptocormia" title="Camptocormia">forward-flexed posture</a> when walking with no flexed arm swing). Other common signs include freezing of gait (brief arrests when the feet seem to get stuck to the floor, especially on turning or changing direction), a slurred, monotonous, quiet voice, <a href="/wiki/Mask-like_facial_expression" class="mw-redirect" title="Mask-like facial expression">mask-like facial expression</a>, and <a href="/wiki/Micrographia_(handwriting)" title="Micrographia (handwriting)">handwriting that gets smaller and smaller</a>.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Neuropsychiatric">Neuropsychiatric</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=4" title="Edit section: Neuropsychiatric">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>PD causes <a href="/wiki/Neuropsychiatry" title="Neuropsychiatry">neuropsychiatric</a> disturbances ranging from mild to severe. They include disorders of cognition, mood, behavior, and thought.<sup id="cite_ref-Jankovic2008_31-10" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> Cognitive disturbances can occur in the early stages or sometimes prior to diagnosis, and increase in prevalence with duration of the disease.<sup id="cite_ref-Jankovic2008_31-11" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup><sup id="cite_ref-pmid18175397_42-0" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup> The most common cognitive deficit is <a href="/wiki/Executive_dysfunction" title="Executive dysfunction">executive dysfunction</a>, which can include problems with planning, <a href="/wiki/Cognitive_flexibility" title="Cognitive flexibility">cognitive flexibility</a>, abstract thinking, rule acquisition, <a href="/wiki/Inhibitory_control" title="Inhibitory control">inhibiting inappropriate actions</a>, initiating appropriate actions, <a href="/wiki/Working_memory" title="Working memory">working memory</a>, and <a href="/wiki/Attentional_control" title="Attentional control">control of attention</a>.<sup id="cite_ref-pmid18175397_42-1" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup><sup id="cite_ref-PD_timing_review_43-0" class="reference"><a href="#cite_note-PD_timing_review-43">&#91;43&#93;</a></sup> Other cognitive difficulties include <a href="/wiki/Bradyphrenia" title="Bradyphrenia">slowed cognitive processing speed</a>, impaired <a href="/wiki/Recall_(memory)" title="Recall (memory)">recall</a>, and impaired perception and estimation of time.<sup id="cite_ref-pmid18175397_42-2" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup><sup id="cite_ref-PD_timing_review_43-1" class="reference"><a href="#cite_note-PD_timing_review-43">&#91;43&#93;</a></sup> Nevertheless, improvement appears when recall is aided by cues.<sup id="cite_ref-pmid18175397_42-3" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup> Visuospatial difficulties are also part of the disease, seen for example when the individual is asked to perform tests of facial recognition and perception of the orientation of drawn lines.<sup id="cite_ref-pmid18175397_42-4" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup><sup id="cite_ref-PD_timing_review_43-2" class="reference"><a href="#cite_note-PD_timing_review-43">&#91;43&#93;</a></sup>
</p><p>A person with PD has two to six times the risk of dementia compared to the general population.<sup id="cite_ref-Jankovic2008_31-12" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup><sup id="cite_ref-pmid18175397_42-5" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup> Up to 78% of people with PD have Parkinson's disease dementia.<sup id="cite_ref-Gomperts2016_44-0" class="reference"><a href="#cite_note-Gomperts2016-44">&#91;44&#93;</a></sup> The prevalence of dementia increases with age, and to a lesser degree, duration of the disease.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup> Dementia is associated with a reduced <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> in people with PD and their <a href="/wiki/Caregiver" title="Caregiver">caregivers</a>, increased mortality, and a higher probability of needing <a href="/wiki/Nursing_home_care" class="mw-redirect" title="Nursing home care">nursing home care</a>.<sup id="cite_ref-pmid18175397_42-6" class="reference"><a href="#cite_note-pmid18175397-42">&#91;42&#93;</a></sup>
</p><p>Impulse-control disorders, including pathological gambling, compulsive sexual behavior, binge eating, compulsive shopping, and reckless generosity, can be caused by medication, particularly orally active dopamine agonists. The <a href="/wiki/Dopamine_dysregulation_syndrome" title="Dopamine dysregulation syndrome">dopamine dysregulation syndrome</a> – with wanting of medication leading to overuse – is a rare complication of levodopa use.<sup id="cite_ref-Noyce_46-0" class="reference"><a href="#cite_note-Noyce-46">&#91;46&#93;</a></sup>
</p><p><a href="/wiki/Punding" title="Punding">Punding</a>, in which complicated, repetitive, aimless, <a href="/wiki/Stereotypy" title="Stereotypy">stereotyped behaviors</a> occur for many hours, is another disturbance caused by anti-Parkinson medication.
</p>
<h3><span class="mw-headline" id="Psychosis">Psychosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=5" title="Edit section: Psychosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Psychosis" title="Psychosis">Psychosis</a> can be considered a symptom with a prevalence at its widest range from 26 to 83%.<sup id="cite_ref-:5_10-1" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup><sup id="cite_ref-47" class="reference"><a href="#cite_note-47">&#91;47&#93;</a></sup> <a href="/wiki/Hallucination" title="Hallucination">Hallucinations</a> or <a href="/wiki/Delusion" title="Delusion">delusions</a> occur in about 50% of people with PD over the course of the illness, and may herald the emergence of dementia. These range from minor hallucinations – "sense of passage" (something quickly passing beside the person) or "sense of presence" (the perception of something/someone standing just to the side or behind the person) – to full blown vivid, <a href="/wiki/Positive_visual_phenomena#Hallucinations" title="Positive visual phenomena">formed visual hallucinations</a> and <a href="/wiki/Paranoid" class="mw-redirect" title="Paranoid">paranoid</a> ideation. Auditory hallucinations are uncommon in PD, and are rarely described as voices. Psychosis is now believed to be an integral part of the disease. A psychosis with delusions and associated <a href="/wiki/Delirium" title="Delirium">delirium</a> is a recognized complication of anti-Parkinson drug treatment and may also be caused by urinary-tract infections (as frequently occurs in the fragile elderly), but drugs and infection are not the only factors, and underlying brain pathology or changes in neurotransmitters or their receptors (e.g., acetylcholine, serotonin) are also thought to play a role in psychosis in PD.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;48&#93;</a></sup><sup id="cite_ref-pmid20538500_49-0" class="reference"><a href="#cite_note-pmid20538500-49">&#91;49&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Behavior_and_mood">Behavior and mood</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=6" title="Edit section: Behavior and mood">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Behavior and mood alterations are more common in PD without cognitive impairment than in the general population, and are usually present in PD with dementia. The most frequent mood difficulties are <a href="/wiki/Depression_(mood)" title="Depression (mood)">depression</a>, <a href="/wiki/Apathy" title="Apathy">apathy</a>, and <a href="/wiki/Anxiety" title="Anxiety">anxiety</a>.<sup id="cite_ref-Jankovic2008_31-13" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup>
</p><p>Depression has been estimated to appear in 20 to 35% of people with PD, and can appear at any stage of the disease. It can manifest with symptoms that are common to the disease process (fatigue, insomnia, and difficulty with concentration), which makes diagnosis difficult. The imbalance and changes in <a href="/wiki/Dopamine" title="Dopamine">dopamine</a>, <a href="/wiki/Serotonin" title="Serotonin">serotonin</a>, and <a href="/wiki/Norepinephrine" title="Norepinephrine">noradrenergic</a> hormones are known to be a primary cause of depression in PD-affected people.<sup id="cite_ref-:5_10-2" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup> Another cause is the functional impairment that is caused by the disease.<sup id="cite_ref-:6_50-0" class="reference"><a href="#cite_note-:6-50">&#91;50&#93;</a></sup> Symptoms of depression can include loss of interest, sadness, guilt, feelings of helplessness/hopelessness/guilt, and suicidal ideation. <a href="/wiki/Suicidal_ideation" title="Suicidal ideation">Suicidal ideation</a> in PD-affected people is higher than in the general population, but suicidal attempts themselves are lower than in people with depression without PD.<sup id="cite_ref-:5_10-3" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup><sup id="cite_ref-:6_50-1" class="reference"><a href="#cite_note-:6-50">&#91;50&#93;</a></sup> Risk factors for depression in PD can include disease onset under age 50, being a woman, previous history of depression, severe motor symptoms, and others.<sup id="cite_ref-:5_10-4" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup>
</p><p><a href="/wiki/Anxiety_disorder" title="Anxiety disorder">Anxiety</a> has been estimated to have a prevalence in PD-affected people usually around 30–40% (60% has been found).<sup id="cite_ref-:5_10-5" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup><sup id="cite_ref-:6_50-2" class="reference"><a href="#cite_note-:6-50">&#91;50&#93;</a></sup> Anxiety can often be found during "off" periods (times when medication is not working as well as it did before) with PD-affected people suffering from panic attacks more frequently compared to the general population. Both anxiety and depression have been found to be associated with decreased quality of life.<sup id="cite_ref-:5_10-6" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup><sup id="cite_ref-:7_51-0" class="reference"><a href="#cite_note-:7-51">&#91;51&#93;</a></sup> Symptoms can range from mild and episodic to chronic with potential causes being abnormal <a href="/wiki/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">gamma-aminobutyric acid</a> levels and embarrassment or fear about symptoms or disease.<sup id="cite_ref-:5_10-7" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup><sup id="cite_ref-:7_51-1" class="reference"><a href="#cite_note-:7-51">&#91;51&#93;</a></sup> Risk factors for anxiety in PD are disease onset under age 50, women, and "off" periods.<sup id="cite_ref-:5_10-8" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup>
</p><p><a href="/wiki/Apathy" title="Apathy">Apathy</a> and <a href="/wiki/Anhedonia" title="Anhedonia">anhedonia</a> can be defined as a loss of motivation and an impaired ability to experience pleasure, respectively. They are symptoms classically associated with depression, but they differ in PD-affected people in treatment and mechanism, and do not always occur with depression. Apathy presents in around 16.5–40%. Symptoms of apathy include reduced initiative/interests in new activities or the world around them, emotional indifference, and loss of affection or concern for others.<sup id="cite_ref-:5_10-9" class="reference"><a href="#cite_note-:5-10">&#91;10&#93;</a></sup> Apathy is associated with deficits in cognitive functions including executive and verbal memory.<sup id="cite_ref-:6_50-3" class="reference"><a href="#cite_note-:6-50">&#91;50&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Other">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=7" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Sleep_disorder" title="Sleep disorder">Sleep disorders</a> are a feature of the disease and can be worsened by medications.<sup id="cite_ref-Jankovic2008_31-14" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> Symptoms can manifest as daytime <a href="/wiki/Somnolence" title="Somnolence">drowsiness</a> (including sudden sleep attacks resembling <a href="/wiki/Narcolepsy" title="Narcolepsy">narcolepsy</a>), disturbances in <a href="/wiki/Rapid_eye_movement_sleep" title="Rapid eye movement sleep">Rapid eye movement sleep</a>, or <a href="/wiki/Insomnia" title="Insomnia">insomnia</a>.<sup id="cite_ref-Jankovic2008_31-15" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> <a href="/wiki/Rapid_eye_movement_sleep_behavior_disorder" title="Rapid eye movement sleep behavior disorder">REM behavior disorder</a>, in which people act out dreams, sometimes injuring themselves or their bed partner, may begin many years before the development of motor or cognitive features of PD or <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">dementia with Lewy bodies</a>.<sup id="cite_ref-52" class="reference"><a href="#cite_note-52">&#91;52&#93;</a></sup>
</p><p>Alterations in the autonomic nervous system can lead to <a href="/wiki/Orthostatic_hypotension" title="Orthostatic hypotension">orthostatic hypotension</a> (low blood pressure upon standing), <a href="/wiki/Seborrhea" class="mw-redirect" title="Seborrhea">oily skin</a>, excessive sweating, <a href="/wiki/Urinary_incontinence" title="Urinary incontinence">urinary incontinence</a>, and altered sexual function.<sup id="cite_ref-Jankovic2008_31-16" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> <a href="/wiki/Constipation" title="Constipation">Constipation</a> and <a href="/wiki/Intestinal_pseudoobstruction" class="mw-redirect" title="Intestinal pseudoobstruction">impaired stomach emptying</a> (gastric dysmotility) can be severe enough to cause discomfort and even endanger health.<sup id="cite_ref-pmid19691125_17-1" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> Changes in perception may include an impaired sense of smell, disturbed vision, pain, and <a href="/wiki/Paresthesia" title="Paresthesia">paresthesia</a> (tingling and numbness).<sup id="cite_ref-Jankovic2008_31-17" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> All of these symptoms can occur years before diagnosis of the disease.<sup id="cite_ref-Jankovic2008_31-18" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=8" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Causes_of_Parkinson%27s_disease" title="Causes of Parkinson&#39;s disease">Causes of Parkinson's disease</a></div>
<p>Many risk factors have been proposed, sometimes in relation to theories concerning possible mechanisms of the disease; however, none has been proven conclusively.<sup id="cite_ref-pmid16713924_53-0" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup> The most frequently replicated relationships are an increased risk in those exposed to pesticides, and a reduced risk in smokers.<sup id="cite_ref-pmid16713924_53-1" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup><sup id="cite_ref-Barreto2015_54-0" class="reference"><a href="#cite_note-Barreto2015-54">&#91;54&#93;</a></sup> A possible link exists between PD and <i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i> infection that can prevent the absorption of some drugs, including levodopa.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup><sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Genetic">Genetic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=9" title="Edit section: Genetic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Structure_of_parkin.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/72/Structure_of_parkin.png/220px-Structure_of_parkin.png" decoding="async" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/72/Structure_of_parkin.png/330px-Structure_of_parkin.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/72/Structure_of_parkin.png/440px-Structure_of_parkin.png 2x" data-file-width="1280" data-file-height="960" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Structure_of_parkin.png" class="internal" title="Enlarge"></a></div>Parkin crystal structure</div></div></div>
<p>Research indicates that PD is the product of a complex interaction of genetic and <a href="/wiki/Environmental_factor" title="Environmental factor">environmental factors</a>.<sup id="cite_ref-Lancet2015_4-9" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> Around 15% of individuals with PD have a <a href="/wiki/First-degree_relatives" class="mw-redirect" title="First-degree relatives">first-degree relative</a> who has the disease,<sup id="cite_ref-pmid15172778_16-3" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup> and 5–10% of people with PD are known to have forms of the disease that occur because of a <a href="/wiki/Mutation" title="Mutation">mutation</a> in one of several specific genes.<sup id="cite_ref-lesage_57-0" class="reference"><a href="#cite_note-lesage-57">&#91;57&#93;</a></sup><sup id="cite_ref-:8_58-0" class="reference"><a href="#cite_note-:8-58">&#91;58&#93;</a></sup> Harboring one of these gene mutations may not lead to the disease; susceptibility factors put the individual at an increased risk, often in combination with other risk factors, which also affect age of onset, severity and progression.<sup id="cite_ref-lesage_57-1" class="reference"><a href="#cite_note-lesage-57">&#91;57&#93;</a></sup> At least 11 <a href="/wiki/Autosomal_dominant" class="mw-redirect" title="Autosomal dominant">autosomal dominant</a> and 9 <a href="/wiki/Autosomal_recessive" class="mw-redirect" title="Autosomal recessive">autosomal recessive</a> <a href="/wiki/Gene_mutation" class="mw-redirect" title="Gene mutation">gene mutations</a> have been implicated in the development of PD. The autosomal dominant genes include <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein"><i>SNCA</i></a>,<i> <a href="/wiki/PARK3" title="PARK3">PARK3</a></i>, <a href="/wiki/Ubiquitin_carboxy-terminal_hydrolase_L1" title="Ubiquitin carboxy-terminal hydrolase L1"><i>UCHL1</i></a>, <i><a href="/wiki/LRRK2" title="LRRK2">LRRK2</a></i>, <a href="/wiki/TNRC15" title="TNRC15"><i>GIGYF2</i></a>, <a href="/wiki/HtrA_serine_peptidase_2" title="HtrA serine peptidase 2"><i>HTRA2</i></a>, <a href="/wiki/Eukaryotic_translation_initiation_factor_4_gamma_1" title="Eukaryotic translation initiation factor 4 gamma 1"><i>EIF4G1</i></a>, <i><a href="/wiki/TMEM230" title="TMEM230">TMEM230</a></i>, <i><a href="/wiki/CHCHD2" title="CHCHD2">CHCHD2</a></i>, <i><a href="/wiki/RIC3" title="RIC3">RIC3</a></i>, and  <i><a href="/wiki/VPS35" title="VPS35">VPS35</a></i>. Autosomal recessive genes include <i><a href="/wiki/Parkin_(ligase)" class="mw-redirect" title="Parkin (ligase)">PRKN</a>, <a href="/wiki/PINK1" title="PINK1">PINK1</a>, <a href="/wiki/PARK7" title="PARK7">PARK7</a>, <a href="/wiki/ATP13A2" title="ATP13A2">ATP13A2</a>, <a href="/wiki/PLA2G6" title="PLA2G6">PLA2G6</a>, <a href="/wiki/FBXO7" title="FBXO7">FBXO7</a>, <a href="/wiki/Auxilin" title="Auxilin">DNAJC6</a>, <a href="/wiki/SYNJ1" class="mw-redirect" title="SYNJ1">SYNJ1</a>,</i> and <i><a href="/w/index.php?title=VPS13C&amp;action=edit&amp;redlink=1" class="new" title="VPS13C (page does not exist)">VPS13C</a></i>. Some genes are <a href="/wiki/Sex_linkage" title="Sex linkage">X-linked</a> or have unknown inheritance pattern; those include <i><a href="/w/index.php?title=PARK10&amp;action=edit&amp;redlink=1" class="new" title="PARK10 (page does not exist)">PARK10</a>, <a href="/w/index.php?title=PARK12&amp;action=edit&amp;redlink=1" class="new" title="PARK12 (page does not exist)">PARK12</a></i>, and <i><a href="/w/index.php?title=PARK16&amp;action=edit&amp;redlink=1" class="new" title="PARK16 (page does not exist)">PARK16</a></i>. A <a href="/wiki/DiGeorge_syndrome" title="DiGeorge syndrome">22q11</a> deletion is also known to be associated with PD.<sup id="cite_ref-59" class="reference"><a href="#cite_note-59">&#91;59&#93;</a></sup><sup id="cite_ref-:8_58-1" class="reference"><a href="#cite_note-:8-58">&#91;58&#93;</a></sup> An <a href="/wiki/Autosomal_dominant" class="mw-redirect" title="Autosomal dominant">autosomal dominant</a> form has been associated with mutations in the<i> <a href="/wiki/LRP10" title="LRP10">LRP10</a></i> gene.<sup id="cite_ref-Quadri2018_12-1" class="reference"><a href="#cite_note-Quadri2018-12">&#91;12&#93;</a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup>
</p><p>About 5% of people with PD have mutations in the <i><a href="/wiki/GBA1" class="mw-redirect" title="GBA1">GBA1</a></i> gene.<sup id="cite_ref-Stoker2018_61-0" class="reference"><a href="#cite_note-Stoker2018-61">&#91;61&#93;</a></sup> These mutations are present in less than 1% of the unaffected population. The risk of developing PD is increased 20–30 fold if these mutations are present. PD associated with these mutations has the same clinical features, but an earlier age of onset and a more rapid cognitive and motor decline. This gene encodes <a href="/wiki/Glucocerebrosidase" title="Glucocerebrosidase">glucocerebrosidase</a>. Low levels of this enzyme cause <a href="/wiki/Gaucher%27s_disease" title="Gaucher&#39;s disease">Gaucher's disease</a>.
</p><p><i>SNCA</i> gene mutations are important in PD because the protein this gene encodes, <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>, is the main component of the <a href="/wiki/Lewy_body" title="Lewy body">Lewy bodies</a> that accumulate in the brains of people with PD.<sup id="cite_ref-lesage_57-2" class="reference"><a href="#cite_note-lesage-57">&#91;57&#93;</a></sup> Alpha-synuclein activates <a href="/wiki/Ataxia_telangiectasia_mutated" class="mw-redirect" title="Ataxia telangiectasia mutated">ataxia telangiectasia mutated</a>, a major <a href="/wiki/DNA_damage_(naturally_occurring)" title="DNA damage (naturally occurring)">DNA damage</a>-repair signaling <a href="/wiki/Kinase" title="Kinase">kinase</a>.<sup id="cite_ref-Abugable2019_62-0" class="reference"><a href="#cite_note-Abugable2019-62">&#91;62&#93;</a></sup> In addition, alpha-synuclein activates the <a href="/wiki/Non-homologous_end_joining" title="Non-homologous end joining">non-homologous end joining</a> <a href="/wiki/DNA_repair" title="DNA repair">DNA repair</a> pathway. The aggregation of alpha-synuclein in Lewy bodies appears to be a link between reduced <a href="/wiki/DNA_repair" title="DNA repair">DNA repair</a> and brain-cell death in PD.<sup id="cite_ref-Abugable2019_62-1" class="reference"><a href="#cite_note-Abugable2019-62">&#91;62&#93;</a></sup>
</p><p>Mutations in some genes, including <i>SNCA</i>, <i>LRRK2</i>, and <i>GBA</i>, have been found to be risk factors for "sporadic" (nonfamilial) PD.<sup id="cite_ref-lesage_57-3" class="reference"><a href="#cite_note-lesage-57">&#91;57&#93;</a></sup> Mutations in the gene <i>LRRK2</i> are the most common known cause of familial and sporadic PD, accounting for around 5% of individuals with a family history of the disease and 3% of sporadic cases.<sup id="cite_ref-pmid18398010_63-0" class="reference"><a href="#cite_note-pmid18398010-63">&#91;63&#93;</a></sup><sup id="cite_ref-lesage_57-4" class="reference"><a href="#cite_note-lesage-57">&#91;57&#93;</a></sup> A mutation in <i>GBA</i> presents the greatest genetic risk of developing Parkinsons disease.<sup id="cite_ref-pmid25904081_64-0" class="reference"><a href="#cite_note-pmid25904081-64">&#91;64&#93;</a></sup>
</p><p>Several Parkinson-related genes are involved in the function of <a href="/wiki/Lysosome" title="Lysosome">lysosomes</a>, organelles that digest cellular waste products. Some cases of PD may be caused by <a href="/wiki/Lysosomal_storage_disease" title="Lysosomal storage disease">lysosomal disorders</a> that reduce the ability of cells to break down alpha-synuclein.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">&#91;65&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Non-genetic">Non-genetic</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=10" title="Edit section: Non-genetic">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Exposure to <a href="/wiki/Pesticides" class="mw-redirect" title="Pesticides">pesticides</a> and a history of head injury have each been linked with PD, but the risks are modest. Never drinking caffeinated beverages is also associated with small increases in risk of developing PD.<sup id="cite_ref-Noyce_46-1" class="reference"><a href="#cite_note-Noyce-46">&#91;46&#93;</a></sup> Some toxins can cause parkinsonism, including <a href="/wiki/Manganese" title="Manganese">manganese</a> and <a href="/wiki/Carbon_disulfide" title="Carbon disulfide">carbon disulfide</a>.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">&#91;66&#93;</a></sup><sup id="cite_ref-:0_67-0" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-68" class="reference"><a href="#cite_note-68">&#91;68&#93;</a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;69&#93;</a></sup>
</p><p>Medical drugs implicated in cases of parkinsonism. Drug-induced parkinsonism is normally reversible by stopping the offending agent,<sup id="cite_ref-:0_67-1" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup> such as <a href="/wiki/Phenothiazine" title="Phenothiazine">phenothiazines</a> (chlorpromazine, promazine, etc.); <a href="/wiki/Butyrophenone" title="Butyrophenone">butyrophenones</a> (haloperidol, benperidol, etc.); <a href="/wiki/Metoclopramide" title="Metoclopramide">metoclopramide</a> and <a href="/wiki/Tetrabenazine" title="Tetrabenazine">Tetrabenazine</a>. <a href="/wiki/MPTP" title="MPTP">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine</a> (MPTP) is a drug known for causing irreversible parkinsonism that is commonly used in animal-model research.<sup id="cite_ref-:0_67-2" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-70" class="reference"><a href="#cite_note-70">&#91;70&#93;</a></sup><sup id="cite_ref-71" class="reference"><a href="#cite_note-71">&#91;71&#93;</a></sup>
</p><p>Low concentrations of <a href="/wiki/Uric_acid" title="Uric acid">urate</a> in the blood is associated with an increased risk of PD.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">&#91;72&#93;</a></sup>
</p><p>Other identifiable causes of parkinsonism include infections and metabolic derangement. Several <a href="/wiki/Neurodegenerative_disorders" class="mw-redirect" title="Neurodegenerative disorders">neurodegenerative disorders</a> also may present with parkinsonism, and are sometimes referred to as "atypical parkinsonism" or <a href="/wiki/Parkinson-plus_syndrome" title="Parkinson-plus syndrome">"Parkinson plus"</a> syndromes (illnesses with parkinsonism plus some other features distinguishing them from PD). They include <a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a>, <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a>, <a href="/wiki/Corticobasal_degeneration" title="Corticobasal degeneration">corticobasal degeneration</a>, and dementia with Lewy bodies.<sup id="cite_ref-pmid15172778_16-4" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup><sup id="cite_ref-pmid205063122_73-0" class="reference"><a href="#cite_note-pmid205063122-73">&#91;73&#93;</a></sup> Dementia with Lewy bodies is another synucleinopathy and it has close pathological similarities with PD, especially with the subset of PD cases with <a href="/wiki/Dementia" title="Dementia">dementia</a> known as <a href="/wiki/Parkinson%27s_disease_dementia" title="Parkinson&#39;s disease dementia">Parkinson's disease dementia</a>. The relationship between PD and DLB is complex and incompletely understood.<sup id="cite_ref-pmid191737622_74-0" class="reference"><a href="#cite_note-pmid191737622-74">&#91;74&#93;</a></sup> They may represent parts of a continuum, with variable distinguishing clinical and pathological features, or they may prove to be separate diseases.<sup id="cite_ref-pmid191737622_74-1" class="reference"><a href="#cite_note-pmid191737622-74">&#91;74&#93;</a></sup>
</p><p>Vascular parkinsonism is the phenomenon of the presence of Parkinson's disease symptoms combined with findings of vascular events (such as a <a href="/wiki/Stroke" title="Stroke">cerebral stroke</a>). The damaging of the <a href="/wiki/Dopaminergic_pathways" title="Dopaminergic pathways">dopaminergic pathways</a> is similar in cause for both vascular parkinsonism and idiopathic PD, so they can present with many of the same symptoms. Differentiation can be made with careful bedside examination, history evaluation, and imaging.<sup id="cite_ref-75" class="reference"><a href="#cite_note-75">&#91;75&#93;</a></sup><sup id="cite_ref-:0_67-3" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-76" class="reference"><a href="#cite_note-76">&#91;76&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=11" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Lewy_Body_alphaSynuclein.jpg" class="image"><img alt="Several brain cells stained in blue. The largest one, a neurone, with an approximately circular form, has a brown circular body inside it. The brown body is about 40% the diameter of the cell in which it appears." src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Lewy_Body_alphaSynuclein.jpg/220px-Lewy_Body_alphaSynuclein.jpg" decoding="async" width="220" height="182" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Lewy_Body_alphaSynuclein.jpg/330px-Lewy_Body_alphaSynuclein.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Lewy_Body_alphaSynuclein.jpg/440px-Lewy_Body_alphaSynuclein.jpg 2x" data-file-width="631" data-file-height="523" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Lewy_Body_alphaSynuclein.jpg" class="internal" title="Enlarge"></a></div>A <a href="/wiki/Lewy_body" title="Lewy body">Lewy body</a> (stained brown) in a brain cell of the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> in Parkinson's disease: The brown colour is positive <a href="/wiki/Immunohistochemistry" title="Immunohistochemistry">immunohistochemistry</a> staining for <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>.</div></div></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Pathophysiology_of_Parkinson%27s_disease" title="Pathophysiology of Parkinson&#39;s disease">Pathophysiology of Parkinson's disease</a></div>
<p>The main <a href="/wiki/Pathology" title="Pathology">pathological</a> characteristics of PD are cell death in the brain's <a href="/wiki/Basal_ganglia" title="Basal ganglia">basal ganglia</a> (affecting up to 70% of the <a href="/wiki/Dopaminergic" title="Dopaminergic">dopamine-secreting</a> neurons in the <a href="/wiki/Substantia_nigra" title="Substantia nigra">substantia nigra</a> <a href="/wiki/Pars_compacta" title="Pars compacta">pars compacta</a> by the end of life).<sup id="cite_ref-pmid18398010_63-1" class="reference"><a href="#cite_note-pmid18398010-63">&#91;63&#93;</a></sup> In Parkinson's disease, alpha-synuclein becomes <a href="/wiki/Protein_folding" title="Protein folding">misfolded</a> and <a href="/wiki/Protein_aggregation" title="Protein aggregation">clump together</a> with other alpha-synuclein. Cells are unable to remove these clumps, and the alpha-synuclein becomes <a href="/wiki/Cytotoxicity" title="Cytotoxicity">cytotoxic</a>, damaging the cells.<sup id="cite_ref-:9_11-1" class="reference"><a href="#cite_note-:9-11">&#91;11&#93;</a></sup><sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;77&#93;</a></sup> These clumps can be seen in neurons under a microscope and are called Lewy bodies. Loss of neurons is accompanied by the death of <a href="/wiki/Astrocyte" title="Astrocyte">astrocytes</a> (star-shaped <a href="/wiki/Neuroglia" class="mw-redirect" title="Neuroglia">glial</a> cells) and a significant increase in the number of <a href="/wiki/Microglia" title="Microglia">microglia</a> (another type of glial cell) in the substantia nigra.<sup id="cite_ref-Jankovic_book-Neuropathology_78-0" class="reference"><a href="#cite_note-Jankovic_book-Neuropathology-78">&#91;78&#93;</a></sup> <a href="/wiki/Braak_staging" title="Braak staging">Braak staging</a> is a way to explain the progression of the parts of the brain affected by PD. According to this staging, PD starts in the medulla and the olfactory bulb before moving to the substantia nigra pars compacta and the rest of the midbrain/basal forebrain. Movement symptom onset is associated when the disease begins to affect the substantia nigra pars compacta.<sup id="cite_ref-:1_14-3" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Journal.pone.0008247.g001.png" class="image"><img alt="Composite of three images, one in the top row (referred to in caption as A), two in the second row (referred to as B). Top shows a mid-line sagittal plane of the brainstem and cerebellum. There are three circles superimposed along the brainstem and an arrow linking them from bottom to top and continuing upward and forward towards the frontal lobes of the brain. A line of text accompanies each circle: lower is &quot;1. Dorsal Motor X Nucleus&quot;, middle is &quot;2. Gain Setting Nuclei&quot; and upper is &quot;3. Substantia Nigra/Amygdala&quot;. The fourth line of text above the others says &quot;4. ...&quot;. The two images at the bottom of the composite are magnetic resonance imaging (MRI) scans, one sagittal and the other transverse, centred at the same brain coordinates (x=-1, y=-36, z=-49). A colored blob marking volume reduction covers most of the brainstem." src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Journal.pone.0008247.g001.png/220px-Journal.pone.0008247.g001.png" decoding="async" width="220" height="210" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Journal.pone.0008247.g001.png/330px-Journal.pone.0008247.g001.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c7/Journal.pone.0008247.g001.png/440px-Journal.pone.0008247.g001.png 2x" data-file-width="1958" data-file-height="1868" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Journal.pone.0008247.g001.png" class="internal" title="Enlarge"></a></div><div><ol style="list-style-type:upper-alpha"><li>Schematic initial progression of Lewy body deposits in the first stages of PD, as proposed by Braak and colleagues</li><li>Localization of the area of significant brain <a href="/wiki/Voxel-based_morphometry" title="Voxel-based morphometry">volume reduction</a> in initial PD compared with a group of participants without the disease in a neuroimaging study, which concluded that <a href="/wiki/Brainstem" title="Brainstem">brainstem</a> damage may be the first identifiable stage of PD <a href="/wiki/Neuropathology" title="Neuropathology">neuropathology</a><sup id="cite_ref-pmid20011063_79-0" class="reference"><a href="#cite_note-pmid20011063-79">&#91;79&#93;</a></sup></li></ol></div></div></div></div>
<p>Five major pathways in the brain connect other brain areas with the basal ganglia. These are known as the <a href="/wiki/Motor_cortex" title="Motor cortex">motor</a>, <a href="/wiki/Frontal_eye_fields" title="Frontal eye fields">oculomotor</a>, <a href="/wiki/Cerebral_cortex#Association_areas" title="Cerebral cortex">associative</a>, <a href="/wiki/Limbic_system" title="Limbic system">limbic</a>, and <a href="/wiki/Orbitofrontal_cortex" title="Orbitofrontal cortex">orbitofrontal</a> circuits, with names indicating the main projection area of each circuit.<sup id="cite_ref-pmid18781672_80-0" class="reference"><a href="#cite_note-pmid18781672-80">&#91;80&#93;</a></sup> All of them are affected in PD, and their disruption explains many of the symptoms of the disease, since these circuits are involved in a wide variety of functions, including movement, attention and learning.<sup id="cite_ref-pmid18781672_80-1" class="reference"><a href="#cite_note-pmid18781672-80">&#91;80&#93;</a></sup> Scientifically, the motor circuit has been examined the most intensively.<sup id="cite_ref-pmid18781672_80-2" class="reference"><a href="#cite_note-pmid18781672-80">&#91;80&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Dopaminergic_pathways.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Dopaminergic_pathways.svg/220px-Dopaminergic_pathways.svg.png" decoding="async" width="220" height="151" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Dopaminergic_pathways.svg/330px-Dopaminergic_pathways.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d8/Dopaminergic_pathways.svg/440px-Dopaminergic_pathways.svg.png 2x" data-file-width="446" data-file-height="307" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Dopaminergic_pathways.svg" class="internal" title="Enlarge"></a></div>An illustration of the dopamine pathways throughout the brain.</div></div></div>
<p>A particular conceptual model of the motor circuit and its alteration with PD has been of great influence since 1980, although some limitations have been pointed out which have led to modifications.<sup id="cite_ref-pmid18781672_80-3" class="reference"><a href="#cite_note-pmid18781672-80">&#91;80&#93;</a></sup> In this model, the basal ganglia normally exert a constant inhibitory influence on a wide range of motor systems, preventing them from becoming active at inappropriate times. When a decision is made to perform a particular action, <a href="/wiki/Inhibitory_postsynaptic_potential" title="Inhibitory postsynaptic potential">inhibition</a> is reduced for the required motor system, thereby releasing it for activation. Dopamine acts to facilitate this release of inhibition, so high levels of dopamine function tend to promote motor activity, while low levels of dopamine function, such as occur in PD, demand greater exertions of effort for any given movement. Thus, the net effect of dopamine depletion is to produce <a href="/wiki/Hypokinesia" title="Hypokinesia">hypokinesia</a>, an overall reduction in motor output.<sup id="cite_ref-pmid18781672_80-4" class="reference"><a href="#cite_note-pmid18781672-80">&#91;80&#93;</a></sup> Drugs that are used to treat PD, conversely, may produce excessive dopamine activity, allowing motor systems to be activated at inappropriate times and thereby producing <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesias</a>.<sup id="cite_ref-pmid18781672_80-5" class="reference"><a href="#cite_note-pmid18781672-80">&#91;80&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Brain_cell_death">Brain cell death</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=12" title="Edit section: Brain cell death">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Brain cells could be lost by several proposed mechanisms.<sup id="cite_ref-pmid20495568_81-0" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> One mechanism consists of an abnormal accumulation of the protein alpha-synuclein bound to <a href="/wiki/Ubiquitin" title="Ubiquitin">ubiquitin</a> in the damaged cells. This insoluble protein accumulates inside neurons forming <a href="/wiki/Inclusion_bodies" title="Inclusion bodies">inclusions</a> called Lewy bodies.<sup id="cite_ref-pmid18398010_63-2" class="reference"><a href="#cite_note-pmid18398010-63">&#91;63&#93;</a></sup><sup id="cite_ref-pmid20563819_82-0" class="reference"><a href="#cite_note-pmid20563819-82">&#91;82&#93;</a></sup> According to the Braak staging, a classification of the disease based on pathological findings proposed by <a href="/wiki/Heiko_Braak" title="Heiko Braak">Heiko Braak</a>, Lewy bodies first appear in the <a href="/wiki/Olfactory_bulb" title="Olfactory bulb">olfactory bulb</a>, <a href="/wiki/Medulla_oblongata" title="Medulla oblongata">medulla oblongata</a>, and <a href="/wiki/Pontine_tegmentum" title="Pontine tegmentum">pontine tegmentum</a>; individuals at this stage may be asymptomatic or may have early nonmotor symptoms (such as loss of sense of smell, or some sleep or automatic dysfunction). As the disease progresses, Lewy bodies develop in the substantia nigra, areas of the <a href="/wiki/Midbrain" title="Midbrain">midbrain</a> and basal <a href="/wiki/Forebrain" title="Forebrain">forebrain</a>, and finally, the <a href="/wiki/Neocortex" title="Neocortex">neocortex</a>.<sup id="cite_ref-pmid18398010_63-3" class="reference"><a href="#cite_note-pmid18398010-63">&#91;63&#93;</a></sup> These brain sites are the main places of neuronal degeneration in PD, but Lewy bodies may not cause cell death and they may be protective (with the abnormal protein sequestered or walled off). Other forms of alpha-synuclein (e.g., <a href="/wiki/Oligomer" title="Oligomer">oligomers</a>) that are not aggregated in Lewy bodies and <a href="/wiki/Lewy_body" title="Lewy body">Lewy neurites</a> may actually be the toxic forms of the protein.<sup id="cite_ref-pmid20495568_81-1" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup><sup id="cite_ref-pmid20563819_82-1" class="reference"><a href="#cite_note-pmid20563819-82">&#91;82&#93;</a></sup> In people with dementia, a generalized presence of Lewy bodies is common in cortical areas. <a href="/wiki/Neurofibrillary_tangle" title="Neurofibrillary tangle">Neurofibrillary tangles</a> and <a href="/wiki/Senile_plaques" class="mw-redirect" title="Senile plaques">senile plaques</a>, characteristic of Alzheimer's disease, are not common unless the person is demented.<sup id="cite_ref-Jankovic_book-Neuropathology_78-1" class="reference"><a href="#cite_note-Jankovic_book-Neuropathology-78">&#91;78&#93;</a></sup>
</p><p>Other cell-death mechanisms include <a href="/wiki/Proteasome" title="Proteasome">proteasomal</a> and <a href="/wiki/Lysosome" title="Lysosome">lysosomal</a> systems dysfunction and reduced <a href="/wiki/Mitochondrion" title="Mitochondrion">mitochondrial</a> activity.<sup id="cite_ref-pmid20495568_81-2" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> Iron accumulation in the substantia nigra is typically observed in conjunction with the protein inclusions. It may be related to <a href="/wiki/Oxidative_stress" title="Oxidative stress">oxidative stress</a>, <a href="/wiki/Protein_aggregation" title="Protein aggregation">protein aggregation</a>, and neuronal death, but the mechanisms are not fully understood.<sup id="cite_ref-pmid20082992_83-0" class="reference"><a href="#cite_note-pmid20082992-83">&#91;83&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=13" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>A physician initially assesses for PD with a careful <a href="/wiki/Medical_history" title="Medical history">medical history</a> and <a href="/wiki/Neurological_examination" title="Neurological examination">neurological examination</a>.<sup id="cite_ref-Jankovic2008_31-19" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup>  Focus is put on confirming motor symptoms (bradykinesia, rest tremor, etc.) and supporting tests with clinical diagnostic criteria. The finding of Lewy bodies in the midbrain on <a href="/wiki/Autopsy" title="Autopsy">autopsy</a> is usually considered final proof that the person had PD. The clinical course of the illness over time may reveal it is not PD, requiring that the clinical presentation be periodically reviewed to confirm the accuracy of the diagnosis.<sup id="cite_ref-Jankovic2008_31-20" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup><sup id="cite_ref-Nice-Diagnosis_84-0" class="reference"><a href="#cite_note-Nice-Diagnosis-84">&#91;84&#93;</a></sup>
</p><p>Multiple causes can occur for parkinsonism or diseases that look similar. <a href="/wiki/Stroke" title="Stroke">Stroke</a>, certain medications, and toxins can cause "secondary parkinsonism" and need to be assessed during visit.<sup id="cite_ref-:1_14-4" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup><sup id="cite_ref-Nice-Diagnosis_84-1" class="reference"><a href="#cite_note-Nice-Diagnosis-84">&#91;84&#93;</a></sup> <a href="/wiki/Parkinson-plus_syndrome" title="Parkinson-plus syndrome">Parkinson-plus syndromes</a>, such as <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a> and <a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a>, must also be considered and <a href="/wiki/Differential_diagnosis" title="Differential diagnosis">ruled out</a> appropriately due to different treatment and disease progression (anti-Parkinson's medications are typically less effective at controlling symptoms in Parkinson-plus syndromes).<sup id="cite_ref-Jankovic2008_31-21" class="reference"><a href="#cite_note-Jankovic2008-31">&#91;31&#93;</a></sup> Faster progression rates, early cognitive dysfunction or postural instability, minimal tremor, or symmetry at onset may indicate a Parkinson-plus disease rather than PD itself.<sup id="cite_ref-pmid12464118_85-0" class="reference"><a href="#cite_note-pmid12464118-85">&#91;85&#93;</a></sup>
</p><p>Medical organizations have created <a href="/wiki/Medical_diagnosis#Diagnostic_criteria" title="Medical diagnosis">diagnostic criteria</a> to ease and standardize the diagnostic process, especially in the early stages of the disease. The most widely known criteria come from the UK Queen Square Brain Bank for Neurological Disorders and the U.S. <a href="/wiki/National_Institute_of_Neurological_Disorders_and_Stroke" title="National Institute of Neurological Disorders and Stroke">National Institute of Neurological Disorders and Stroke</a>. The Queen Square Brain Bank criteria require slowness of movement (bradykinesia) plus either rigidity, resting tremor, or postural instability. Other possible causes of these symptoms need to be ruled out. Finally, three or more of the following supportive features are required during onset or evolution: unilateral onset, tremor at rest, progression in time, asymmetry of motor symptoms, response to levodopa for at least five years, the clinical course of at least ten years and appearance of <a href="/wiki/Dyskinesia" title="Dyskinesia">dyskinesias</a> induced by the intake of excessive levodopa.<sup id="cite_ref-86" class="reference"><a href="#cite_note-86">&#91;86&#93;</a></sup> Assessment of <a href="/wiki/Sudomotor" title="Sudomotor">sudomotor</a> function through <a href="/wiki/Electrochemical_skin_conductance" title="Electrochemical skin conductance">electrochemical skin conductance</a> can be helpful in diagnosing <a href="/wiki/Dysautonomia" title="Dysautonomia">dysautonomia</a>.<sup id="cite_ref-87" class="reference"><a href="#cite_note-87">&#91;87&#93;</a></sup>
</p><p>When PD diagnoses are checked by autopsy, movement disorders experts are found on average to be 79.6% accurate at initial assessment and 83.9% accurate after they have refined their diagnoses at follow-up examinations. When clinical diagnoses performed mainly by nonexperts are checked by autopsy, the average accuracy is 73.8%. Overall, 80.6% of PD diagnoses are accurate, and 82.7% of diagnoses using the Brain Bank criteria are accurate.<sup id="cite_ref-88" class="reference"><a href="#cite_note-88">&#91;88&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Imaging">Imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=14" title="Edit section: Imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/CT_scan" title="CT scan">Computed tomography</a> (CT) scans of people with PD usually appear normal.<sup id="cite_ref-pmid20351351_89-0" class="reference"><a href="#cite_note-pmid20351351-89">&#91;89&#93;</a></sup> Magnetic resonance imaging has become more accurate in diagnosis of the disease over time, specifically through iron-sensitive <a href="/wiki/Relaxation_(NMR)#T2*_and_magnetic_field_inhomogeneity" title="Relaxation (NMR)">T2*</a> and <a href="/wiki/Susceptibility_weighted_imaging" title="Susceptibility weighted imaging">susceptibility weighted imaging</a> sequences at a magnetic field strength of at least 3T, both of which can demonstrate absence of the characteristic 'swallow tail' imaging pattern in the <a href="/wiki/Dorsolateral" class="mw-redirect" title="Dorsolateral">dorsolateral</a> substantia nigra.<sup id="cite_ref-90" class="reference"><a href="#cite_note-90">&#91;90&#93;</a></sup> In a meta-analysis, absence of this pattern was highly <a href="/wiki/Sensitivity_and_specificity#Sensitivity" title="Sensitivity and specificity">sensitive</a> and <a href="/wiki/Sensitivity_and_specificity#Specificity" title="Sensitivity and specificity">specific</a> for the disease.<sup id="cite_ref-91" class="reference"><a href="#cite_note-91">&#91;91&#93;</a></sup> A meta-analysis found that <a href="/wiki/MRI_sequence#Neuromelanin_imaging" title="MRI sequence">neuromelanin-MRI</a> can discriminate individuals with Parkinson's from healthy subjects.<sup id="cite_ref-92" class="reference"><a href="#cite_note-92">&#91;92&#93;</a></sup> <a href="/wiki/Diffusion_MRI" title="Diffusion MRI">Diffusion MRI</a> has shown potential in distinguishing between PD and Parkinson-plus syndromes, though its diagnostic value is still under investigation.<sup id="cite_ref-pmid20351351_89-1" class="reference"><a href="#cite_note-pmid20351351-89">&#91;89&#93;</a></sup> CT and MRI are also used to rule out other diseases that can be secondary causes of parkinsonism, most commonly <a href="/wiki/Encephalitis" title="Encephalitis">encephalitis</a> and <a href="/wiki/Stroke" title="Stroke">chronic ischemic insults</a>, as well as less frequent entities such as basal ganglia <a href="/wiki/Neoplasm" title="Neoplasm">tumors</a> and <a href="/wiki/Hydrocephalus" title="Hydrocephalus">hydrocephalus</a>.<sup id="cite_ref-pmid20351351_89-2" class="reference"><a href="#cite_note-pmid20351351-89">&#91;89&#93;</a></sup>
</p><p>The <a href="/wiki/Metabolism" title="Metabolism">metabolic activity</a> of <a href="/wiki/Dopamine_transporter" title="Dopamine transporter">dopamine transporters</a> in the basal ganglia can be directly measured with <a href="/wiki/Positron_emission_tomography" title="Positron emission tomography">positron emission tomography</a> and <a href="/wiki/Single-photon_emission_computed_tomography" title="Single-photon emission computed tomography">single-photon emission computed tomography</a> scans, with the <a href="/wiki/DaTSCAN" class="mw-redirect" title="DaTSCAN">DaTSCAN</a> being a common proprietary version of this study. It has shown high agreement with clinical diagnoses of PD.<sup id="cite_ref-93" class="reference"><a href="#cite_note-93">&#91;93&#93;</a></sup> Reduced dopamine-related activity in the basal ganglia can help exclude drug-induced Parkinsonism. This finding is not entirely specific, however, and can be seen with both PD and Parkinson-plus disorders.<sup id="cite_ref-pmid20351351_89-3" class="reference"><a href="#cite_note-pmid20351351-89">&#91;89&#93;</a></sup> In the United States, DaTSCANs are only <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a> approved to distinguish PD or Parkinsonian syndromes from <a href="/wiki/Essential_tremor" title="Essential tremor">essential tremor</a>.<sup id="cite_ref-94" class="reference"><a href="#cite_note-94">&#91;94&#93;</a></sup>
</p><p>Iodine-123-meta-iodobenzylguanidine myocardial <a href="/wiki/Scintigraphy" title="Scintigraphy">scintigraphy</a> can help find denervation of the muscles around the heart, which can support a PD diagnosis.<sup id="cite_ref-:1_14-5" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=15" title="Edit section: Differential diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Secondary parkinsonism – The multiple causes of parkinsonism can be differentiated between with careful history, physical examination, and appropriate imaging.<sup id="cite_ref-:0_67-4" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-:1_14-6" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup><sup id="cite_ref-:11_95-0" class="reference"><a href="#cite_note-:11-95">&#91;95&#93;</a></sup> This topic is further discussed in the causes section <a href="/wiki/Parkinson%27s_disease#Causes" title="Parkinson&#39;s disease">here</a>.
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Hot_cross_bun_sign.jpg" class="image"><img alt="An MRI finding that is seen commonly in Multiple System atrophy. This occurs on the Pons." src="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Hot_cross_bun_sign.jpg/220px-Hot_cross_bun_sign.jpg" decoding="async" width="220" height="239" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Hot_cross_bun_sign.jpg/330px-Hot_cross_bun_sign.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/05/Hot_cross_bun_sign.jpg/440px-Hot_cross_bun_sign.jpg 2x" data-file-width="580" data-file-height="630" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Hot_cross_bun_sign.jpg" class="internal" title="Enlarge"></a></div>"Hot Cross Bun" sign that is commonly found in MRI of Multiple System Atrophy.</div></div></div>
<p><a href="/wiki/Parkinson-plus_syndrome" title="Parkinson-plus syndrome">Parkinson-plus syndrome</a> – Multiple diseases can be considered part of the Parkinson's plus group, including <a href="/wiki/Corticobasal_syndrome" title="Corticobasal syndrome">corticobasal syndrome</a>, <a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">multiple system atrophy</a>, <a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">progressive supranuclear palsy</a>, and <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">dementia with lewy bodies</a>. Differential diagnosis can be narrowed down with careful history and physical (especially focused on onset of specific symptoms), progression of the disease, and response to treatment.<sup id="cite_ref-96" class="reference"><a href="#cite_note-96">&#91;96&#93;</a></sup><sup id="cite_ref-:11_95-1" class="reference"><a href="#cite_note-:11-95">&#91;95&#93;</a></sup> Some key features between them:<sup id="cite_ref-:0_67-5" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-:11_95-2" class="reference"><a href="#cite_note-:11-95">&#91;95&#93;</a></sup>
</p>
<ul><li><a href="/wiki/Corticobasal_syndrome" title="Corticobasal syndrome">Corticobasal syndrome</a> - levodopa-resistance, <a href="/wiki/Myoclonus" title="Myoclonus">myoclonus</a>, <a href="/wiki/Dystonia" title="Dystonia">dystonia</a>, corticosensory loss, <a href="/wiki/Apraxia" title="Apraxia">apraxia</a>, and <a href="/wiki/Non-fluent_aphasia" class="mw-redirect" title="Non-fluent aphasia">non-fluent aphasia</a></li>
<li><a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">Multiple system atrophy</a> – levodopa resistance, rapidly progressive, autonomic failure, stridor, present <a href="/wiki/Plantar_reflex" title="Plantar reflex">Babinski sign</a>, cerebellar ataxia, and specific MRI findings</li>
<li><a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">Progressive supranuclear palsy</a> – levodopa resistance, restrictive vertical gaze, specific MRI findings, and early and different postural difficulties</li>
<li><a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a> – levodopa resistance, cognitive predominance before motor symptoms, and fluctuating cognitive symptoms, (visual hallucinations are very common in this disease, but PD patients also have them)</li>
<li><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a> – This can at first look like parkinsonism, but has key differentiators. In essential tremor, the tremor gets worse with action (whereas in PD, it gets better),  a lack of other symptoms is common in PD, and normal DatSCAN is seen.<sup id="cite_ref-:11_95-3" class="reference"><a href="#cite_note-:11-95">&#91;95&#93;</a></sup><sup id="cite_ref-:0_67-6" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup></li></ul>
<p>Other conditions that can have similar presentations to PD include:<sup id="cite_ref-Greenland2018_97-0" class="reference"><a href="#cite_note-Greenland2018-97">&#91;97&#93;</a></sup><sup id="cite_ref-:0_67-7" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r1054258005">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li{margin-left:0;padding-left:3.2em;text-indent:-3.2em}.mw-parser-output .refbegin-hanging-indents ul,.mw-parser-output .refbegin-hanging-indents ul li{list-style:none}@media(max-width:720px){.mw-parser-output .refbegin-hanging-indents>ul>li{padding-left:1.6em;text-indent:-1.6em}}.mw-parser-output .refbegin-columns{margin-top:0.3em}.mw-parser-output .refbegin-columns ul{margin-top:0}.mw-parser-output .refbegin-columns li{page-break-inside:avoid;break-inside:avoid-column}</style><div class="refbegin refbegin-columns references-column-count references-column-count-2" style="column-count: 2;">
<ul><li><a href="/wiki/Arthritis" title="Arthritis">Arthritis</a></li>
<li><a href="/wiki/Creutzfeldt%E2%80%93Jakob_disease" title="Creutzfeldt–Jakob disease">Creutzfeldt–Jakob disease</a></li>
<li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a></li>
<li><a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">Depression</a></li>
<li><a href="/wiki/Fragile_X-associated_tremor/ataxia_syndrome" title="Fragile X-associated tremor/ataxia syndrome">Fragile X-associated tremor/ataxia syndrome</a></li>
<li><a href="/wiki/Frontotemporal_dementia_and_parkinsonism_linked_to_chromosome_17" title="Frontotemporal dementia and parkinsonism linked to chromosome 17">Frontotemporal dementia and parkinsonism linked to chromosome 17</a></li>
<li><a href="/wiki/Huntington%E2%80%99s_disease" class="mw-redirect" title="Huntington’s disease">Huntington’s disease</a></li>
<li><a href="/wiki/Basal_ganglia_calcification" class="mw-redirect" title="Basal ganglia calcification">Idiopathic basal ganglia calcification</a></li>
<li><a href="/wiki/Neurodegeneration_with_brain_iron_accumulation" title="Neurodegeneration with brain iron accumulation">Neurodegeneration with brain iron accumulation</a></li>
<li><a href="/wiki/Normal-pressure_hydrocephalus" class="mw-redirect" title="Normal-pressure hydrocephalus">Normal-pressure hydrocephalus</a></li>
<li>Obsessional slowness</li>
<li>Psychogenic parkinsonism</li>
<li><a href="/wiki/Wilson%E2%80%99s_disease" class="mw-redirect" title="Wilson’s disease">Wilson’s disease</a></li></ul>
</div>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=16" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Exercise in middle age may reduce the risk of PD later in life.<sup id="cite_ref-Neuro2011_18-1" class="reference"><a href="#cite_note-Neuro2011-18">&#91;18&#93;</a></sup> <a href="/wiki/Caffeine" title="Caffeine">Caffeine</a> also appears protective with a greater decrease in risk occurring with a larger intake of caffeinated beverages such as coffee.<sup id="cite_ref-pmid20182023_98-0" class="reference"><a href="#cite_note-pmid20182023-98">&#91;98&#93;</a></sup> 
</p><p><a href="/wiki/Antioxidant" title="Antioxidant">Antioxidants</a>, such as <a href="/wiki/Vitamin_C" title="Vitamin C">vitamins C</a> and <a href="/wiki/Vitamin_E" title="Vitamin E">E</a>, have been proposed to protect against the disease, but results of studies have been contradictory and no positive effect has been proven.<sup id="cite_ref-pmid16713924_53-2" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup> The results regarding fat and <a href="/wiki/Fatty_acid" title="Fatty acid">fatty acids</a> have been contradictory, with various studies reporting protective, risk-increasing, or no effects.<sup id="cite_ref-pmid16713924_53-3" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup> There have been preliminary indications that the use of <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">anti-inflammatory</a> drugs and <a href="/wiki/Calcium_channel_blocker" title="Calcium channel blocker">calcium channel blockers</a> may be protective.<sup id="cite_ref-Lancet2015_4-10" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> A 2010 <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> found that <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">nonsteroidal anti-inflammatory drugs</a> (apart from <a href="/wiki/Aspirin" title="Aspirin">aspirin</a>), have been associated with at least a 15% (higher in long-term and regular users) reduction in the incidence of the development of PD.<sup id="cite_ref-Gagne-2010_99-0" class="reference"><a href="#cite_note-Gagne-2010-99">&#91;99&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=17" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Management_of_Parkinson%27s_disease" title="Management of Parkinson&#39;s disease">Management of Parkinson's disease</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:332px;"><a href="/wiki/File:Pharmacological_treatment_of_Parkinson%27s_disease.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/10/Pharmacological_treatment_of_Parkinson%27s_disease.png/330px-Pharmacological_treatment_of_Parkinson%27s_disease.png" decoding="async" width="330" height="330" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/10/Pharmacological_treatment_of_Parkinson%27s_disease.png/495px-Pharmacological_treatment_of_Parkinson%27s_disease.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/10/Pharmacological_treatment_of_Parkinson%27s_disease.png/660px-Pharmacological_treatment_of_Parkinson%27s_disease.png 2x" data-file-width="8500" data-file-height="8500" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Pharmacological_treatment_of_Parkinson%27s_disease.png" class="internal" title="Enlarge"></a></div>Pharmacological treatment of Parkinson's disease</div></div></div>
<p>No cure for Parkinson's disease is known. Medications, surgery, and <a href="/wiki/Physical_therapy" title="Physical therapy">physical treatment</a> may provide relief, improve the quality of a person's life, and are much more effective than treatments available for other neurological disorders such as Alzheimer's disease, <a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">motor neuron disease</a>, and <a href="/wiki/Parkinson-plus_syndrome" title="Parkinson-plus syndrome">Parkinson-plus syndromes</a>.<sup id="cite_ref-:3_100-0" class="reference"><a href="#cite_note-:3-100">&#91;100&#93;</a></sup> The main families of drugs useful for treating motor symptoms are <a href="/wiki/L-DOPA" title="L-DOPA">levodopa</a> always combined with a <a href="/wiki/Aromatic_L-amino_acid_decarboxylase_inhibitor" title="Aromatic L-amino acid decarboxylase inhibitor">dopa decarboxylase inhibitor</a> and sometimes also with a <a href="/wiki/COMT_inhibitor" class="mw-redirect" title="COMT inhibitor">COMT inhibitor</a>, <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a>, and <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">MAO-B inhibitors</a>. The stage of the disease and the age at disease onset determine which group is most useful.<sup id="cite_ref-:3_100-1" class="reference"><a href="#cite_note-:3-100">&#91;100&#93;</a></sup>
</p><p><a href="/wiki/Braak_staging" title="Braak staging">Braak staging</a> of PD uses six stages that can identify early, middle, and late stages.<sup id="cite_ref-:4_101-0" class="reference"><a href="#cite_note-:4-101">&#91;101&#93;</a></sup> The initial stage in which some disability has already developed and requires pharmacological treatment is followed by later stages associated with the development of complications related to levodopa usage, and a third stage when symptoms unrelated to dopamine deficiency or levodopa treatment may predominate.<sup id="cite_ref-:4_101-1" class="reference"><a href="#cite_note-:4-101">&#91;101&#93;</a></sup>
</p><p>Treatment in the first stage aims for an optimal <a href="/wiki/Trade-off" title="Trade-off">trade-off</a> between symptom control and treatment side effects. The start of levodopa treatment may be postponed by initially using other medications, such as MAO-B inhibitors and dopamine agonists, instead, in the hope of delaying the onset of complications due to levodopa use.<sup id="cite_ref-Nice-pharma_102-0" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Levodopa is still the most effective treatment for the motor symptoms of PD, though, and should not be delayed in people when their quality of life is impaired. Levodopa-related dyskinesias correlate more strongly with duration and severity of the disease than duration of levodopa treatment, so delaying this therapy may not provide much longer dyskinesia-free time than early use.<sup id="cite_ref-103" class="reference"><a href="#cite_note-103">&#91;103&#93;</a></sup>
</p><p>In later stages, the aim is to reduce PD symptoms, while controlling fluctuations in the effect of the medication. Sudden withdrawals from medication or its overuse must be managed.<sup id="cite_ref-Nice-pharma_102-1" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> When oral medications are not enough to control symptoms, surgery, <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a>, subcutaneous waking-day <a href="/wiki/Apomorphine" title="Apomorphine">apomorphine</a> infusion, and <a href="/wiki/Enteral_administration" title="Enteral administration">enteral</a> dopa pumps may be useful.<sup id="cite_ref-Pedrosa2013_104-0" class="reference"><a href="#cite_note-Pedrosa2013-104">&#91;104&#93;</a></sup> Late-stage PD presents many challenges requiring a variety of treatments, including those for psychiatric symptoms particularly depression, orthostatic hypotension, bladder dysfunction, and <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a>.<sup id="cite_ref-Pedrosa2013_104-1" class="reference"><a href="#cite_note-Pedrosa2013-104">&#91;104&#93;</a></sup> In the final stages of the disease, <a href="/wiki/Palliative_care" title="Palliative care">palliative care</a> is provided to improve a person's quality of life.<sup id="cite_ref-Nice-palliative_105-0" class="reference"><a href="#cite_note-Nice-palliative-105">&#91;105&#93;</a></sup>
</p><p>A 2020 Cochrane review found no certain evidence that cognitive training is beneficial for people with Parkinson's disease, dementia or mild cognitive impairment.<sup id="cite_ref-106" class="reference"><a href="#cite_note-106">&#91;106&#93;</a></sup> The findings are based on low certainty evidence of seven studies.
</p>
<h3><span class="mw-headline" id="Medications">Medications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=18" title="Edit section: Medications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<table class="box-Update plainlinks metadata ambox ambox-content ambox-Update" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="Ambox current red Americas.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/42px-Ambox_current_red_Americas.svg.png" decoding="async" width="42" height="34" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/63px-Ambox_current_red_Americas.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/84px-Ambox_current_red_Americas.svg.png 2x" data-file-width="360" data-file-height="290" /></div></td><td class="mbox-text"><div class="mbox-text-span">This article needs to be <b>updated</b>. The reason given is: <style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32171387">32171387</a>.<span class="hide-when-compact"> Please help update this article to reflect recent events or newly available information.</span>  <span class="date-container"><i>(<span class="date">October 2020</span>)</i></span></div></td></tr></tbody></table>
<h4><span class="mw-headline" id="Levodopa">Levodopa</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=19" title="Edit section: Levodopa">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The motor symptoms of PD are the result of reduced dopamine production in the brain's basal ganglia. Dopamine does not cross the <a href="/wiki/Blood-brain_barrier" class="mw-redirect" title="Blood-brain barrier">blood-brain barrier</a>, so it cannot be taken as a medicine to boost the brain's depleted levels of dopamine, but a <a href="/wiki/Precursor_(chemistry)" title="Precursor (chemistry)">precursor</a> of dopamine, levodopa, can pass through to the brain, where it is readily converted to dopamine, and administration of levodopa temporarily diminishes the motor symptoms of PD. Levodopa has been the most widely used PD treatment for over 40 years.<sup id="cite_ref-Nice-pharma_102-2" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup>
</p><p>Only 5–10% of levodopa crosses the blood–brain barrier. Much of the remainder is metabolized to dopamine elsewhere in the body, causing a variety of side effects, including <a href="/wiki/Nausea" title="Nausea">nausea</a>, vomiting, and orthostatic hypotension.<sup id="cite_ref-107" class="reference"><a href="#cite_note-107">&#91;107&#93;</a></sup> <a href="/wiki/Carbidopa" title="Carbidopa">Carbidopa</a> and <a href="/wiki/Benserazide" title="Benserazide">benserazide</a> are <a href="/wiki/Aromatic_L-amino_acid_decarboxylase_inhibitor" title="Aromatic L-amino acid decarboxylase inhibitor">dopa decarboxylase inhibitors</a> that do not cross the blood-brain barrier and inhibit the conversion of levodopa to dopamine outside the brain, reducing side effects and improving the availability of levodopa for passage into the brain. One of these drugs is usually taken along with levodopa, often combined with levodopa in the same pill.<sup id="cite_ref-Oertel2017_108-0" class="reference"><a href="#cite_note-Oertel2017-108">&#91;108&#93;</a></sup>
</p><p>Levodopa use leads in the long term to the development of complications, such as involuntary movements (dyskinesias) and fluctuations in the effectiveness of the medication.<sup id="cite_ref-Nice-pharma_102-3" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> When fluctuations occur, a person can cycle through phases with good response to medication and reduced PD symptoms ("on" state), and phases with poor response to medication and significant PD symptoms ("off" state).<sup id="cite_ref-Nice-pharma_102-4" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Using lower doses of levodopa may reduce the risk and severity of these levodopa-induced complications.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109">&#91;109&#93;</a></sup> A former strategy to reduce levodopa-related dyskinesia and fluctuations was to withdraw levodopa medication for some time. This is now discouraged, since it can bring on dangerous side effects such as <a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">neuroleptic malignant syndrome</a>.<sup id="cite_ref-Nice-pharma_102-5" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Most people with PD eventually need levodopa and later develop levodopa-induced fluctuations and dyskinesias.<sup id="cite_ref-Nice-pharma_102-6" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup>
</p><p><a href="/wiki/Modified-release_dosage_(medicine)" class="mw-redirect" title="Modified-release dosage (medicine)">Controlled-release</a> (CR) versions of levodopa are available. Older CR levodopa preparations have poor and unreliable <a href="/wiki/Absorption_(pharmacokinetics)" class="mw-redirect" title="Absorption (pharmacokinetics)">absorption</a> and <a href="/wiki/Bioavailability" title="Bioavailability">bioavailability</a> and have not demonstrated improved control of PD motor symptoms or a reduction in levodopa-related complications when compared to immediate-release preparations. A newer extended-release levodopa preparation does seem to be more effective in reducing fluctuations, but in many people, problems persist. Intestinal infusions of levodopa (Duodopa) can result in striking improvements in fluctuations compared to oral levodopa when the fluctuations are due to insufficient uptake caused by <a href="/wiki/Gastroparesis" title="Gastroparesis">gastroparesis</a>. Other oral, longer-acting formulations are under study, and other modes of delivery (inhaled, transdermal) are being developed.<sup id="cite_ref-Oertel2017_108-1" class="reference"><a href="#cite_note-Oertel2017-108">&#91;108&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="COMT_inhibitors">COMT inhibitors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=20" title="Edit section: COMT inhibitors">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Wiki-COMT.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Wiki-COMT.png/220px-Wiki-COMT.png" decoding="async" width="220" height="148" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Wiki-COMT.png/330px-Wiki-COMT.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Wiki-COMT.png/440px-Wiki-COMT.png 2x" data-file-width="1160" data-file-height="778" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Wiki-COMT.png" class="internal" title="Enlarge"></a></div>COMT metabolizes levodopa to 3-O-methyldopa. COMT inhibitors help stop this reaction, allowing for more levodopa to cross the blood-brain barrier and become dopamine where it is needed.<sup id="cite_ref-110" class="reference"><a href="#cite_note-110">&#91;110&#93;</a></sup></div></div></div>
<p>During the course of PD, affected people can experience what is known as a "wearing off phenomenon", where they have a recurrence of symptoms after a dose of levodopa, but right before their next dose.<sup id="cite_ref-:1_14-7" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup> Catechol-O-methyltransferase (COMT) is a protein that degrades levodopa before it can cross the <a href="/wiki/Blood%E2%80%93brain_barrier" title="Blood–brain barrier">blood-brain barrier</a> and these inhibitors allow for more levodopa to cross.<sup id="cite_ref-:2_111-0" class="reference"><a href="#cite_note-:2-111">&#91;111&#93;</a></sup> They are normally not used in the management of early symptoms, but can be used in conjunction with levodopa/carbidopa when a person is experiencing the "wearing off phenomenon" with their motor symptoms.<sup id="cite_ref-:1_14-8" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup>
</p><p>Three COMT inhibitors are available to treat adults with PD and end-of-dose motor fluctuations – <a href="/wiki/Opicapone" title="Opicapone">opicapone</a>, <a href="/wiki/Entacapone" title="Entacapone">entacapone</a>, and <a href="/wiki/Tolcapone" title="Tolcapone">tolcapone</a>.<sup id="cite_ref-:1_14-9" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup> Tolcapone has been available for several years, but its usefulness is limited by possible liver damage complications, so requires liver-function monitoring.<sup id="cite_ref-112" class="reference"><a href="#cite_note-112">&#91;112&#93;</a></sup><sup id="cite_ref-:0_67-8" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-:1_14-10" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup><sup id="cite_ref-:2_111-1" class="reference"><a href="#cite_note-:2-111">&#91;111&#93;</a></sup> Entacapone and opicapone have not been shown to cause significant alterations to liver function.<sup id="cite_ref-:2_111-2" class="reference"><a href="#cite_note-:2-111">&#91;111&#93;</a></sup><sup id="cite_ref-113" class="reference"><a href="#cite_note-113">&#91;113&#93;</a></sup><sup id="cite_ref-114" class="reference"><a href="#cite_note-114">&#91;114&#93;</a></sup> Licensed preparations of entacapone contain entacapone alone or in combination with carbidopa and levodopa.<sup id="cite_ref-115" class="reference"><a href="#cite_note-115">&#91;115&#93;</a></sup><sup id="cite_ref-:0_67-9" class="reference"><a href="#cite_note-:0-67">&#91;67&#93;</a></sup><sup id="cite_ref-116" class="reference"><a href="#cite_note-116">&#91;116&#93;</a></sup> Opicapone is a once-daily COMT inhibitor.<sup id="cite_ref-117" class="reference"><a href="#cite_note-117">&#91;117&#93;</a></sup><sup id="cite_ref-:1_14-11" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Dopamine_agonists">Dopamine agonists</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=21" title="Edit section: Dopamine agonists">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Several <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">dopamine agonists</a> that bind to dopamine receptors in the brain have similar effects to levodopa.<sup id="cite_ref-Nice-pharma_102-7" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> These were initially used as a complementary therapy to levodopa for individuals experiencing levodopa complications (on-off fluctuations and dyskinesias); they are now mainly used on their own as first therapy for the motor symptoms of PD with the aim of delaying the initiation of levodopa therapy, thus delaying the onset of levodopa's complications.<sup id="cite_ref-Nice-pharma_102-8" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup><sup id="cite_ref-118" class="reference"><a href="#cite_note-118">&#91;118&#93;</a></sup> Dopamine agonists include <a href="/wiki/Bromocriptine" title="Bromocriptine">bromocriptine</a>, <a href="/wiki/Pergolide" title="Pergolide">pergolide</a>, <a href="/wiki/Pramipexole" title="Pramipexole">pramipexole</a>, <a href="/wiki/Ropinirole" title="Ropinirole">ropinirole</a>, <a href="/wiki/Piribedil" title="Piribedil">piribedil</a>, <a href="/wiki/Cabergoline" title="Cabergoline">cabergoline</a>, <a href="/wiki/Apomorphine" title="Apomorphine">apomorphine</a>, and <a href="/wiki/Lisuride" title="Lisuride">lisuride</a>.
</p><p>Though dopamine agonists are less effective than levodopa at controlling PD motor symptoms, they are usually effective enough to manage these symptoms in the first years of treatment.<sup id="cite_ref-pmid15172778_16-5" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup> Dyskinesias due to dopamine agonists are rare in younger people who have PD, but along with other complications, become more common with older age at onset.<sup id="cite_ref-pmid15172778_16-6" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup> Thus, dopamine agonists are the preferred initial treatment for younger-onset PD, and levodopa is preferred for older-onset PD.<sup id="cite_ref-pmid15172778_16-7" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup>
</p><p>Dopamine agonists produce significant, although usually mild, side effects, including drowsiness, hallucinations, insomnia, nausea, and constipation.<sup id="cite_ref-Nice-pharma_102-9" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Sometimes, side effects appear even at a minimal clinically effective dose, leading the physician to search for a different drug.<sup id="cite_ref-Nice-pharma_102-10" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Agonists have been related to impulse-control disorders (such as compulsive sexual activity, eating, gambling, and shopping) even more strongly than levodopa.<sup id="cite_ref-pmid20123548_119-0" class="reference"><a href="#cite_note-pmid20123548-119">&#91;119&#93;</a></sup> They tend to be more expensive than levodopa.<sup id="cite_ref-pmid15172778_16-8" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup>
</p><p><a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a>, a  dopamine agonist, may be used to reduce off periods and dyskinesia in late PD.<sup id="cite_ref-Nice-pharma_102-11" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> It is administered only by intermittent injections or continuous <a href="/wiki/Hypodermoclysis" title="Hypodermoclysis">subcutaneous infusions</a>.<sup id="cite_ref-Nice-pharma_102-12" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Since secondary effects such as confusion and hallucinations are common, individuals receiving apomorphine treatment should be closely monitored.<sup id="cite_ref-Nice-pharma_102-13" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> Two dopamine agonists administered through skin patches (<a href="/wiki/Lisuride" title="Lisuride">lisuride</a> and <a href="/wiki/Rotigotine" title="Rotigotine">rotigotine</a>) are useful for people in the initial stages and possibly to control off states in those in advanced states.<sup id="cite_ref-Jankovic_book-Pharma_120-0" class="reference"><a href="#cite_note-Jankovic_book-Pharma-120">&#91;120&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="MAO-B_inhibitors">MAO-B inhibitors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=22" title="Edit section: MAO-B inhibitors">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>MAO-B inhibitors (<a href="/wiki/Safinamide" title="Safinamide">safinamide</a>, <a href="/wiki/Selegiline" title="Selegiline">selegiline</a> and <a href="/wiki/Rasagiline" title="Rasagiline">rasagiline</a>) increase the amount of dopamine in the basal ganglia by inhibiting the activity of <a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">monoamine oxidase B</a>, an enzyme that breaks down dopamine.<sup id="cite_ref-Nice-pharma_102-14" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup> They have been found to help alleviate motor symptoms when used as monotherapy (on their own); when used in conjunction with levodopa, they reduce the time spent in the "off" phase. Selegiline has been shown to delay the need for levodopa commencement, suggesting that it might be neuroprotective and slow the progression of the disease (but this has not been proven).<sup id="cite_ref-:10_121-0" class="reference"><a href="#cite_note-:10-121">&#91;121&#93;</a></sup> An initial study indicated that selegiline in combination with levodopa increased the risk of death, but this has been refuted.<sup id="cite_ref-122" class="reference"><a href="#cite_note-122">&#91;122&#93;</a></sup>
</p><p>Common side effects are nausea, dizziness, insomnia, sleepiness, and (in selegiline and rasagiline) orthostatic hypotension.<sup id="cite_ref-:10_121-1" class="reference"><a href="#cite_note-:10-121">&#91;121&#93;</a></sup><sup id="cite_ref-:1_14-12" class="reference"><a href="#cite_note-:1-14">&#91;14&#93;</a></sup> Along with dopamine, MAO-Bs are known to increase serotonin, so care must be taken when used with certain antidepressants due to a potentially dangerous condition known as <a href="/wiki/Serotonin_syndrome" title="Serotonin syndrome">serotonin syndrome</a>.<sup id="cite_ref-:10_121-2" class="reference"><a href="#cite_note-:10-121">&#91;121&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Other_drugs">Other drugs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=23" title="Edit section: Other drugs">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Other drugs such as <a href="/wiki/Amantadine" title="Amantadine">amantadine</a> and <a href="/wiki/Anticholinergic" title="Anticholinergic">anticholinergics</a> may be useful as treatment of motor symptoms, but the evidence supporting them lacks quality, so they are not first-choice treatments.<sup id="cite_ref-Nice-pharma_102-15" class="reference"><a href="#cite_note-Nice-pharma-102">&#91;102&#93;</a></sup><sup id="cite_ref-123" class="reference"><a href="#cite_note-123">&#91;123&#93;</a></sup> In addition to motor symptoms, PD is accompanied by a diverse range of symptoms. Several drugs have been used to treat some of these problems.<sup id="cite_ref-Nice-NonMotor_124-0" class="reference"><a href="#cite_note-Nice-NonMotor-124">&#91;124&#93;</a></sup> Examples are the use of <a href="/wiki/Quetiapine" title="Quetiapine">quetiapine</a> for psychosis, <a href="/wiki/Acetylcholinesterase_inhibitor" title="Acetylcholinesterase inhibitor">cholinesterase inhibitors</a> for dementia, and <a href="/wiki/Modafinil" title="Modafinil">modafinil</a> for <a href="/wiki/Excessive_daytime_sleepiness" title="Excessive daytime sleepiness">excessive daytime sleepiness</a>.<sup id="cite_ref-Nice-NonMotor_124-1" class="reference"><a href="#cite_note-Nice-NonMotor-124">&#91;124&#93;</a></sup><sup id="cite_ref-pmid19559160_125-0" class="reference"><a href="#cite_note-pmid19559160-125">&#91;125&#93;</a></sup> In 2016, <a href="/wiki/Pimavanserin" title="Pimavanserin">pimavanserin</a> was approved for the management of PD psychosis.<sup id="cite_ref-126" class="reference"><a href="#cite_note-126">&#91;126&#93;</a></sup> Doxepin and rasagline may reduce physical fatigue in PD.<sup id="cite_ref-Elbers2015_127-0" class="reference"><a href="#cite_note-Elbers2015-127">&#91;127&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=24" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Parkinson_surgery.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/170px-Parkinson_surgery.jpg" decoding="async" width="170" height="254" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/255px-Parkinson_surgery.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/91/Parkinson_surgery.jpg/340px-Parkinson_surgery.jpg 2x" data-file-width="787" data-file-height="1174" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Parkinson_surgery.jpg" class="internal" title="Enlarge"></a></div>Placement of an electrode into the brain: The head is stabilised in a frame for <a href="/wiki/Stereotactic_surgery" title="Stereotactic surgery">stereotactic surgery</a>.</div></div></div>
<p>Treating motor symptoms with surgery was once a common practice, but since the discovery of levodopa, the number of operations has declined.<sup id="cite_ref-Nice-surgery_128-0" class="reference"><a href="#cite_note-Nice-surgery-128">&#91;128&#93;</a></sup> Studies in the past few decades have led to great improvements in surgical techniques, so surgery is again being used in people with advanced PD for whom drug therapy is no longer sufficient.<sup id="cite_ref-Nice-surgery_128-1" class="reference"><a href="#cite_note-Nice-surgery-128">&#91;128&#93;</a></sup> Surgery for PD can be divided in two main groups – lesional and <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a> (DBS). Target areas for DBS or lesions include the <a href="/wiki/Thalamus" title="Thalamus">thalamus</a>,  <a href="/wiki/Globus_pallidus" title="Globus pallidus">globus pallidus</a>, or <a href="/wiki/Subthalamic_nucleus" title="Subthalamic nucleus">subthalamic nucleus</a>.<sup id="cite_ref-Nice-surgery_128-2" class="reference"><a href="#cite_note-Nice-surgery-128">&#91;128&#93;</a></sup> DBS involves the implantation of a medical device called a <a href="/wiki/Neurostimulation" title="Neurostimulation">neurostimulator</a>, which sends electrical impulses to specific parts of the brain. DBS is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.<sup id="cite_ref-pmid20937936_129-0" class="reference"><a href="#cite_note-pmid20937936-129">&#91;129&#93;</a></sup> Other, less common surgical therapies involve intentional formation of lesions to suppress overactivity of specific <a href="https://en.wiktionary.org/wiki/subcortical" class="extiw" title="wikt:subcortical">subcortical</a> areas. For example, <a href="/wiki/Pallidotomy" title="Pallidotomy">pallidotomy</a> involves surgical destruction of the globus pallidus to control dyskinesia.<sup id="cite_ref-Nice-surgery_128-3" class="reference"><a href="#cite_note-Nice-surgery-128">&#91;128&#93;</a></sup>
</p><p>Four areas of the brain have been treated with neural stimulators in PD.<sup id="cite_ref-Dallapiazza2018_130-0" class="reference"><a href="#cite_note-Dallapiazza2018-130">&#91;130&#93;</a></sup> These are the globus pallidus interna, thalamus, subthalamic nucleus, and  <a href="/wiki/Pedunculopontine_nucleus" title="Pedunculopontine nucleus">pedunculopontine nucleus</a>. DBS of the globus pallidus interna improves motor function, while DBS of the thalamic DBS improves tremor, but has little effect on bradykinesia or rigidity. DBS of the subthalamic nucleus is usually avoided if a history of depression or neurocognitive impairment is present. DBS of the subthalamic nucleus is associated with a reduction in medication. Pedunculopontine nucleus DBS remains experimental at present. Generally, DBS is associated with 30–60% improvement in motor score evaluations.<sup id="cite_ref-131" class="reference"><a href="#cite_note-131">&#91;131&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Rehabilitation">Rehabilitation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=25" title="Edit section: Rehabilitation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Further information: <a href="/wiki/Management_of_Parkinson%27s_disease" title="Management of Parkinson&#39;s disease">Management of Parkinson's disease</a></div>
<p>Exercise programs are recommended in people with PD.<sup id="cite_ref-Neuro2011_18-2" class="reference"><a href="#cite_note-Neuro2011-18">&#91;18&#93;</a></sup> Some evidence shows that speech or mobility problems can improve with rehabilitation, although studies are scarce and of low quality.<sup id="cite_ref-Nice-rehab_132-0" class="reference"><a href="#cite_note-Nice-rehab-132">&#91;132&#93;</a></sup><sup id="cite_ref-pmid18181210_133-0" class="reference"><a href="#cite_note-pmid18181210-133">&#91;133&#93;</a></sup> Regular <a href="/wiki/Physical_exercise" class="mw-redirect" title="Physical exercise">physical exercise</a> with or without <a href="/wiki/Physical_therapy" title="Physical therapy">physical therapy</a> can be beneficial to maintain and improve mobility, flexibility, strength, gait speed, and quality of life.<sup id="cite_ref-pmid18181210_133-1" class="reference"><a href="#cite_note-pmid18181210-133">&#91;133&#93;</a></sup> When an exercise program is performed under the supervision of a physiotherapist,  more improvements occur in motor symptoms, mental and emotional functions, daily living activities, and quality of life compared to a self-supervised exercise program at home.<sup id="cite_ref-134" class="reference"><a href="#cite_note-134">&#91;134&#93;</a></sup> Clinical exercises may be an effective intervention targeting overall well-being of individuals with Parkinson's. Improvement in motor function and depression may happen.<sup id="cite_ref-135" class="reference"><a href="#cite_note-135">&#91;135&#93;</a></sup>
</p><p>In improving flexibility and range of motion for people experiencing rigidity, generalized relaxation techniques such as gentle rocking have been found to decrease excessive muscle tension. Other effective techniques to promote relaxation include slow rotational movements of the extremities and trunk, rhythmic initiation, <a href="/wiki/Diaphragmatic_breathing" title="Diaphragmatic breathing">diaphragmatic breathing</a>, and <a href="/wiki/Meditation" title="Meditation">meditation</a> techniques.<sup id="cite_ref-136" class="reference"><a href="#cite_note-136">&#91;136&#93;</a></sup> As for gait and addressing the challenges associated with the disease such as hypokinesia, shuffling, and decreased arm swing, physiotherapists have a variety of strategies to improve functional mobility and safety. Areas of interest concerning gait during rehabilitation programs focus on improving gait speed, the base of support, stride length, and trunk and arm-swing movement. Strategies include using assistive equipment (pole walking and treadmill walking), verbal cueing (manual, visual, and auditory), exercises (marching and PNF patterns), and altering environments (surfaces, inputs, open vs. closed).<sup id="cite_ref-137" class="reference"><a href="#cite_note-137">&#91;137&#93;</a></sup> Strengthening exercises have shown improvements in strength and motor function for people with primary muscular weakness and weakness related to inactivity with mild to moderate PD, but reports show a significant interaction between strength and the time the medications were taken. Therefore,  people with PD should perform exercises 45 minutes to one hour after medications when they are at their best.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138">&#91;138&#93;</a></sup> Also, due to the forward flexed posture, and respiratory dysfunctions in advanced PD, deep diaphragmatic breathing exercises are beneficial in improving chest-wall mobility and vital capacity.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">&#91;139&#93;</a></sup> Exercise may improve constipation.<sup id="cite_ref-pmid19691125_17-2" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> If exercise reduces physical fatigue in PD remains unclear.<sup id="cite_ref-Elbers2015_127-1" class="reference"><a href="#cite_note-Elbers2015-127">&#91;127&#93;</a></sup>
</p><p><a href="/wiki/Strength_training" title="Strength training">Strength training</a> exercise has been shown to increase <a href="/wiki/Manual_dexterity" class="mw-redirect" title="Manual dexterity">manual dexterity</a> in PD patients after exercising with manual putty. This positively affects everyday life when gripping for PD patients.<sup id="cite_ref-140" class="reference"><a href="#cite_note-140">&#91;140&#93;</a></sup>
</p><p>One of the most widely practiced <a href="/wiki/Speech_therapy" class="mw-redirect" title="Speech therapy">treatments for speech</a> disorders associated with PD is the <a href="/wiki/Lee_Silverman_voice_treatment" title="Lee Silverman voice treatment">Lee Silverman voice treatment</a> (LSVT).<sup id="cite_ref-Nice-rehab_132-1" class="reference"><a href="#cite_note-Nice-rehab-132">&#91;132&#93;</a></sup><sup id="cite_ref-pmid17117354_141-0" class="reference"><a href="#cite_note-pmid17117354-141">&#91;141&#93;</a></sup> Speech therapy and specifically LSVT may improve speech.<sup id="cite_ref-Nice-rehab_132-2" class="reference"><a href="#cite_note-Nice-rehab-132">&#91;132&#93;</a></sup> <a href="/wiki/Occupational_therapy" title="Occupational therapy">Occupational therapy</a> (OT) aims to promote health and quality of life by helping people with the disease to participate in as many of their <a href="/wiki/Daily_living_skills" class="mw-redirect" title="Daily living skills">daily living activities</a> as possible.<sup id="cite_ref-Nice-rehab_132-3" class="reference"><a href="#cite_note-Nice-rehab-132">&#91;132&#93;</a></sup> Few studies have been conducted on the effectiveness of OT, and their quality is poor, although with some indication that it may improve motor skills and quality of life for the duration of the therapy.<sup id="cite_ref-Nice-rehab_132-4" class="reference"><a href="#cite_note-Nice-rehab-132">&#91;132&#93;</a></sup><sup id="cite_ref-pmid17636709_142-0" class="reference"><a href="#cite_note-pmid17636709-142">&#91;142&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Palliative_care">Palliative care</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=26" title="Edit section: Palliative care">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Palliative_care" title="Palliative care">Palliative care</a> is specialized medical care for people with serious illnesses, including Parkinson's. The goal of this speciality is to improve quality of life for both the person with PD and the family by providing relief from the symptoms, pain, and stress of illnesses.<sup id="cite_ref-pmid17531914_143-0" class="reference"><a href="#cite_note-pmid17531914-143">&#91;143&#93;</a></sup> As Parkinson's is not a curable disease, all treatments are focused on slowing decline and improving quality of life, and are therefore palliative in nature.<sup id="cite_ref-pmid24182372_144-0" class="reference"><a href="#cite_note-pmid24182372-144">&#91;144&#93;</a></sup>
</p><p>Palliative care should be involved earlier, rather than later, in the disease course.<sup id="cite_ref-pmid22771241_145-0" class="reference"><a href="#cite_note-pmid22771241-145">&#91;145&#93;</a></sup><sup id="cite_ref-pmid20081638_146-0" class="reference"><a href="#cite_note-pmid20081638-146">&#91;146&#93;</a></sup> Palliative care specialists can help with physical symptoms, emotional factors such as loss of function and jobs, depression, fear, and existential concerns.<sup id="cite_ref-pmid22771241_145-1" class="reference"><a href="#cite_note-pmid22771241-145">&#91;145&#93;</a></sup><sup id="cite_ref-pmid20081638_146-1" class="reference"><a href="#cite_note-pmid20081638-146">&#91;146&#93;</a></sup><sup id="cite_ref-pmid24801658_147-0" class="reference"><a href="#cite_note-pmid24801658-147">&#91;147&#93;</a></sup>
</p><p>Along with offering emotional support to both the affected person and family, palliative care serves an important role in addressing goals of care. People with PD may have many difficult decisions to make as the disease progresses, such as wishes for <a href="/wiki/Feeding_tube" title="Feeding tube">feeding tube</a>, <a href="/wiki/Non-invasive_ventilation" title="Non-invasive ventilation">noninvasive ventilator</a> or <a href="/wiki/Tracheotomy" title="Tracheotomy">tracheostomy</a>, wishes for or against <a href="/wiki/Cardiopulmonary_resuscitation" title="Cardiopulmonary resuscitation">cardiopulmonary resuscitation</a>, and when to use <a href="/wiki/Hospice" title="Hospice">hospice</a> care.<sup id="cite_ref-pmid24182372_144-1" class="reference"><a href="#cite_note-pmid24182372-144">&#91;144&#93;</a></sup> Palliative-care team members can help answer questions and guide people with PD on these complex and emotional topics to help them make the best decision based on their own values.<sup id="cite_ref-pmid20081638_146-2" class="reference"><a href="#cite_note-pmid20081638-146">&#91;146&#93;</a></sup><sup id="cite_ref-pmid24195263_148-0" class="reference"><a href="#cite_note-pmid24195263-148">&#91;148&#93;</a></sup>
</p><p>Muscles and nerves that control the digestive process may be affected by PD, resulting in constipation and <a href="/wiki/Gastroparesis" title="Gastroparesis">gastroparesis</a> (food remaining in the stomach for a longer period than normal).<sup id="cite_ref-pmid19691125_17-3" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> A balanced diet, based on periodical nutritional assessments, is recommended, and should be designed to avoid weight loss or gain and minimize the consequences of gastrointestinal dysfunction.<sup id="cite_ref-pmid19691125_17-4" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> As the disease advances, swallowing difficulties (<a href="/wiki/Dysphagia" title="Dysphagia">dysphagia</a>) may appear. In such cases, using <a href="/wiki/Thickening_agent" title="Thickening agent">thickening agents</a> for liquid intake and an upright posture when eating may be useful; both measures reduce the risk of choking. <a href="/wiki/Gastrostomy" title="Gastrostomy">Gastrostomy</a> to deliver food directly into the stomach is possible in severe cases.<sup id="cite_ref-pmid19691125_17-5" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup>
</p><p>Levodopa and proteins use the same transportation system in the intestine and the blood–brain barrier, thereby competing for access.<sup id="cite_ref-pmid19691125_17-6" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> Taking them together results in reduced effectiveness of the drug.<sup id="cite_ref-pmid19691125_17-7" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> Therefore, when levodopa is introduced, excessive protein consumption is discouraged, and a well-balanced <a href="/wiki/Mediterranean_diet" title="Mediterranean diet">Mediterranean diet</a> is recommended. In advanced stages, additional intake of low-protein products such as bread or pasta is recommended for similar reasons.<sup id="cite_ref-pmid19691125_17-8" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> To minimize interaction with proteins, levodopa should be taken 30 minutes before meals.<sup id="cite_ref-pmid19691125_17-9" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup> At the same time, regimens for PD restrict proteins during breakfast and lunch, allowing protein intake in the evening.<sup id="cite_ref-pmid19691125_17-10" class="reference"><a href="#cite_note-pmid19691125-17">&#91;17&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=27" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Unified_Parkinson%27s_disease_rating_scale" title="Unified Parkinson&#39;s disease rating scale">Unified Parkinson's disease rating scale</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Parkinson_disease_world_map_-_DALY_-_WHO2004.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Parkinson_disease_world_map_-_DALY_-_WHO2004.svg/290px-Parkinson_disease_world_map_-_DALY_-_WHO2004.svg.png" decoding="async" width="290" height="128" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Parkinson_disease_world_map_-_DALY_-_WHO2004.svg/435px-Parkinson_disease_world_map_-_DALY_-_WHO2004.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/c/c1/Parkinson_disease_world_map_-_DALY_-_WHO2004.svg/580px-Parkinson_disease_world_map_-_DALY_-_WHO2004.svg.png 2x" data-file-width="940" data-file-height="415" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Parkinson_disease_world_map_-_DALY_-_WHO2004.svg" class="internal" title="Enlarge"></a></div>Global burden of Parkinson's disease, measured in <a href="/wiki/Disability-adjusted_life_year" title="Disability-adjusted life year">disability-adjusted life years</a> per 100,000&#160;inhabitants in 2004 <div> <table class="multicol" role="presentation" style="border-collapse: collapse; padding: 0; border: 0; background:transparent; width:100%;">  <tbody><tr> <td style="text-align: left; vertical-align: top;"> <style data-mw-deduplicate="TemplateStyles:r981673959">.mw-parser-output .legend{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .legend-color{display:inline-block;min-width:1.25em;height:1.25em;line-height:1.25;margin:1px 0;text-align:center;border:1px solid black;background-color:transparent;color:black}.mw-parser-output .legend-text{}</style><div class="legend"><span class="legend-color" style="background-color:#b3b3b3; color:black;">&#160;</span>&#160;no data</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffff65; color:black;">&#160;</span>&#160;&lt;&#160;5</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#fff200; color:black;">&#160;</span>&#160;5–12.5</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffdc00; color:black;">&#160;</span>&#160;12.5–20</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffc600; color:black;">&#160;</span>&#160;20–27.5</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffb000; color:black;">&#160;</span>&#160;27.5–35</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff9a00; color:black;">&#160;</span>&#160;35–42.5</div>  </td> <td style="text-align: left; vertical-align: top;"> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff8400; color:black;">&#160;</span>&#160;42.5–50</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff6e00; color:black;">&#160;</span>&#160;50–57.5</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff5800; color:black;">&#160;</span>&#160;57.5–65</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff4200; color:black;">&#160;</span>&#160;65–72.5</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff2c00; color:black;">&#160;</span>&#160;72.5–80</div> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#cb0000; color:white;">&#160;</span>&#160;&gt;&#160;80</div> &#32; </td></tr></tbody></table></div></div></div></div>
<p>PD invariably progresses with time. A severity rating method known as the <a href="/wiki/Unified_Parkinson%27s_disease_rating_scale" title="Unified Parkinson&#39;s disease rating scale">Unified Parkinson's disease rating scale</a> (UPDRS) is the most commonly used metric for a clinical study. A modified version known as the MDS-UPDRS is also sometimes used. An older scaling method known as the <a href="/wiki/Hoehn_and_Yahr_scale" title="Hoehn and Yahr scale">Hoehn and Yahr scale</a> (originally published in 1967), and a similar scale known as the Modified Hoehn and Yahr scale, have also been commonly used. The Hoehn and Yahr scale defines five basic stages of progression.
</p><p>Motor symptoms, if not treated, advance aggressively in the early stages of the disease and more slowly later. Untreated, individuals are expected to lose independent <a href="/wiki/Ambulation" class="mw-redirect" title="Ambulation">ambulation</a> after an average of eight years and be bedridden after 10 years.<sup id="cite_ref-pmid17131223_149-0" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> However, it is uncommon to find untreated people nowadays. Medication has improved the prognosis of motor symptoms, while at the same time it is a new source of disability, because of the undesired effects of levodopa after years of use.<sup id="cite_ref-pmid17131223_149-1" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> In people taking levodopa, the progression time of symptoms to a stage of high dependency from caregivers may be over 15 years.<sup id="cite_ref-pmid17131223_149-2" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> Predicting what course the disease will take for a given individual is difficult.<sup id="cite_ref-pmid17131223_149-3" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> Age is the best predictor of disease progression.<sup id="cite_ref-pmid20495568_81-3" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> The rate of motor decline is greater in those with less impairment at the time of diagnosis, while cognitive impairment is more frequent in those who are over 70 years of age at symptom onset.<sup id="cite_ref-pmid20495568_81-4" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup>
</p><p>Since current therapies improve motor symptoms, disability at present is mainly related to nonmotor features of the disease.<sup id="cite_ref-pmid20495568_81-5" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> Nevertheless, the relationship between disease progression and disability is not linear. Disability is initially related to motor symptoms.<sup id="cite_ref-pmid17131223_149-4" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> As the disease advances, disability is more related to motor symptoms that do not respond adequately to medication, such as swallowing/speech difficulties, and gait/balance problems; and also to levodopa-induced complications, which appear in up to 50% of individuals after 5 years of levodopa usage.<sup id="cite_ref-pmid17131223_149-5" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> Finally, after ten years most people with the disease have autonomic disturbances, sleep problems, mood alterations and cognitive decline.<sup id="cite_ref-pmid17131223_149-6" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> All of these symptoms, especially cognitive decline, greatly increase disability.<sup id="cite_ref-pmid20495568_81-6" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup><sup id="cite_ref-pmid17131223_149-7" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup>
</p><p>The <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> of people with PD is reduced.<sup id="cite_ref-pmid17131223_149-8" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> <a href="/wiki/Standardized_mortality_ratio" title="Standardized mortality ratio">Mortality ratios</a> are around twice those of unaffected people.<sup id="cite_ref-pmid17131223_149-9" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup>  Cognitive decline and dementia, old age at onset, a more advanced disease state, and presence of swallowing problems are all mortality <a href="/wiki/Risk_factor" title="Risk factor">risk factors</a>. A disease pattern mainly characterized by tremor as opposed to rigidity, though, predicts an improved survival.<sup id="cite_ref-pmid17131223_149-10" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup> Death from <a href="/wiki/Aspiration_pneumonia" title="Aspiration pneumonia">aspiration pneumonia</a> is twice as common in individuals with PD as in the healthy population.<sup id="cite_ref-pmid17131223_149-11" class="reference"><a href="#cite_note-pmid17131223-149">&#91;149&#93;</a></sup>
</p><p>In 2016, PD resulted in about 211,000 deaths globally, an increase of 161% since 1990.<sup id="cite_ref-GlobalBurden2016_150-0" class="reference"><a href="#cite_note-GlobalBurden2016-150">&#91;150&#93;</a></sup> The overall death rate increased by 19% to 1.81 per 100,000 people during that time.<sup id="cite_ref-GlobalBurden2016_150-1" class="reference"><a href="#cite_note-GlobalBurden2016-150">&#91;150&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=28" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:292px;"><a href="/wiki/File:Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/58/Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg/290px-Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg.png" decoding="async" width="290" height="128" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/58/Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg/435px-Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/58/Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg/580px-Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg.png 2x" data-file-width="940" data-file-height="415" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Parkinsons_disease_world_map-Deaths_per_million_persons-WHO2012.svg" class="internal" title="Enlarge"></a></div>Deaths from PD per million persons in 2012 <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1054258005"/><div class="refbegin refbegin-columns references-column-count references-column-count-3" style="column-count: 3;"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffff20; color:black;">&#160;</span>&#160;0–1</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffe820; color:black;">&#160;</span>&#160;2–4</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffd820; color:black;">&#160;</span>&#160;5–6</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffc020; color:black;">&#160;</span>&#160;7–8</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ffa020; color:black;">&#160;</span>&#160;9–10</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#ff9a20; color:black;">&#160;</span>&#160;11–12</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#f08015; color:black;">&#160;</span>&#160;13–17</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#e06815; color:black;">&#160;</span>&#160;18–36</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#d85010; color:black;">&#160;</span>&#160;37–62</div><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r981673959"/><div class="legend"><span class="legend-color" style="background-color:#d02010; color:white;">&#160;</span>&#160;63–109</div></div></div></div></div>
<p>PD is the second most common <a href="/wiki/Neurodegeneration" class="mw-redirect" title="Neurodegeneration">neurodegenerative disorder</a> after <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a> and affects approximately seven million people globally and one million people in the United States.<sup id="cite_ref-OFP_38-1" class="reference"><a href="#cite_note-OFP-38">&#91;38&#93;</a></sup><sup id="cite_ref-pmid16713924_53-4" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup><sup id="cite_ref-pmid23225012_151-0" class="reference"><a href="#cite_note-pmid23225012-151">&#91;151&#93;</a></sup> The <a href="/wiki/Prevalence" title="Prevalence">proportion in a population at a given time</a> is about 0.3% in industrialized countries. PD is more common in the elderly and rates rise from 1% in those over 60 years of age to 4% of the population over 80.<sup id="cite_ref-pmid16713924_53-5" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup> The mean age of onset is around 60 years, although 5–10% of cases, classified as young onset PD, begin between the ages of 20 and 50.<sup id="cite_ref-pmid15172778_16-9" class="reference"><a href="#cite_note-pmid15172778-16">&#91;16&#93;</a></sup> Males are more often affected than females at a ratio of around 3:2.<sup id="cite_ref-Lancet2015_4-11" class="reference"><a href="#cite_note-Lancet2015-4">&#91;4&#93;</a></sup> PD may be less prevalent in those of African and Asian ancestry, although this finding is disputed.<sup id="cite_ref-pmid16713924_53-6" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup> The <a href="/wiki/Incidence_(epidemiology)" title="Incidence (epidemiology)">number of new cases per year</a> of PD is between 8 and 18 per 100,000 person–years.<sup id="cite_ref-pmid16713924_53-7" class="reference"><a href="#cite_note-pmid16713924-53">&#91;53&#93;</a></sup>
</p><p>The age-adjusted rate of Parkinson's disease in Estonia is 28.0/100,000 person years.<sup id="cite_ref-Kad2019_152-0" class="reference"><a href="#cite_note-Kad2019-152">&#91;152&#93;</a></sup> The Estonian rate has been stable between 2000 and 2019.<sup id="cite_ref-Kad2019_152-1" class="reference"><a href="#cite_note-Kad2019-152">&#91;152&#93;</a></sup> The incidence of Parkinson's disease has increased in China. It is estimated that China will have nearly half of the Parkinson's disease population in the world in 2030.<sup id="cite_ref-153" class="reference"><a href="#cite_note-153">&#91;153&#93;</a></sup> By the year 2040 the number of patients is expected to grow to approximately 14 million people; this growth has been referred to as the <i>Parkinson's pandemic.</i><sup id="cite_ref-154" class="reference"><a href="#cite_note-154">&#91;154&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=29" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/History_of_Parkinson%27s_disease" title="History of Parkinson&#39;s disease">History of Parkinson's disease</a></div>
<div class="thumb tleft"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Charcot1893.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Charcot1893.jpg/170px-Charcot1893.jpg" decoding="async" width="170" height="269" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Charcot1893.jpg/255px-Charcot1893.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d2/Charcot1893.jpg/340px-Charcot1893.jpg 2x" data-file-width="957" data-file-height="1512" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Charcot1893.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, who made important contributions to the understanding of the disease and proposed its current name honoring <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a></div></div></div>
<p>Several early sources, including an <a href="/wiki/Ancient_Egypt" title="Ancient Egypt">Egyptian</a> <a href="/wiki/Papyrus" title="Papyrus">papyrus</a>, an <a href="/wiki/Ayurveda" title="Ayurveda">Ayurvedic</a> medical treatise, the <a href="/wiki/Bible" title="Bible">Bible</a>, and <a href="/wiki/Galen" title="Galen">Galen</a>'s writings, describe symptoms resembling those of PD.<sup id="cite_ref-pmid15568171_155-0" class="reference"><a href="#cite_note-pmid15568171-155">&#91;155&#93;</a></sup> After Galen there are no references unambiguously related to PD until the 17th century.<sup id="cite_ref-pmid15568171_155-1" class="reference"><a href="#cite_note-pmid15568171-155">&#91;155&#93;</a></sup> In the 17th and 18th centuries, several authors wrote about elements of the disease, including <a href="/wiki/Franciscus_Sylvius" title="Franciscus Sylvius">Sylvius</a>, <a href="/wiki/Hieronymus_David_Gaubius" title="Hieronymus David Gaubius">Gaubius</a>, <a href="/wiki/John_Hunter_(surgeon)" title="John Hunter (surgeon)">Hunter</a> and <a href="/wiki/Auguste_Fran%C3%A7ois_Chomel" title="Auguste François Chomel">Chomel</a>.<sup id="cite_ref-pmid15568171_155-2" class="reference"><a href="#cite_note-pmid15568171-155">&#91;155&#93;</a></sup><sup id="cite_ref-pmid19892136_156-0" class="reference"><a href="#cite_note-pmid19892136-156">&#91;156&#93;</a></sup><sup id="cite_ref-pmid9380070_157-0" class="reference"><a href="#cite_note-pmid9380070-157">&#91;157&#93;</a></sup>
</p><p>In 1817, an English doctor, <a href="/wiki/James_Parkinson" title="James Parkinson">James Parkinson</a>, published his essay reporting six cases of paralysis agitans.<sup id="cite_ref-pmid18175393_21-1" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> <i>An Essay on the Shaking Palsy</i> described the characteristic resting tremor, abnormal posture and gait, paralysis and diminished muscle strength, and the way that the disease progresses over time.<sup id="cite_ref-ParkinsonJEssay_19-1" class="reference"><a href="#cite_note-ParkinsonJEssay-19">&#91;19&#93;</a></sup><sup id="cite_ref-pmid9399240_158-0" class="reference"><a href="#cite_note-pmid9399240-158">&#91;158&#93;</a></sup> Early neurologists who made further additions to the knowledge of the disease include <a href="/wiki/Armand_Trousseau" title="Armand Trousseau">Trousseau</a>, <a href="/wiki/William_Gowers_(neurologist)" title="William Gowers (neurologist)">Gowers</a>, <a href="/wiki/Samuel_Alexander_Kinnier_Wilson" title="Samuel Alexander Kinnier Wilson">Kinnier Wilson</a> and <a href="/wiki/Wilhelm_Heinrich_Erb" title="Wilhelm Heinrich Erb">Erb</a>, and most notably <a href="/wiki/Jean-Martin_Charcot" title="Jean-Martin Charcot">Jean-Martin Charcot</a>, whose studies between 1868 and 1881 were a landmark in the understanding of the disease.<sup id="cite_ref-pmid18175393_21-2" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> Among other advances, he made the distinction between rigidity, weakness and bradykinesia.<sup id="cite_ref-pmid18175393_21-3" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> He also championed the renaming of the disease in honor of James Parkinson.<sup id="cite_ref-pmid18175393_21-4" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup>
</p><p>In 1912, <a href="/wiki/Frederic_Lewy" title="Frederic Lewy">Frederic Lewy</a> described microscopic particles in affected brains, later named Lewy bodies.<sup id="cite_ref-pmid18175393_21-5" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> In 1919, <a href="/wiki/Konstantin_Tretiakoff" title="Konstantin Tretiakoff">Konstantin Tretiakoff</a> reported that the substantia nigra was the main cerebral structure affected, but this finding was not widely accepted until it was confirmed by further studies published by <a href="/wiki/Rolf_Hassler" title="Rolf Hassler">Rolf Hassler</a> in 1938.<sup id="cite_ref-pmid18175393_21-6" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> The underlying biochemical changes in the brain were identified in the 1950s, due largely to the work of <a href="/wiki/Arvid_Carlsson" title="Arvid Carlsson">Arvid Carlsson</a> on the neurotransmitter dopamine and <a href="/wiki/Oleh_Hornykiewicz" title="Oleh Hornykiewicz">Oleh Hornykiewicz</a> on its role on PD.<sup id="cite_ref-pmid18781671_159-0" class="reference"><a href="#cite_note-pmid18781671-159">&#91;159&#93;</a></sup> In 1997, alpha-synuclein was found to be the main component of Lewy bodies by <a href="/wiki/Maria_Grazia_Spillantini" title="Maria Grazia Spillantini">Spillantini</a>, <a href="/wiki/John_Q._Trojanowski" title="John Q. Trojanowski">Trojanowski</a>, <a href="/wiki/Michel_Goedert" title="Michel Goedert">Goedert</a> and others.<sup id="cite_ref-pmid20563819_82-2" class="reference"><a href="#cite_note-pmid20563819-82">&#91;82&#93;</a></sup>
</p><p>Anticholinergics and surgery (lesioning of the <a href="/wiki/Corticospinal_pathway" class="mw-redirect" title="Corticospinal pathway">corticospinal pathway</a> or some of the basal ganglia structures) were the only treatments until the arrival of levodopa, which reduced their use dramatically.<sup id="cite_ref-pmid19892136_156-1" class="reference"><a href="#cite_note-pmid19892136-156">&#91;156&#93;</a></sup><sup id="cite_ref-pmid9361073_160-0" class="reference"><a href="#cite_note-pmid9361073-160">&#91;160&#93;</a></sup> <a href="/wiki/Levodopa" class="mw-redirect" title="Levodopa">Levodopa</a> was first synthesized in 1911 by <a href="/wiki/Casimir_Funk" title="Casimir Funk">Casimir Funk</a>, but it received little attention until the mid 20th century.<sup id="cite_ref-pmid18781671_159-1" class="reference"><a href="#cite_note-pmid18781671-159">&#91;159&#93;</a></sup> It entered clinical practice in 1967 and brought about a revolution in the management of PD.<sup id="cite_ref-pmid18781671_159-2" class="reference"><a href="#cite_note-pmid18781671-159">&#91;159&#93;</a></sup><sup id="cite_ref-161" class="reference"><a href="#cite_note-161">&#91;161&#93;</a></sup> By the late 1980s <a href="/wiki/Deep_brain_stimulation" title="Deep brain stimulation">deep brain stimulation</a> introduced by <a href="/wiki/Alim_Louis_Benabid" title="Alim Louis Benabid">Alim Louis Benabid</a> and colleagues at <a href="/wiki/Grenoble" title="Grenoble">Grenoble</a>, France, emerged as a possible treatment.<sup id="cite_ref-pmid18684199_162-0" class="reference"><a href="#cite_note-pmid18684199-162">&#91;162&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=30" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Cost">Cost</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=31" title="Edit section: Cost">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<table class="box-Update plainlinks metadata ambox ambox-content ambox-Update" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="Ambox current red Americas.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/42px-Ambox_current_red_Americas.svg.png" decoding="async" width="42" height="34" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/63px-Ambox_current_red_Americas.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/84px-Ambox_current_red_Americas.svg.png 2x" data-file-width="360" data-file-height="290" /></div></td><td class="mbox-text"><div class="mbox-text-span">Parts of this article (those related to this subsection) need to be <b>updated</b>.<span class="hide-when-compact"> Please help update this article to reflect recent events or newly available information.</span>  <span class="date-container"><i>(<span class="date">August 2020</span>)</i></span></div></td></tr></tbody></table>
<div class="thumb tright"><div class="thumbinner" style="width:127px;"><a href="/wiki/File:Pdtulip-aware3-72dpi.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Pdtulip-aware3-72dpi.jpg/125px-Pdtulip-aware3-72dpi.jpg" decoding="async" width="125" height="132" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/09/Pdtulip-aware3-72dpi.jpg/188px-Pdtulip-aware3-72dpi.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/0/09/Pdtulip-aware3-72dpi.jpg 2x" data-file-width="205" data-file-height="216" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Pdtulip-aware3-72dpi.jpg" class="internal" title="Enlarge"></a></div>"Parkinson's awareness" logo with red tulip symbol</div></div></div>
<p>The costs of PD to society are high, but precise calculations are difficult due to methodological issues in research and differences between countries.<sup id="cite_ref-pmid17702630_163-0" class="reference"><a href="#cite_note-pmid17702630-163">&#91;163&#93;</a></sup> The annual cost in the UK is estimated to be between £49 million and £3.3 billion, while the cost per affected person per year in the U.S. is probably around $10,000 and the total burden around $23 billion.<sup id="cite_ref-pmid17702630_163-1" class="reference"><a href="#cite_note-pmid17702630-163">&#91;163&#93;</a></sup> The largest share of direct cost comes from <a href="/wiki/Inpatient_care" title="Inpatient care">inpatient care</a> and nursing homes, while the share coming from medication is substantially lower.<sup id="cite_ref-pmid17702630_163-2" class="reference"><a href="#cite_note-pmid17702630-163">&#91;163&#93;</a></sup> Indirect costs are high, due to reduced productivity and the burden on caregivers.<sup id="cite_ref-pmid17702630_163-3" class="reference"><a href="#cite_note-pmid17702630-163">&#91;163&#93;</a></sup> In addition to economic costs, PD reduces quality of life of those with the disease and their caregivers.<sup id="cite_ref-pmid17702630_163-4" class="reference"><a href="#cite_note-pmid17702630-163">&#91;163&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Advocacy">Advocacy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=32" title="Edit section: Advocacy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The birthday of James Parkinson, 11 April, has been designated as World Parkinson's Day.<sup id="cite_ref-pmid18175393_21-7" class="reference"><a href="#cite_note-pmid18175393-21">&#91;21&#93;</a></sup> A red tulip was chosen by international organizations as the symbol of the disease in 2005; it represents the 'James Parkinson' tulip <a href="/wiki/Cultivar" title="Cultivar">cultivar</a>, registered in 1981 by a Dutch horticulturalist.<sup id="cite_ref-tulip_164-0" class="reference"><a href="#cite_note-tulip-164">&#91;164&#93;</a></sup> Advocacy organizations include the <a href="/wiki/National_Parkinson_Foundation" class="mw-redirect" title="National Parkinson Foundation">National Parkinson Foundation</a>, which has provided more than $180 million in care, research, and support services since 1982,<sup id="cite_ref-urlNational_Parkinson_Foundation_–_Mission_165-0" class="reference"><a href="#cite_note-urlNational_Parkinson_Foundation_–_Mission-165">&#91;165&#93;</a></sup> <a href="/wiki/Parkinson%27s_Disease_Foundation" class="mw-redirect" title="Parkinson&#39;s Disease Foundation">Parkinson's Disease Foundation</a>, which has distributed more than $115 million for research and nearly $50 million for education and advocacy programs since its founding in 1957 by William Black;<sup id="cite_ref-166" class="reference"><a href="#cite_note-166">&#91;166&#93;</a></sup><sup id="cite_ref-167" class="reference"><a href="#cite_note-167">&#91;167&#93;</a></sup> the <a href="/wiki/American_Parkinson_Disease_Association" title="American Parkinson Disease Association">American Parkinson Disease Association</a>, founded in 1961;<sup id="cite_ref-168" class="reference"><a href="#cite_note-168">&#91;168&#93;</a></sup> and the <a href="/wiki/European_Parkinson%27s_Disease_Association" title="European Parkinson&#39;s Disease Association">European Parkinson's Disease Association</a>, founded in 1992.<sup id="cite_ref-169" class="reference"><a href="#cite_note-169">&#91;169&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Notable_cases">Notable cases</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=33" title="Edit section: Notable cases">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/List_of_people_diagnosed_with_Parkinson%27s_disease" title="List of people diagnosed with Parkinson&#39;s disease">List of people diagnosed with Parkinson's disease</a></div>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Muhammad_Ali,_Davos.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Muhammad_Ali%2C_Davos.jpg/170px-Muhammad_Ali%2C_Davos.jpg" decoding="async" width="170" height="347" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Muhammad_Ali%2C_Davos.jpg/255px-Muhammad_Ali%2C_Davos.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/ba/Muhammad_Ali%2C_Davos.jpg/340px-Muhammad_Ali%2C_Davos.jpg 2x" data-file-width="1346" data-file-height="2748" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Muhammad_Ali,_Davos.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a> at the <a href="/wiki/World_Economic_Forum" title="World Economic Forum">World Economic Forum</a> in <a href="/wiki/Davos" title="Davos">Davos</a>, at the age of 64. He had shown signs of parkinsonism from the age of 38 until his death.</div></div></div>
<p>Actor <a href="/wiki/Michael_J._Fox" title="Michael J. Fox">Michael J. Fox</a> has PD and has greatly increased the public awareness of the disease.<sup id="cite_ref-MJF_TIME_22-1" class="reference"><a href="#cite_note-MJF_TIME-22">&#91;22&#93;</a></sup> After diagnosis, Fox embraced his Parkinson's in television roles, sometimes acting without medication,  to further illustrate the effects of the condition. He has written two autobiographies in which his fight against the disease plays a major role,<sup id="cite_ref-MJF_guardian_170-0" class="reference"><a href="#cite_note-MJF_guardian-170">&#91;170&#93;</a></sup> and appeared before the <a href="/wiki/United_States_Congress" title="United States Congress">United States Congress</a> without medication to illustrate the effects of the disease.<sup id="cite_ref-MJF_guardian_170-1" class="reference"><a href="#cite_note-MJF_guardian-170">&#91;170&#93;</a></sup> <a href="/wiki/The_Michael_J._Fox_Foundation" title="The Michael J. Fox Foundation">The Michael J. Fox Foundation</a> aims to develop a cure for Parkinson's disease.<sup id="cite_ref-MJF_guardian_170-2" class="reference"><a href="#cite_note-MJF_guardian-170">&#91;170&#93;</a></sup> Fox received an <a href="/wiki/Honorary_degree" title="Honorary degree">honorary doctorate</a> in medicine from <a href="/wiki/Karolinska_Institutet" class="mw-redirect" title="Karolinska Institutet">Karolinska Institutet</a> for his contributions to research in Parkinson's disease.<sup id="cite_ref-doctorate_Fox_171-0" class="reference"><a href="#cite_note-doctorate_Fox-171">&#91;171&#93;</a></sup>
</p><p>Professional cyclist and Olympic medalist <a href="/wiki/Davis_Phinney" title="Davis Phinney">Davis Phinney</a>, who was diagnosed with young-onset Parkinson's at age 40, started the <a href="/wiki/Davis_Phinney_Foundation" title="Davis Phinney Foundation">Davis Phinney Foundation</a> in 2004 to support PD research, focusing on quality of life for people with the disease.<sup id="cite_ref-Mac2008_23-1" class="reference"><a href="#cite_note-Mac2008-23">&#91;23&#93;</a></sup><sup id="cite_ref-DPF_172-0" class="reference"><a href="#cite_note-DPF-172">&#91;172&#93;</a></sup>
</p><p>Boxer <a href="/wiki/Muhammad_Ali" title="Muhammad Ali">Muhammad Ali</a> showed signs of PD when he was 38, but was not diagnosed until he was 42, and has been called the "world's most famous Parkinson's patient".<sup id="cite_ref-Ali_NN_comment_24-1" class="reference"><a href="#cite_note-Ali_NN_comment-24">&#91;24&#93;</a></sup> Whether he had PD or <a href="/wiki/Dementia_pugilistica" class="mw-redirect" title="Dementia pugilistica">parkinsonism related to boxing</a> is unresolved.<sup id="cite_ref-Ali_NN_173-0" class="reference"><a href="#cite_note-Ali_NN-173">&#91;173&#93;</a></sup><sup id="cite_ref-Ali_NYT_174-0" class="reference"><a href="#cite_note-Ali_NYT-174">&#91;174&#93;</a></sup>
</p><p>At the time of his suicide in 2014, <a href="/wiki/Robin_Williams" title="Robin Williams">Robin Williams</a>, the American actor and comedian, had been diagnosed with PD.<sup id="cite_ref-Gallman2015_175-0" class="reference"><a href="#cite_note-Gallman2015-175">&#91;175&#93;</a></sup> According to his widow, his autopsy found diffuse Lewy body disease,<sup id="cite_ref-Gallman2015_175-1" class="reference"><a href="#cite_note-Gallman2015-175">&#91;175&#93;</a></sup><sup id="cite_ref-176" class="reference"><a href="#cite_note-176">&#91;176&#93;</a></sup><sup id="cite_ref-177" class="reference"><a href="#cite_note-177">&#91;177&#93;</a></sup> while the autopsy used the term <i>diffuse Lewy body dementia</i>.<sup id="cite_ref-LBDA_178-0" class="reference"><a href="#cite_note-LBDA-178">&#91;178&#93;</a></sup> Dennis Dickson, a spokesperson for the Lewy Body Dementia Association, clarified the distinction by stating that <i>diffuse Lewy body dementia</i> is more commonly called <i>diffuse Lewy body disease</i> and refers to the underlying disease process.<sup id="cite_ref-LBDA_178-1" class="reference"><a href="#cite_note-LBDA-178">&#91;178&#93;</a></sup>  <a href="/wiki/Ian_G._McKeith" title="Ian G. McKeith">Ian G. McKeith</a>, professor and researcher of Lewy body dementias, commented that Williams' symptoms and autopsy findings were explained by <a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">dementia with Lewy bodies</a>.<sup id="cite_ref-179" class="reference"><a href="#cite_note-179">&#91;179&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=34" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">See also: <a href="/wiki/Parkinson%27s_disease_clinical_research" title="Parkinson&#39;s disease clinical research">Parkinson's disease clinical research</a></div>
<table class="box-Update plainlinks metadata ambox ambox-content ambox-Update" role="presentation"><tbody><tr><td class="mbox-image"><div style="width:52px"><img alt="Ambox current red Americas.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/42px-Ambox_current_red_Americas.svg.png" decoding="async" width="42" height="34" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/63px-Ambox_current_red_Americas.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Ambox_current_red_Americas.svg/84px-Ambox_current_red_Americas.svg.png 2x" data-file-width="360" data-file-height="290" /></div></td><td class="mbox-text"><div class="mbox-text-span">Parts of this article (those related to this subsection) need to be <b>updated</b>.<span class="hide-when-compact"> Please help update this article to reflect recent events or newly available information.</span>  <span class="date-container"><i>(<span class="date">July 2020</span>)</i></span></div></td></tr></tbody></table>
<p>No disease-modifying drugs (drugs that target the causes or damage) are approved for Parkinson's, so this is a major focus of Parkinson's research.<sup id="cite_ref-Poewe2017_180-0" class="reference"><a href="#cite_note-Poewe2017-180">&#91;180&#93;</a></sup> Active research directions include the search for new <a href="/wiki/Animal_model" class="mw-redirect" title="Animal model">animal models</a> of the disease and studies of the potential usefulness of <a href="/wiki/Gene_therapy" title="Gene therapy">gene therapy</a>, <a href="/wiki/Stem_cell" title="Stem cell">stem cell</a> transplants, and <a href="/wiki/Neuroprotective" class="mw-redirect" title="Neuroprotective">neuroprotective</a> agents.<sup id="cite_ref-Poewe2017_180-1" class="reference"><a href="#cite_note-Poewe2017-180">&#91;180&#93;</a></sup> To aid in earlier diagnosis, research criteria for identifying <a href="/wiki/Prodrome" title="Prodrome">prodromal</a> <a href="/wiki/Biomarker_(medicine)" title="Biomarker (medicine)">biomarkers</a> of the disease have been established.<sup id="cite_ref-181" class="reference"><a href="#cite_note-181">&#91;181&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Animal_models">Animal models</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=35" title="Edit section: Animal models">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>PD is not known to occur naturally in any species other than humans, although animal models that show some features of the disease are used in research. The appearance of parkinsonism in the early 1980s in a group of drug addicts  who consumed a contaminated batch of the synthetic <a href="/wiki/Opiate" title="Opiate">opiate</a> <a href="/wiki/Desmethylprodine" title="Desmethylprodine">MPPP</a> led to the discovery of the chemical <a href="/wiki/MPTP" title="MPTP">MPTP</a> as an agent that causes parkinsonism in nonhuman primates and humans.<sup id="cite_ref-pmid6823561_182-0" class="reference"><a href="#cite_note-pmid6823561-182">&#91;182&#93;</a></sup> Other predominant toxin-based models employ the insecticide <a href="/wiki/Rotenone" title="Rotenone">rotenone</a>, the herbicide paraquat, and the fungicide <a href="/wiki/Maneb" title="Maneb">maneb</a>.<sup id="cite_ref-pmid19729209_183-0" class="reference"><a href="#cite_note-pmid19729209-183">&#91;183&#93;</a></sup> Models based on toxins are most commonly used in <a href="/wiki/Primate" title="Primate">primates</a>. <a href="/wiki/Transgene" title="Transgene">Transgenic</a> rodent models that replicate various aspects of PD have been developed.<sup id="cite_ref-pmid18642640_184-0" class="reference"><a href="#cite_note-pmid18642640-184">&#91;184&#93;</a></sup> The use of <a href="/wiki/Neurotoxin" title="Neurotoxin">neurotoxin</a> <a href="/wiki/Oxidopamine" title="Oxidopamine">6-hydroxydopamine</a> creates a model of PD in rats by targeting and destroying dopaminergic neurons in the nigrostriatal pathway when injected into the substantia nigra.<sup id="cite_ref-185" class="reference"><a href="#cite_note-185">&#91;185&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Gene_therapy">Gene therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=36" title="Edit section: Gene therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Gene_therapy_in_Parkinson%27s_disease" title="Gene therapy in Parkinson&#39;s disease">Gene therapy in Parkinson's disease</a></div>
<p><a href="/wiki/Gene_therapy" title="Gene therapy">Gene therapy</a> typically involves the use of a noninfectious <a href="/wiki/Virus" title="Virus">virus</a> (i.e., a <a href="/wiki/Viral_vector" title="Viral vector">viral vector</a> such as the <a href="/wiki/Adeno-associated_virus" title="Adeno-associated virus">adeno-associated virus</a>) to shuttle genetic material into a part of the brain. Several approaches have been tried. These approaches have involved the expression of growth factors to try to prevent damage (<a href="/wiki/Neurturin" title="Neurturin">Neurturin</a> – a <a href="/wiki/GDNF_family_of_ligands" title="GDNF family of ligands">GDNF</a>-family growth factor), and enzymes such as glutamic acid decarboxylase (<a href="/wiki/Glutamate_decarboxylase" title="Glutamate decarboxylase">GAD</a> – the enzyme that produces <a href="/wiki/Gamma-Aminobutyric_acid" title="Gamma-Aminobutyric acid">GABA</a>), tyrosine hydroxylase (the enzyme that produces L-DOPA) and <a href="/wiki/Catechol-O-methyltransferase" title="Catechol-O-methyltransferase">catechol-O-methyl transferase</a> (COMT – the enzyme that converts L-DOPA to dopamine). There have been no reported safety concerns, but the approaches have largely failed in phase 2 clinical trials.<sup id="cite_ref-Poewe2017_180-2" class="reference"><a href="#cite_note-Poewe2017-180">&#91;180&#93;</a></sup> The delivery of GAD showed promise in phase 2 trials in 2011, but whilst effective at improving motor function, was inferior to DBS. Follow-up studies in the same cohort have suggested persistent improvement.<sup id="cite_ref-186" class="reference"><a href="#cite_note-186">&#91;186&#93;</a></sup>
</p><p>There have been phase 1 clinical trials in recent years that have shown success. In a phase 1 trial sponsored by Genzyme/Voyager, the gene encoding for aromatic amino acid decarboxylase (AADC) was delivered to the putamen in the brains of people with PD. AADC is an enzyme which is key in the transformation of levodopa to dopamine. The decreasing levels of this AADC enzyme in PD could be linked with the loss of levodopa’s efficiency with time. Thus, increase in AADC expression through gene therapy could result in more effective levodopa treatment. The outcomes of this phase 1 trial were promising in that the people who received the therapy showed modest improvement.<sup id="cite_ref-187" class="reference"><a href="#cite_note-187">&#91;187&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Neuroprotective_treatments">Neuroprotective treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=37" title="Edit section: Neuroprotective treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:GDNF.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/GDNF.jpg/220px-GDNF.jpg" decoding="async" width="220" height="143" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6a/GDNF.jpg/330px-GDNF.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6a/GDNF.jpg/440px-GDNF.jpg 2x" data-file-width="1889" data-file-height="1230" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:GDNF.jpg" class="internal" title="Enlarge"></a></div>Several chemical compounds, such as <a href="/wiki/Glial_cell_line-derived_neurotrophic_factor" title="Glial cell line-derived neurotrophic factor">GDNF</a> (chemical structure pictured) have been proposed as neuroprotectors in PD, but their effectiveness has not been proven.</div></div></div>
<p>Investigations on <a href="/wiki/Neuroprotection" title="Neuroprotection">neuroprotection</a> are at the forefront of PD research. Several molecules have been proposed as potential treatments.<sup id="cite_ref-pmid20495568_81-7" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> However, none of them has been conclusively demonstrated to reduce degeneration.<sup id="cite_ref-pmid20495568_81-8" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> Agents currently under investigation include, <a href="/wiki/Glutamic_acid" title="Glutamic acid">antiglutamatergics</a>, <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">monoamine oxidase inhibitors</a> (<a href="/wiki/Selegiline" title="Selegiline">selegiline</a>, <a href="/wiki/Rasagiline" title="Rasagiline">rasagiline</a>), <a href="/wiki/Mitochondrion" title="Mitochondrion">promitochondrials</a> (<a href="/wiki/Coenzyme_Q10" title="Coenzyme Q10">coenzyme Q10</a>, <a href="/wiki/Creatine" title="Creatine">creatine</a>), <a href="/wiki/Calcium_channel_blocker" title="Calcium channel blocker">calcium channel blockers</a> (<a href="/wiki/Isradipine" title="Isradipine">isradipine</a>) and <a href="/wiki/Growth_factor" title="Growth factor">growth factors</a> (<a href="/wiki/Glial_cell_line-derived_neurotrophic_factor" title="Glial cell line-derived neurotrophic factor">GDNF</a>).<sup id="cite_ref-pmid20495568_81-9" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> Reducing <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a> pathology is a major focus of preclinical research.<sup id="cite_ref-Dimond_188-0" class="reference"><a href="#cite_note-Dimond-188">&#91;188&#93;</a></sup> A <a href="/wiki/Vaccine" title="Vaccine">vaccine</a> that primes the human immune system to destroy <a href="/wiki/Alpha-synuclein" title="Alpha-synuclein">alpha-synuclein</a>, PD01A (developed by Austrian company, Affiris), entered clinical trials and a phase 1 report in 2020 suggested safety and tolerability.<sup id="cite_ref-189" class="reference"><a href="#cite_note-189">&#91;189&#93;</a></sup><sup id="cite_ref-NS1_190-0" class="reference"><a href="#cite_note-NS1-190">&#91;190&#93;</a></sup> In 2018, an antibody, PRX002/RG7935, showed preliminary safety evidence in stage I trials supporting continuation to stage II trials.<sup id="cite_ref-JAMA_191-0" class="reference"><a href="#cite_note-JAMA-191">&#91;191&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Cell-based_therapies">Cell-based therapies</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=38" title="Edit section: Cell-based therapies">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"/><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Cell-based_therapies_for_Parkinson%27s_disease" title="Cell-based therapies for Parkinson&#39;s disease">Cell-based therapies for Parkinson's disease</a></div>
<p>Since early in the 1980s, <a href="/wiki/Fetus" title="Fetus">fetal</a>, <a href="/wiki/Pig" title="Pig">porcine</a>, <a href="/wiki/Common_carotid_artery" title="Common carotid artery">carotid</a> or <a href="/wiki/Retina" title="Retina">retinal</a> tissues have been used in <a href="/wiki/Cell-based_therapies_for_Parkinson%27s_disease" title="Cell-based therapies for Parkinson&#39;s disease">cell transplants</a>, in which dissociated cells are injected into the substantia nigra in the hope that they will incorporate themselves into the brain in a way that replaces the dopamine-producing cells that have been lost.<sup id="cite_ref-pmid20495568_81-10" class="reference"><a href="#cite_note-pmid20495568-81">&#91;81&#93;</a></sup> These sources of tissues have been largely replaced by <a href="/wiki/Induced_pluripotent_stem_cell" title="Induced pluripotent stem cell">induced pluripotent stem cell</a> derived dopaminergic neurons, as this is thought to represent a more feasible source of tissue.  Initial evidence showed <a href="/wiki/Mesencephalon" class="mw-redirect" title="Mesencephalon">mesencephalic</a> dopamine-producing cell transplants being beneficial, but <a href="/wiki/Double-blind#Double-blind_trials" class="mw-redirect" title="Double-blind">double-blind trials</a> to date have not determined a long-term benefit.<sup id="cite_ref-hench_192-0" class="reference"><a href="#cite_note-hench-192">&#91;192&#93;</a></sup> An additional significant problem was the excess release of dopamine by the transplanted tissue, leading to <a href="/wiki/Tardive_dyskinesia" title="Tardive dyskinesia">dyskinesia</a>.<sup id="cite_ref-hench_192-1" class="reference"><a href="#cite_note-hench-192">&#91;192&#93;</a></sup> In 2020, a first in human clinical trial reported the transplantation of induced pluripotent stem cells into the brain of a person suffering from PD.<sup id="cite_ref-193" class="reference"><a href="#cite_note-193">&#91;193&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Other_2">Other</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=39" title="Edit section: Other">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Repetitive_transcranial_magnetic_stimulation" class="mw-redirect" title="Repetitive transcranial magnetic stimulation">Repetitive transcranial magnetic stimulation</a> temporarily improves levodopa-induced dyskinesias.<sup id="cite_ref-pmid20714078_194-0" class="reference"><a href="#cite_note-pmid20714078-194">&#91;194&#93;</a></sup> Its usefulness in PD is an open research topic.<sup id="cite_ref-pmid20714064_195-0" class="reference"><a href="#cite_note-pmid20714064-195">&#91;195&#93;</a></sup> Several <a href="/wiki/Nutrient" title="Nutrient">nutrients</a> have been proposed as possible treatments; however there is no evidence that <a href="/wiki/Vitamin" title="Vitamin">vitamins</a> or <a href="/wiki/Food_additive" title="Food additive">food additives</a> improve symptoms.<sup id="cite_ref-pmid16606908_196-0" class="reference"><a href="#cite_note-pmid16606908-196">&#91;196&#93;</a></sup> No evidence substantiates that <a href="/wiki/Acupuncture" title="Acupuncture">acupuncture</a> and practice of <a href="/wiki/Qigong" title="Qigong">Qigong</a>, or <a href="/wiki/T%27ai_chi_ch%27uan" class="mw-redirect" title="T&#39;ai chi ch&#39;uan">T'ai chi</a>, have any effect on the course of the disease or symptoms.<sup id="cite_ref-pmid18374620_197-0" class="reference"><a href="#cite_note-pmid18374620-197">&#91;197&#93;</a></sup><sup id="cite_ref-pmid18973253_198-0" class="reference"><a href="#cite_note-pmid18973253-198">&#91;198&#93;</a></sup><sup id="cite_ref-pmid18618661_199-0" class="reference"><a href="#cite_note-pmid18618661-199">&#91;199&#93;</a></sup>
</p><p>The role of the <a href="/wiki/Gut%E2%80%93brain_axis" title="Gut–brain axis">gut–brain axis</a> and the <a href="/wiki/Gut_flora" class="mw-redirect" title="Gut flora">gut flora</a> in PD became a topic of study in the 2010s, starting with work in germ-free transgenic mice, in which <a href="/wiki/Fecal_transplant" class="mw-redirect" title="Fecal transplant">fecal transplants</a> from people with PD had worse outcomes. Some studies in humans have shown a correlation between patterns of <a href="/wiki/Dysbiosis" title="Dysbiosis">dysbiosis</a> in the gut flora in the people with PD, and these patterns, along with a measure of severity of constipation, could diagnose PD with a 90% specificity but only a 67% sensitivity. As of 2017, some scientists hypothesized that changes in the gut flora might be an early site of PD pathology, or might be part of the pathology.<sup id="cite_ref-200" class="reference"><a href="#cite_note-200">&#91;200&#93;</a></sup><sup id="cite_ref-201" class="reference"><a href="#cite_note-201">&#91;201&#93;</a></sup> Evidence indicates that gut microbiota can produce <a href="/wiki/Lipopolysaccharide" title="Lipopolysaccharide">lipopolysaccharide</a> that interferes with the normal function of α-synuclein.<sup id="cite_ref-202" class="reference"><a href="#cite_note-202">&#91;202&#93;</a></sup>
</p><p>Ventures have been undertaken to explore antagonists of <a href="/wiki/Adenosine_receptor" title="Adenosine receptor">adenosine receptors</a> (specifically <a href="/wiki/Adenosine_A2A_receptor" title="Adenosine A2A receptor">A<sub>2A</sub></a>) as an avenue for novel drugs for Parkinson's.<sup id="cite_ref-203" class="reference"><a href="#cite_note-203">&#91;203&#93;</a></sup> Of these, <a href="/wiki/Istradefylline" title="Istradefylline">istradefylline</a> has emerged as the most successful medication and was approved for medical use in the United States in 2019.<sup id="cite_ref-FDA2020_204-0" class="reference"><a href="#cite_note-FDA2020-204">&#91;204&#93;</a></sup> It is approved as an add-on treatment to the levodopa/carbidopa regime.<sup id="cite_ref-FDA2020_204-1" class="reference"><a href="#cite_note-FDA2020-204">&#91;204&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=40" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-NIH2016-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-NIH2016_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIH2016_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NIH2016_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NIH2016_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NIH2016_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NIH2016_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NIH2016_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NIH2016_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NIH2016_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NIH2016_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NIH2016_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NIH2016_1-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-Disease-Information-Page">"Parkinson's Disease Information Page"</a>. <i>NINDS</i>. 30 June 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">18 July</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NINDS&amp;rft.atitle=Parkinson%27s+Disease+Information+Page&amp;rft.date=2016-06-30&amp;rft_id=https%3A%2F%2Fwww.ninds.nih.gov%2FDisorders%2FAll-Disorders%2FParkinsons-Disease-Information-Page&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Sv2016-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Sv2016_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Sv2016_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Sv2016_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Sv2016_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Sv2016_2-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSveinbjornsdottir2016" class="citation journal cs1">Sveinbjornsdottir S (October 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjnc.13691">"The clinical symptoms of Parkinson's disease"</a>. <i>Journal of Neurochemistry</i>. <b>139</b> (Suppl 1): 318–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjnc.13691">10.1111/jnc.13691</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27401947">27401947</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurochemistry&amp;rft.atitle=The+clinical+symptoms+of+Parkinson%27s+disease&amp;rft.volume=139&amp;rft.issue=Suppl+1&amp;rft.pages=318-24&amp;rft.date=2016-10&amp;rft_id=info%3Adoi%2F10.1111%2Fjnc.13691&amp;rft_id=info%3Apmid%2F27401947&amp;rft.aulast=Sveinbjornsdottir&amp;rft.aufirst=S&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fjnc.13691&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Car2016-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-Car2016_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Car2016_3-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCarroll2016" class="citation book cs1">Carroll WM (2016). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=mRl6DAAAQBAJ&amp;pg=PA188"><i>International Neurology</i></a>. John Wiley &amp; Sons. p.&#160;188. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1118777367" title="Special:BookSources/978-1118777367"><bdi>978-1118777367</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908154209/https://books.google.com/books?id=mRl6DAAAQBAJ&amp;pg=PA188">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=International+Neurology&amp;rft.pages=188&amp;rft.pub=John+Wiley+%26+Sons&amp;rft.date=2016&amp;rft.isbn=978-1118777367&amp;rft.aulast=Carroll&amp;rft.aufirst=WM&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DmRl6DAAAQBAJ%26pg%3DPA188&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Lancet2015-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lancet2015_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Lancet2015_4-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKaliaLang2015" class="citation journal cs1">Kalia LV, Lang AE (August 2015). "Parkinson's disease". <i>Lancet</i>. <b>386</b> (9996): 896–912. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2814%2961393-3">10.1016/s0140-6736(14)61393-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25904081">25904081</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5502904">5502904</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Parkinson%27s+disease&amp;rft.volume=386&amp;rft.issue=9996&amp;rft.pages=896-912&amp;rft.date=2015-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5502904%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25904081&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2814%2961393-3&amp;rft.aulast=Kalia&amp;rft.aufirst=LV&amp;rft.au=Lang%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFerri2010" class="citation book cs1">Ferri FF (2010). "Chapter P". <i>Ferri's differential diagnosis&#160;: a practical guide to the differential diagnosis of symptoms, signs, and clinical disorders</i> (2nd&#160;ed.). Philadelphia, PA: Elsevier/Mosby. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0323076999" title="Special:BookSources/978-0323076999"><bdi>978-0323076999</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Chapter+P&amp;rft.btitle=Ferri%27s+differential+diagnosis+%3A+a+practical+guide+to+the+differential+diagnosis+of+symptoms%2C+signs%2C+and+clinical+disorders&amp;rft.place=Philadelphia%2C+PA&amp;rft.edition=2nd&amp;rft.pub=Elsevier%2FMosby&amp;rft.date=2010&amp;rft.isbn=978-0323076999&amp;rft.aulast=Ferri&amp;rft.aufirst=FF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Macleod2014-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-Macleod2014_6-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMacleodTaylorCounsell2014" class="citation journal cs1">Macleod AD, Taylor KS, Counsell CE (November 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.25898">"Mortality in Parkinson's disease: a systematic review and meta-analysis"</a>. <i>Movement Disorders</i>. <b>29</b> (13): 1615–22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.25898">10.1002/mds.25898</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24821648">24821648</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Mortality+in+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=29&amp;rft.issue=13&amp;rft.pages=1615-22&amp;rft.date=2014-11&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.25898&amp;rft_id=info%3Apmid%2F24821648&amp;rft.aulast=Macleod&amp;rft.aufirst=AD&amp;rft.au=Taylor%2C+KS&amp;rft.au=Counsell%2C+CE&amp;rft_id=%2F%2Fdoi.org%2F10.1002%252Fmds.25898&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-GBD2015Pre-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-GBD2015Pre_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GBD2015Pre_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVosAllenAroraBarber2016" class="citation journal cs1">Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A,  et&#160;al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577">"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015"</a>. <i>Lancet</i>. <b>388</b> (10053): 1545–1602. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2816%2931678-6">10.1016/S0140-6736(16)31678-6</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5055577">5055577</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27733282">27733282</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Global%2C+regional%2C+and+national+incidence%2C+prevalence%2C+and+years+lived+with+disability+for+310+diseases+and+injuries%2C+1990%E2%80%932015%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2015&amp;rft.volume=388&amp;rft.issue=10053&amp;rft.pages=1545-1602&amp;rft.date=2016-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5055577%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27733282&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2816%2931678-6&amp;rft.aulast=Vos&amp;rft.aufirst=T&amp;rft.au=Allen%2C+C&amp;rft.au=Arora%2C+M&amp;rft.au=Barber%2C+RM&amp;rft.au=Bhutta%2C+ZA&amp;rft.au=Brown%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5055577&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-GBD2015De-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-GBD2015De_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GBD2015De_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWangNaghaviAllenBarber2016" class="citation journal cs1">Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A,  et&#160;al. (GBD 2015 Mortality and Causes of Death Collaborators) (October 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903">"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015"</a>. <i>Lancet</i>. <b>388</b> (10053): 1459–1544. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0140-6736%2816%2931012-1">10.1016/s0140-6736(16)31012-1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5388903">5388903</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27733281">27733281</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Global%2C+regional%2C+and+national+life+expectancy%2C+all-cause+mortality%2C+and+cause-specific+mortality+for+249+causes+of+death%2C+1980%E2%80%932015%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2015&amp;rft.volume=388&amp;rft.issue=10053&amp;rft.pages=1459-1544&amp;rft.date=2016-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5388903%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27733281&amp;rft_id=info%3Adoi%2F10.1016%2Fs0140-6736%2816%2931012-1&amp;rft.aulast=Wang&amp;rft.aufirst=H&amp;rft.au=Naghavi%2C+M&amp;rft.au=Allen%2C+C&amp;rft.au=Barber%2C+RM&amp;rft.au=Bhutta%2C+ZA&amp;rft.au=Carter%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5388903&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-PF-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-PF_9-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.parkinson.org/understanding-parkinsons">"Understanding Parkinson's"</a>. <i>Parkinson's Foundation</i><span class="reference-accessdate">. Retrieved <span class="nowrap">12 August</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Parkinson%27s+Foundation&amp;rft.atitle=Understanding+Parkinson%27s&amp;rft_id=https%3A%2F%2Fwww.parkinson.org%2Funderstanding-parkinsons&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:5-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-:5_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:5_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:5_10-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:5_10-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:5_10-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-:5_10-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-:5_10-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-:5_10-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-:5_10-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-:5_10-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHanAhnKimShin2018" class="citation journal cs1">Han JW, Ahn YD, Kim WS, Shin CM, Jeong SJ, Song YS,  et&#160;al. (November 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6236081">"Psychiatric Manifestation in Patients with Parkinson's Disease"</a>. <i>Journal of Korean Medical Science</i>. <b>33</b> (47): e300. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3346%2Fjkms.2018.33.e300">10.3346/jkms.2018.33.e300</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6236081">6236081</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30450025">30450025</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Korean+Medical+Science&amp;rft.atitle=Psychiatric+Manifestation+in+Patients+with+Parkinson%27s+Disease&amp;rft.volume=33&amp;rft.issue=47&amp;rft.pages=e300&amp;rft.date=2018-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6236081%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30450025&amp;rft_id=info%3Adoi%2F10.3346%2Fjkms.2018.33.e300&amp;rft.aulast=Han&amp;rft.aufirst=JW&amp;rft.au=Ahn%2C+YD&amp;rft.au=Kim%2C+WS&amp;rft.au=Shin%2C+CM&amp;rft.au=Jeong%2C+SJ&amp;rft.au=Song%2C+YS&amp;rft.au=Bae%2C+YJ&amp;rft.au=Kim%2C+JM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6236081&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:9-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-:9_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:9_11-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVillar-PiquéLopes_da_FonsecaOuteiro2016" class="citation journal cs1">Villar-Piqué A, Lopes da Fonseca T, Outeiro TF (October 2016). "Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies". <i>Journal of Neurochemistry</i>. <b>139</b> (Suppl 1): 240–255. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjnc.13249">10.1111/jnc.13249</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26190401">26190401</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:11420411">11420411</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurochemistry&amp;rft.atitle=Structure%2C+function+and+toxicity+of+alpha-synuclein%3A+the+Bermuda+triangle+in+synucleinopathies&amp;rft.volume=139&amp;rft.issue=Suppl+1&amp;rft.pages=240-255&amp;rft.date=2016-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11420411%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26190401&amp;rft_id=info%3Adoi%2F10.1111%2Fjnc.13249&amp;rft.aulast=Villar-Piqu%C3%A9&amp;rft.aufirst=A&amp;rft.au=Lopes+da+Fonseca%2C+T&amp;rft.au=Outeiro%2C+TF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Quadri2018-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Quadri2018_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Quadri2018_12-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFQuadriMandemakersGrochowskaMasius2018" class="citation journal cs1">Quadri M, Mandemakers W, Grochowska MM, Masius R, Geut H, Fabrizio E,  et&#160;al. (July 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs1474-4422%2818%2930179-0">"LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study"</a>. <i>The Lancet. Neurology</i>. <b>17</b> (7): 597–608. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs1474-4422%2818%2930179-0">10.1016/s1474-4422(18)30179-0</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29887161">29887161</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:47009438">47009438</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=LRP10+genetic+variants+in+familial+Parkinson%27s+disease+and+dementia+with+Lewy+bodies%3A+a+genome-wide+linkage+and+sequencing+study&amp;rft.volume=17&amp;rft.issue=7&amp;rft.pages=597-608&amp;rft.date=2018-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A47009438%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29887161&amp;rft_id=info%3Adoi%2F10.1016%2Fs1474-4422%2818%2930179-0&amp;rft.aulast=Quadri&amp;rft.aufirst=M&amp;rft.au=Mandemakers%2C+W&amp;rft.au=Grochowska%2C+MM&amp;rft.au=Masius%2C+R&amp;rft.au=Geut%2C+H&amp;rft.au=Fabrizio%2C+E&amp;rft.au=Breedveld%2C+GJ&amp;rft.au=Kuipers%2C+D&amp;rft.au=Minneboo%2C+M&amp;rft.au=Vergouw%2C+LJ&amp;rft.au=Carreras+Mascaro%2C+A&amp;rft.au=Yonova-Doing%2C+E&amp;rft.au=Simons%2C+E&amp;rft.au=Zhao%2C+T&amp;rft.au=Di+Fonzo%2C+AB&amp;rft.au=Chang%2C+HC&amp;rft.au=Parchi%2C+P&amp;rft.au=Melis%2C+M&amp;rft.au=Correia+Guedes%2C+L&amp;rft.au=Criscuolo%2C+C&amp;rft.au=Thomas%2C+A&amp;rft.au=Brouwer%2C+RW&amp;rft.au=Heijsman%2C+D&amp;rft.au=Ingrassia%2C+AM&amp;rft.au=Calandra+Buonaura%2C+G&amp;rft.au=Rood%2C+JP&amp;rft.au=Capellari%2C+S&amp;rft.au=Rozemuller%2C+AJ&amp;rft.au=Sarchioto%2C+M&amp;rft.au=Fen+Chien%2C+H&amp;rft.au=Vanacore%2C+N&amp;rft.au=Olgiati%2C+S&amp;rft.au=Wu-Chou%2C+YH&amp;rft.au=Yeh%2C+TH&amp;rft.au=Boon%2C+AJ&amp;rft.au=Hoogers%2C+SE&amp;rft.au=Ghazvini%2C+M&amp;rft.au=IJpma%2C+AS&amp;rft.au=van+IJcken%2C+WF&amp;rft.au=Onofrj%2C+M&amp;rft.au=Barone%2C+P&amp;rft.au=Nicholl%2C+DJ&amp;rft.au=Puschmann%2C+A&amp;rft.au=De+Mari%2C+M&amp;rft.au=Kievit%2C+AJ&amp;rft.au=Barbosa%2C+E&amp;rft.au=De+Michele%2C+G&amp;rft.au=Majoor-Krakauer%2C+D&amp;rft.au=van+Swieten%2C+JC&amp;rft.au=de+Jong%2C+FJ&amp;rft.au=Ferreira%2C+JJ&amp;rft.au=Cossu%2C+G&amp;rft.au=Lu%2C+CS&amp;rft.au=Meco%2C+G&amp;rft.au=Cortelli%2C+P&amp;rft.au=van+de+Berg%2C+WD&amp;rft.au=Bonifati%2C+V&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fs1474-4422%252818%252930179-0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-nutri2009-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-nutri2009_13-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBarranco_QuintanaAllamDel_CastilloNavajas2009" class="citation journal cs1">Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF (February 2009). "Parkinson's disease and tea: a quantitative review". <i>Journal of the American College of Nutrition</i>. <b>28</b> (1): 1–6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F07315724.2009.10719754">10.1080/07315724.2009.10719754</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19571153">19571153</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26605333">26605333</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+College+of+Nutrition&amp;rft.atitle=Parkinson%27s+disease+and+tea%3A+a+quantitative+review&amp;rft.volume=28&amp;rft.issue=1&amp;rft.pages=1-6&amp;rft.date=2009-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26605333%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19571153&amp;rft_id=info%3Adoi%2F10.1080%2F07315724.2009.10719754&amp;rft.aulast=Barranco+Quintana&amp;rft.aufirst=JL&amp;rft.au=Allam%2C+MF&amp;rft.au=Del+Castillo%2C+AS&amp;rft.au=Navajas%2C+RF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:1-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:1_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:1_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:1_14-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-:1_14-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-:1_14-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-:1_14-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-:1_14-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-:1_14-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-:1_14-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-:1_14-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-:1_14-12"><sup><i><b>m</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFArmstrongOkun2020" class="citation journal cs1">Armstrong MJ, Okun MS (February 2020). "Diagnosis and Treatment of Parkinson Disease: A Review". <i>JAMA</i>. <b>323</b> (6): 548–560. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2019.22360">10.1001/jama.2019.22360</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32044947">32044947</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:211079287">211079287</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Diagnosis+and+Treatment+of+Parkinson+Disease%3A+A+Review&amp;rft.volume=323&amp;rft.issue=6&amp;rft.pages=548-560&amp;rft.date=2020-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A211079287%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32044947&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2019.22360&amp;rft.aulast=Armstrong&amp;rft.aufirst=MJ&amp;rft.au=Okun%2C+MS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMosley2010" class="citation book cs1">Mosley AD (2010). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=tE6VgburpxkC&amp;pg=PA89"><i>The encyclopedia of Parkinson's disease</i></a> (2nd&#160;ed.). New York: Facts on File. p.&#160;89. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1438127491" title="Special:BookSources/978-1438127491"><bdi>978-1438127491</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908154209/https://books.google.com/books?id=tE6VgburpxkC&amp;pg=PA89">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+encyclopedia+of+Parkinson%27s+disease&amp;rft.place=New+York&amp;rft.pages=89&amp;rft.edition=2nd&amp;rft.pub=Facts+on+File&amp;rft.date=2010&amp;rft.isbn=978-1438127491&amp;rft.aulast=Mosley&amp;rft.aufirst=AD&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DtE6VgburpxkC%26pg%3DPA89&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15172778-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15172778_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid15172778_16-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSamiiNuttRansom2004" class="citation journal cs1">Samii A, Nutt JG, Ransom BR (May 2004). "Parkinson's disease". <i>Lancet</i>. <b>363</b> (9423): 1783–1793. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2804%2916305-8">10.1016/S0140-6736(04)16305-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15172778">15172778</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35364322">35364322</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Parkinson%27s+disease&amp;rft.volume=363&amp;rft.issue=9423&amp;rft.pages=1783-1793&amp;rft.date=2004-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35364322%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F15172778&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2804%2916305-8&amp;rft.aulast=Samii&amp;rft.aufirst=A&amp;rft.au=Nutt%2C+JG&amp;rft.au=Ransom%2C+BR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19691125-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19691125_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid19691125_17-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBarichellaCeredaPezzoli2009" class="citation journal cs1">Barichella M, Cereda E, Pezzoli G (October 2009). "Major nutritional issues in the management of Parkinson's disease". <i>Movement Disorders</i>. <b>24</b> (13): 1881–1892. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.22705">10.1002/mds.22705</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/2434%2F67795">2434/67795</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19691125">19691125</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23528416">23528416</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Major+nutritional+issues+in+the+management+of+Parkinson%27s+disease&amp;rft.volume=24&amp;rft.issue=13&amp;rft.pages=1881-1892&amp;rft.date=2009-10&amp;rft_id=info%3Ahdl%2F2434%2F67795&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23528416%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19691125&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22705&amp;rft.aulast=Barichella&amp;rft.aufirst=M&amp;rft.au=Cereda%2C+E&amp;rft.au=Pezzoli%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Neuro2011-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Neuro2011_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Neuro2011_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Neuro2011_18-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAhlskog2011" class="citation journal cs1">Ahlskog JE (July 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3136051">"Does vigorous exercise have a neuroprotective effect in Parkinson disease?"</a>. <i>Neurology</i>. <b>77</b> (3): 288–294. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2Fwnl.0b013e318225ab66">10.1212/wnl.0b013e318225ab66</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3136051">3136051</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21768599">21768599</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Does+vigorous+exercise+have+a+neuroprotective+effect+in+Parkinson+disease%3F&amp;rft.volume=77&amp;rft.issue=3&amp;rft.pages=288-294&amp;rft.date=2011-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3136051%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21768599&amp;rft_id=info%3Adoi%2F10.1212%2Fwnl.0b013e318225ab66&amp;rft.aulast=Ahlskog&amp;rft.aufirst=JE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3136051&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-ParkinsonJEssay-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-ParkinsonJEssay_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ParkinsonJEssay_19-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFParkinson1817" class="citation book cs1">Parkinson J (1817). <a rel="nofollow" class="external text" href="http://www.gutenberg.org/files/23777/23777-h/23777-h.htm"><i>An Essay on the Shaking Palsy</i></a>. London: Whittingham and Roland for Sherwood, Neely, and Jones. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150924210730/http://www.gutenberg.org/files/23777/23777-h/23777-h.htm">Archived</a> from the original on 24 September 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=An+Essay+on+the+Shaking+Palsy&amp;rft.place=London&amp;rft.pub=Whittingham+and+Roland+for+Sherwood%2C+Neely%2C+and+Jones&amp;rft.date=1817&amp;rft.aulast=Parkinson&amp;rft.aufirst=J&amp;rft_id=http%3A%2F%2Fwww.gutenberg.org%2Ffiles%2F23777%2F23777-h%2F23777-h.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShulmanDe_JagerFeany2011" class="citation journal cs1">Shulman JM, De Jager PL, Feany MB (February 2011) [25 October 2010]. "Parkinson's disease: genetics and pathogenesis". <i>Annual Review of Pathology</i>. <b>6</b>: 193–222. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1146%2Fannurev-pathol-011110-130242">10.1146/annurev-pathol-011110-130242</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21034221">21034221</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:8328666">8328666</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Pathology&amp;rft.atitle=Parkinson%27s+disease%3A+genetics+and+pathogenesis&amp;rft.volume=6&amp;rft.pages=193-222&amp;rft.date=2011-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8328666%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21034221&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-pathol-011110-130242&amp;rft.aulast=Shulman&amp;rft.aufirst=JM&amp;rft.au=De+Jager%2C+PL&amp;rft.au=Feany%2C+MB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18175393-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18175393_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid18175393_21-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLees2007" class="citation journal cs1">Lees AJ (September 2007). "Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday". <i>Movement Disorders</i>. <b>22</b> (Suppl 17): S327–34. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.21684">10.1002/mds.21684</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18175393">18175393</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:9471754">9471754</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Unresolved+issues+relating+to+the+shaking+palsy+on+the+celebration+of+James+Parkinson%27s+250th+birthday&amp;rft.volume=22&amp;rft.issue=Suppl+17&amp;rft.pages=S327-34&amp;rft.date=2007-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A9471754%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18175393&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21684&amp;rft.aulast=Lees&amp;rft.aufirst=AJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-MJF_TIME-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-MJF_TIME_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MJF_TIME_22-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDavis2007" class="citation news cs1">Davis P (3 May 2007). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110425013526/http://www.time.com/time/specials/2007/time100/article/0,28804,1595326_1615754_1615882,00.html">"Michael J. Fox"</a>. <i>The TIME 100</i>. <a href="/wiki/Time_(magazine)" title="Time (magazine)">Time</a>. Archived from <a rel="nofollow" class="external text" href="http://www.time.com/time/specials/2007/time100/article/0,28804,1595326_1615754_1615882,00.html">the original</a> on 25 April 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+TIME+100&amp;rft.atitle=Michael+J.+Fox&amp;rft.date=2007-05-03&amp;rft.aulast=Davis&amp;rft.aufirst=P&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fspecials%2F2007%2Ftime100%2Farticle%2F0%2C28804%2C1595326_1615754_1615882%2C00.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Mac2008-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Mac2008_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Mac2008_23-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMacur2008" class="citation news cs1">Macur J (26 March 2008). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2008/03/26/sports/othersports/26cycling.html?pagewanted=all&amp;_r=0">"For the Phinney Family, a Dream and a Challenge"</a>. <i>The New York Times</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20141106025145/http://www.nytimes.com/2008/03/26/sports/othersports/26cycling.html?pagewanted=all&amp;_r=0">Archived</a> from the original on 6 November 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">25 May</span> 2013</span>. <q>About 1.5 million Americans have received a diagnosis of Parkinson's disease, but only 5 to 10 percent learn of it before age 40, according to the National Parkinson Foundation. Davis Phinney was among the few.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=For+the+Phinney+Family%2C+a+Dream+and+a+Challenge&amp;rft.date=2008-03-26&amp;rft.aulast=Macur&amp;rft.aufirst=J&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2008%2F03%2F26%2Fsports%2Fothersports%2F26cycling.html%3Fpagewanted%3Dall%26_r%3D0&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Ali_NN_comment-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ali_NN_comment_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ali_NN_comment_24-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrey2006" class="citation journal cs1">Brey RL (April 2006). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20110927022505/http://www.aan.com/elibrary/neurologynow/?event=home.showArticle&amp;id=ovid.com%3A%2Fbib%2Fovftdb%2F01222928-200602020-00003">"Muhammad Ali's Message: Keep Moving Forward"</a>. <i>Neurology Now</i>. <b>2</b> (2): 8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01222928-200602020-00003">10.1097/01222928-200602020-00003</a>. Archived from <a rel="nofollow" class="external text" href="http://www.aan.com/elibrary/neurologynow/?event=home.showArticle&amp;id=ovid.com:/bib/ovftdb/01222928-200602020-00003">the original</a> on 27 September 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">22 August</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology+Now&amp;rft.atitle=Muhammad+Ali%27s+Message%3A+Keep+Moving+Forward&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=8&amp;rft.date=2006-04&amp;rft_id=info%3Adoi%2F10.1097%2F01222928-200602020-00003&amp;rft.aulast=Brey&amp;rft.aufirst=RL&amp;rft_id=http%3A%2F%2Fwww.aan.com%2Felibrary%2Fneurologynow%2F%3Fevent%3Dhome.showArticle%26id%3Dovid.com%3A%2Fbib%2Fovftdb%2F01222928-200602020-00003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAlltucker2018" class="citation news cs1">Alltucker K (31 July 2018). <a rel="nofollow" class="external text" href="https://www.usatoday.com/story/news/nation/2018/07/31/alan-alda-has-parkinsons-disease-5-things-know/871265002/">"Alan Alda has Parkinson's disease: Here are 5 things you should know"</a>. <i>USA Today</i><span class="reference-accessdate">. Retrieved <span class="nowrap">6 May</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Alan+Alda+has+Parkinson%27s+disease%3A+Here+are+5+things+you+should+know&amp;rft.date=2018-07-31&amp;rft.aulast=Alltucker&amp;rft.aufirst=K&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fnews%2Fnation%2F2018%2F07%2F31%2Falan-alda-has-parkinsons-disease-5-things-know%2F871265002%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Jankovic_book-Epidemiology2-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jankovic_book-Epidemiology2_26-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSchrag2007" class="citation book cs1">Schrag A (2007). "Epidemiology of movement disorders".  In Tolosa E, Jankovic JJ (eds.). <i>Parkinson's disease and movement disorders</i>. Hagerstown, Maryland: Lippincott Williams &amp; Wilkins. pp.&#160;50–66. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-7881-7" title="Special:BookSources/978-0-7817-7881-7"><bdi>978-0-7817-7881-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Epidemiology+of+movement+disorders&amp;rft.btitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.place=Hagerstown%2C+Maryland&amp;rft.pages=50-66&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2007&amp;rft.isbn=978-0-7817-7881-7&amp;rft.aulast=Schrag&amp;rft.aufirst=A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid164896092-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid164896092_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid164896092_27-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGalpernLang2006" class="citation journal cs1">Galpern WR, Lang AE (March 2006) [17 February 2006]. "Interface between tauopathies and synucleinopathies: a tale of two proteins". <i>Annals of Neurology</i>. <b>59</b> (3): 449–58. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.20819">10.1002/ana.20819</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16489609">16489609</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19395939">19395939</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Interface+between+tauopathies+and+synucleinopathies%3A+a+tale+of+two+proteins&amp;rft.volume=59&amp;rft.issue=3&amp;rft.pages=449-58&amp;rft.date=2006-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19395939%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16489609&amp;rft_id=info%3Adoi%2F10.1002%2Fana.20819&amp;rft.aulast=Galpern&amp;rft.aufirst=WR&amp;rft.au=Lang%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMarrasLang2013" class="citation journal cs1">Marras C, Lang A (April 2013). <a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2012-303455">"Parkinson's disease subtypes: lost in translation?"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>84</b> (4): 409–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp-2012-303455">10.1136/jnnp-2012-303455</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22952329">22952329</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Parkinson%27s+disease+subtypes%3A+lost+in+translation%3F&amp;rft.volume=84&amp;rft.issue=4&amp;rft.pages=409-15&amp;rft.date=2013-04&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp-2012-303455&amp;rft_id=info%3Apmid%2F22952329&amp;rft.aulast=Marras&amp;rft.aufirst=C&amp;rft.au=Lang%2C+A&amp;rft_id=%2F%2Fdoi.org%2F10.1136%252Fjnnp-2012-303455&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text">Photo by Arthur Londe from <i>Nouvelle Iconographie de la Salpètrière</i>, vol. 5, p. 226</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCharcotSigerson1879" class="citation book cs1">Charcot JM, Sigerson G (1879). <a rel="nofollow" class="external text" href="https://archive.org/details/lecturesondisea05chargoog"><i>Lectures on the diseases of the nervous system</i></a> (Second&#160;ed.). Philadelphia: Henry C. Lea. pp.&#160;<a rel="nofollow" class="external text" href="https://archive.org/details/lecturesondisea05chargoog/page/n131">113</a>. <q>The strokes forming the letters are very irregular and sinuous, whilst the irregularities and sinuosities are of a very limited width. (...) the down-strokes are all, with the exception of the first letter, made with comparative firmness and are, in fact, nearly normal – the finer up-strokes, on the contrary, are all tremulous in appearance (...).</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Lectures+on+the+diseases+of+the+nervous+system&amp;rft.place=Philadelphia&amp;rft.pages=113&amp;rft.edition=Second&amp;rft.pub=Henry+C.+Lea&amp;rft.date=1879&amp;rft.aulast=Charcot&amp;rft.aufirst=JM&amp;rft.au=Sigerson%2C+G&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Flecturesondisea05chargoog&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Jankovic2008-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jankovic2008_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-Jankovic2008_31-21"><sup><i><b>v</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJankovic2008" class="citation journal cs1">Jankovic J (April 2008). <a rel="nofollow" class="external text" href="http://jnnp.bmj.com/content/79/4/368.full">"Parkinson's disease: clinical features and diagnosis"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>79</b> (4): 368–76. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.2007.131045">10.1136/jnnp.2007.131045</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18344392">18344392</a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150819084941/http://jnnp.bmj.com/content/79/4/368.full">Archived</a> from the original on 19 August 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=Parkinson%27s+disease%3A+clinical+features+and+diagnosis&amp;rft.volume=79&amp;rft.issue=4&amp;rft.pages=368-76&amp;rft.date=2008-04&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.2007.131045&amp;rft_id=info%3Apmid%2F18344392&amp;rft.aulast=Jankovic&amp;rft.aufirst=J&amp;rft_id=http%3A%2F%2Fjnnp.bmj.com%2Fcontent%2F79%2F4%2F368.full&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Cooper-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-Cooper_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Cooper_32-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCooperEichhornRodnitzky2008" class="citation book cs1">Cooper G, Eichhorn G, Rodnitzky RL (2008). "Parkinson's disease".  In Conn PM (ed.). <i>Neuroscience in medicine</i>. Totowa, NJ: Humana Press. pp.&#160;508–12. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-60327-454-8" title="Special:BookSources/978-1-60327-454-8"><bdi>978-1-60327-454-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Parkinson%27s+disease&amp;rft.btitle=Neuroscience+in+medicine&amp;rft.place=Totowa%2C+NJ&amp;rft.pages=508-12&amp;rft.pub=Humana+Press&amp;rft.date=2008&amp;rft.isbn=978-1-60327-454-8&amp;rft.aulast=Cooper&amp;rft.aufirst=G&amp;rft.au=Eichhorn%2C+G&amp;rft.au=Rodnitzky%2C+RL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeesHardyRevesz2009" class="citation journal cs1">Lees AJ, Hardy J, Revesz T (June 2009). "Parkinson's disease". <i>Lancet</i>. <b>373</b> (9680): 2055–66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2809%2960492-X">10.1016/S0140-6736(09)60492-X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19524782">19524782</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:42608600">42608600</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Parkinson%27s+disease&amp;rft.volume=373&amp;rft.issue=9680&amp;rft.pages=2055-66&amp;rft.date=2009-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A42608600%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19524782&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2809%2960492-X&amp;rft.aulast=Lees&amp;rft.aufirst=AJ&amp;rft.au=Hardy%2C+J&amp;rft.au=Revesz%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Banich-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-Banich_34-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBanichCompton2011" class="citation book cs1">Banich MT, Compton RJ (2011). "Motor control". <i>Cognitive neuroscience</i>. Belmont, CA: Wadsworth, Cengage learning. pp.&#160;108–44. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-8400-3298-0" title="Special:BookSources/978-0-8400-3298-0"><bdi>978-0-8400-3298-0</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Motor+control&amp;rft.btitle=Cognitive+neuroscience&amp;rft.place=Belmont%2C+CA&amp;rft.pages=108-44&amp;rft.pub=Wadsworth%2C+Cengage+learning&amp;rft.date=2011&amp;rft.isbn=978-0-8400-3298-0&amp;rft.aulast=Banich&amp;rft.aufirst=MT&amp;rft.au=Compton%2C+RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLongmoreWilkinsonTurmezeiCheung2007" class="citation book cs1">Longmore M, Wilkinson IB, Turmezei T, Cheung CK (4 January 2007). <i>Oxford Handbook of Clinical Medicine</i>. <a href="/wiki/Oxford_University_Press" title="Oxford University Press">Oxford University Press</a>. p.&#160;486. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-19-856837-7" title="Special:BookSources/978-0-19-856837-7"><bdi>978-0-19-856837-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Oxford+Handbook+of+Clinical+Medicine&amp;rft.pages=486&amp;rft.pub=Oxford+University+Press&amp;rft.date=2007-01-04&amp;rft.isbn=978-0-19-856837-7&amp;rft.aulast=Longmore&amp;rft.aufirst=M&amp;rft.au=Wilkinson%2C+IB&amp;rft.au=Turmezei%2C+T&amp;rft.au=Cheung%2C+CK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Jankovic_book-Rigidity-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jankovic_book-Rigidity_36-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFungThompson2007" class="citation book cs1">Fung VS, Thompson PD (2007). "Rigidity and spasticity".  In Tolosa E, Jankovic E (eds.). <i>Parkinson's disease and movement disorders</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. pp.&#160;504–13. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-7881-7" title="Special:BookSources/978-0-7817-7881-7"><bdi>978-0-7817-7881-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Rigidity+and+spasticity&amp;rft.btitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.place=Hagerstown%2C+MD&amp;rft.pages=504-13&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2007&amp;rft.isbn=978-0-7817-7881-7&amp;rft.aulast=Fung&amp;rft.aufirst=VS&amp;rft.au=Thompson%2C+PD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFO&#39;SullivanSchmitz2007" class="citation book cs1">O'Sullivan SB, Schmitz TJ (2007). "Parkinson's Disease". <i>Physical Rehabilitation</i> (5th&#160;ed.). Philadelphia: F.A. Davis. pp.&#160;856–57.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Parkinson%27s+Disease&amp;rft.btitle=Physical+Rehabilitation&amp;rft.place=Philadelphia&amp;rft.pages=856-57&amp;rft.edition=5th&amp;rft.pub=F.A.+Davis&amp;rft.date=2007&amp;rft.aulast=O%27Sullivan&amp;rft.aufirst=SB&amp;rft.au=Schmitz%2C+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-OFP-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-OFP_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-OFP_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFYaoHartTerzella2013" class="citation journal cs1">Yao SC, Hart AD, Terzella MJ (May 2013). "An evidence-based osteopathic approach to Parkinson disease". <i>Osteopathic Family Physician</i>. <b>5</b> (3): 96–101. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.osfp.2013.01.003">10.1016/j.osfp.2013.01.003</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Osteopathic+Family+Physician&amp;rft.atitle=An+evidence-based+osteopathic+approach+to+Parkinson+disease&amp;rft.volume=5&amp;rft.issue=3&amp;rft.pages=96-101&amp;rft.date=2013-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.osfp.2013.01.003&amp;rft.aulast=Yao&amp;rft.aufirst=SC&amp;rft.au=Hart%2C+AD&amp;rft.au=Terzella%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHallettPoewe2008" class="citation book cs1">Hallett M, Poewe W (13 October 2008). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=fEezGoZ4h7YC&amp;pg=PA417"><i>Therapeutics of Parkinson's Disease and Other Movement Disorders</i></a>. John Wiley &amp; Sons. p.&#160;417. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-470-71400-3" title="Special:BookSources/978-0-470-71400-3"><bdi>978-0-470-71400-3</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908154209/https://books.google.com/books?id=fEezGoZ4h7YC&amp;pg=PA417">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Therapeutics+of+Parkinson%27s+Disease+and+Other+Movement+Disorders&amp;rft.pages=417&amp;rft.pub=John+Wiley+%26+Sons&amp;rft.date=2008-10-13&amp;rft.isbn=978-0-470-71400-3&amp;rft.aulast=Hallett&amp;rft.aufirst=M&amp;rft.au=Poewe%2C+W&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DfEezGoZ4h7YC%26pg%3DPA417&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHoehnYahr1967" class="citation journal cs1">Hoehn MM, Yahr MD (May 1967). <a rel="nofollow" class="external text" href="https://doi.org/10.1212%2Fwnl.17.5.427">"Parkinsonism: onset, progression and mortality"</a>. <i>Neurology</i>. <b>17</b> (5): 427–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2Fwnl.17.5.427">10.1212/wnl.17.5.427</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/6067254">6067254</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Parkinsonism%3A+onset%2C+progression+and+mortality&amp;rft.volume=17&amp;rft.issue=5&amp;rft.pages=427-42&amp;rft.date=1967-05&amp;rft_id=info%3Adoi%2F10.1212%2Fwnl.17.5.427&amp;rft_id=info%3Apmid%2F6067254&amp;rft.aulast=Hoehn&amp;rft.aufirst=MM&amp;rft.au=Yahr%2C+MD&amp;rft_id=%2F%2Fdoi.org%2F10.1212%252Fwnl.17.5.427&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPahwaLyons2003" class="citation book cs1">Pahwa R, Lyons KE (25 March 2003). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=gX5mAIk5F6UC&amp;pg=PA76"><i>Handbook of Parkinson's Disease</i></a> (Third&#160;ed.). CRC Press. p.&#160;76. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-203-91216-4" title="Special:BookSources/978-0-203-91216-4"><bdi>978-0-203-91216-4</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20170908154209/https://books.google.com/books?id=gX5mAIk5F6UC&amp;pg=PA76">Archived</a> from the original on 8 September 2017.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Handbook+of+Parkinson%27s+Disease&amp;rft.pages=76&amp;rft.edition=Third&amp;rft.pub=CRC+Press&amp;rft.date=2003-03-25&amp;rft.isbn=978-0-203-91216-4&amp;rft.aulast=Pahwa&amp;rft.aufirst=R&amp;rft.au=Lyons%2C+KE&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DgX5mAIk5F6UC%26pg%3DPA76&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18175397-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18175397_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18175397_42-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18175397_42-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18175397_42-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18175397_42-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18175397_42-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid18175397_42-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCaballolMartíTolosa2007" class="citation journal cs1">Caballol N, Martí MJ, Tolosa E (September 2007). "Cognitive dysfunction and dementia in Parkinson disease". <i>Movement Disorders</i>. <b>22</b> (Suppl 17): S358–66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.21677">10.1002/mds.21677</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18175397">18175397</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3229727">3229727</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Cognitive+dysfunction+and+dementia+in+Parkinson+disease&amp;rft.volume=22&amp;rft.issue=Suppl+17&amp;rft.pages=S358-66&amp;rft.date=2007-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3229727%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18175397&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21677&amp;rft.aulast=Caballol&amp;rft.aufirst=N&amp;rft.au=Mart%C3%AD%2C+MJ&amp;rft.au=Tolosa%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-PD_timing_review-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-PD_timing_review_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PD_timing_review_43-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PD_timing_review_43-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFParkerLamichhaneCaetanoNarayanan2013" class="citation journal cs1">Parker KL, Lamichhane D, Caetano MS, Narayanan NS (October 2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3813949">"Executive dysfunction in Parkinson's disease and timing deficits"</a>. <i>Frontiers in Integrative Neuroscience</i>. <b>7</b>: 75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnint.2013.00075">10.3389/fnint.2013.00075</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3813949">3813949</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24198770">24198770</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Integrative+Neuroscience&amp;rft.atitle=Executive+dysfunction+in+Parkinson%27s+disease+and+timing+deficits&amp;rft.volume=7&amp;rft.pages=75&amp;rft.date=2013-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3813949%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24198770&amp;rft_id=info%3Adoi%2F10.3389%2Ffnint.2013.00075&amp;rft.aulast=Parker&amp;rft.aufirst=KL&amp;rft.au=Lamichhane%2C+D&amp;rft.au=Caetano%2C+MS&amp;rft.au=Narayanan%2C+NS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3813949&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Gomperts2016-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gomperts2016_44-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGomperts2016" class="citation journal cs1">Gomperts SN (April 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5390937">"Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia"</a>. <i>Continuum (Minneap Minn)</i> (Review). <b>22</b> (2 Dementia): 435–63. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FCON.0000000000000309">10.1212/CON.0000000000000309</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5390937">5390937</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27042903">27042903</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Continuum+%28Minneap+Minn%29&amp;rft.atitle=Lewy+Body+Dementias%3A+Dementia+With+Lewy+Bodies+and+Parkinson+Disease+Dementia&amp;rft.volume=22&amp;rft.issue=2+Dementia&amp;rft.pages=435-63&amp;rft.date=2016-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5390937%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27042903&amp;rft_id=info%3Adoi%2F10.1212%2FCON.0000000000000309&amp;rft.aulast=Gomperts&amp;rft.aufirst=SN&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5390937&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGarcia-PtacekKramberger2016" class="citation journal cs1">Garcia-Ptacek S, Kramberger MG (September 2016). "Parkinson Disease and Dementia". <i>Journal of Geriatric Psychiatry and Neurology</i>. <b>29</b> (5): 261–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F0891988716654985">10.1177/0891988716654985</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27502301">27502301</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:21279235">21279235</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Geriatric+Psychiatry+and+Neurology&amp;rft.atitle=Parkinson+Disease+and+Dementia&amp;rft.volume=29&amp;rft.issue=5&amp;rft.pages=261-70&amp;rft.date=2016-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A21279235%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27502301&amp;rft_id=info%3Adoi%2F10.1177%2F0891988716654985&amp;rft.aulast=Garcia-Ptacek&amp;rft.aufirst=S&amp;rft.au=Kramberger%2C+MG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Noyce-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-Noyce_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Noyce_46-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNoyceBestwickSilveira-Moriyama2012" class="citation journal cs1">Noyce AJ, Bestwick JP, Silveira-Moriyama L,  et&#160;al. (December 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3556649">"Meta-analysis of early nonmotor features and risk factors for Parkinson disease"</a>. <i>Annals of Neurology</i> (Review). <b>72</b> (6): 893–901. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.23687">10.1002/ana.23687</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3556649">3556649</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23071076">23071076</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=Meta-analysis+of+early+nonmotor+features+and+risk+factors+for+Parkinson+disease&amp;rft.volume=72&amp;rft.issue=6&amp;rft.pages=893-901&amp;rft.date=2012-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556649%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23071076&amp;rft_id=info%3Adoi%2F10.1002%2Fana.23687&amp;rft.aulast=Noyce&amp;rft.aufirst=AJ&amp;rft.au=Bestwick%2C+JP&amp;rft.au=Silveira-Moriyama%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3556649&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFfytcheCreesePolitisChaudhuri2017" class="citation journal cs1">Ffytche DH, Creese B, Politis M, Chaudhuri KR, Weintraub D, Ballard C, Aarsland D (February 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5656278">"The psychosis spectrum in Parkinson disease"</a>. <i>Nature Reviews. Neurology</i>. <b>13</b> (2): 81–95. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrneurol.2016.200">10.1038/nrneurol.2016.200</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5656278">5656278</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28106066">28106066</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Neurology&amp;rft.atitle=The+psychosis+spectrum+in+Parkinson+disease&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=81-95&amp;rft.date=2017-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5656278%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28106066&amp;rft_id=info%3Adoi%2F10.1038%2Fnrneurol.2016.200&amp;rft.aulast=Ffytche&amp;rft.aufirst=DH&amp;rft.au=Creese%2C+B&amp;rft.au=Politis%2C+M&amp;rft.au=Chaudhuri%2C+KR&amp;rft.au=Weintraub%2C+D&amp;rft.au=Ballard%2C+C&amp;rft.au=Aarsland%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5656278&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShergillWalkerLe_Katona1998" class="citation journal cs1">Shergill SS, Walker Z, Le Katona C (October 1998). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2170290">"A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>65</b> (4): 610–1. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.65.4.610">10.1136/jnnp.65.4.610</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2170290">2170290</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9771806">9771806</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=A+preliminary+investigation+of+laterality+in+Parkinson%27s+disease+and+susceptibility+to+psychosis&amp;rft.volume=65&amp;rft.issue=4&amp;rft.pages=610-1&amp;rft.date=1998-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2170290%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F9771806&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.65.4.610&amp;rft.aulast=Shergill&amp;rft.aufirst=SS&amp;rft.au=Walker%2C+Z&amp;rft.au=Le+Katona%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2170290&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20538500-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20538500_49-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFriedman2010" class="citation journal cs1">Friedman JH (November 2010). "Parkinson's disease psychosis 2010: a review article". <i>Parkinsonism &amp; Related Disorders</i>. <b>16</b> (9): 553–60. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2010.05.004">10.1016/j.parkreldis.2010.05.004</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20538500">20538500</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Parkinson%27s+disease+psychosis+2010%3A+a+review+article&amp;rft.volume=16&amp;rft.issue=9&amp;rft.pages=553-60&amp;rft.date=2010-11&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2010.05.004&amp;rft_id=info%3Apmid%2F20538500&amp;rft.aulast=Friedman&amp;rft.aufirst=JH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:6-50"><span class="mw-cite-backlink">^ <a href="#cite_ref-:6_50-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:6_50-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:6_50-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:6_50-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWeintraubMamikonyan2019" class="citation journal cs1">Weintraub D, Mamikonyan E (September 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7015280">"The Neuropsychiatry of Parkinson Disease: A Perfect Storm"</a>. <i>The American Journal of Geriatric Psychiatry</i>. <b>27</b> (9): 998–1018. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jagp.2019.03.002">10.1016/j.jagp.2019.03.002</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7015280">7015280</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31006550">31006550</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Geriatric+Psychiatry&amp;rft.atitle=The+Neuropsychiatry+of+Parkinson+Disease%3A+A+Perfect+Storm&amp;rft.volume=27&amp;rft.issue=9&amp;rft.pages=998-1018&amp;rft.date=2019-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7015280%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31006550&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jagp.2019.03.002&amp;rft.aulast=Weintraub&amp;rft.aufirst=D&amp;rft.au=Mamikonyan%2C+E&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7015280&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:7-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-:7_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:7_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGoetz2010" class="citation journal cs1">Goetz CG (2010). <a rel="nofollow" class="external text" href="http://doi.wiley.com/10.1002/mds.22636">"New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease"</a>. <i>Movement Disorders</i>. <b>25</b> (S1): S104-9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.22636">10.1002/mds.22636</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20187250">20187250</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35420377">35420377</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=New+developments+in+depression%2C+anxiety%2C+compulsiveness%2C+and+hallucinations+in+Parkinson%27s+disease&amp;rft.volume=25&amp;rft.issue=S1&amp;rft.pages=S104-9&amp;rft.date=2010&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35420377%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20187250&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22636&amp;rft.aulast=Goetz&amp;rft.aufirst=CG&amp;rft_id=http%3A%2F%2Fdoi.wiley.com%2F10.1002%2Fmds.22636&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-52">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKimJeon2014" class="citation journal cs1">Kim YE, Jeon BS (1 January 2014). "Clinical implication of REM sleep behavior disorder in Parkinson's disease". <i>Journal of Parkinson's Disease</i>. <b>4</b> (2): 237–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2Fjpd-130293">10.3233/jpd-130293</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24613864">24613864</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Parkinson%27s+Disease&amp;rft.atitle=Clinical+implication+of+REM+sleep+behavior+disorder+in+Parkinson%27s+disease&amp;rft.volume=4&amp;rft.issue=2&amp;rft.pages=237-44&amp;rft.date=2014-01-01&amp;rft_id=info%3Adoi%2F10.3233%2Fjpd-130293&amp;rft_id=info%3Apmid%2F24613864&amp;rft.aulast=Kim&amp;rft.aufirst=YE&amp;rft.au=Jeon%2C+BS&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16713924-53"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid16713924_53-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid16713924_53-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFde_LauBreteler2006" class="citation journal cs1">de Lau LM, Breteler MM (June 2006). "Epidemiology of Parkinson's disease". <i>The Lancet. Neurology</i>. <b>5</b> (6): 525–35. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2806%2970471-9">10.1016/S1474-4422(06)70471-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16713924">16713924</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39310242">39310242</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Epidemiology+of+Parkinson%27s+disease&amp;rft.volume=5&amp;rft.issue=6&amp;rft.pages=525-35&amp;rft.date=2006-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39310242%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16713924&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2806%2970471-9&amp;rft.aulast=de+Lau&amp;rft.aufirst=LM&amp;rft.au=Breteler%2C+MM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Barreto2015-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-Barreto2015_54-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBarretoIarkovMoran2015" class="citation journal cs1">Barreto GE, Iarkov A, Moran VE (January 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4288130">"Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease"</a>. <i>Frontiers in Aging Neuroscience</i>. <b>6</b>: 340. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnagi.2014.00340">10.3389/fnagi.2014.00340</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4288130">4288130</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25620929">25620929</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Aging+Neuroscience&amp;rft.atitle=Beneficial+effects+of+nicotine%2C+cotinine+and+its+metabolites+as+potential+agents+for+Parkinson%27s+disease&amp;rft.volume=6&amp;rft.pages=340&amp;rft.date=2015-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4288130%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25620929&amp;rft_id=info%3Adoi%2F10.3389%2Ffnagi.2014.00340&amp;rft.aulast=Barreto&amp;rft.aufirst=GE&amp;rft.au=Iarkov%2C+A&amp;rft.au=Moran%2C+VE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4288130&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFÇamcıOğuz2016" class="citation journal cs1">Çamcı G, Oğuz S (April 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4828559">"Association between Parkinson's Disease and <i>Helicobacter Pylori</i>"</a>. <i>Journal of Clinical Neurology</i>. <b>12</b> (2): 147–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3988%2Fjcn.2016.12.2.147">10.3988/jcn.2016.12.2.147</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4828559">4828559</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26932258">26932258</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Neurology&amp;rft.atitle=Association+between+Parkinson%27s+Disease+and+Helicobacter+Pylori&amp;rft.volume=12&amp;rft.issue=2&amp;rft.pages=147-50&amp;rft.date=2016-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4828559%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26932258&amp;rft_id=info%3Adoi%2F10.3988%2Fjcn.2016.12.2.147&amp;rft.aulast=%C3%87amc%C4%B1&amp;rft.aufirst=G&amp;rft.au=O%C4%9Fuz%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4828559&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMcGeeLuDisbrow2018" class="citation journal cs1">McGee DJ, Lu XH, Disbrow EA (2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6130334">"Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease"</a>. <i>Journal of Parkinson's Disease</i>. <b>8</b> (3): 367–74. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJPD-181327">10.3233/JPD-181327</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6130334">6130334</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29966206">29966206</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Parkinson%27s+Disease&amp;rft.atitle=Stomaching+the+Possibility+of+a+Pathogenic+Role+for+Helicobacter+pylori+in+Parkinson%27s+Disease&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=367-74&amp;rft.date=2018&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6130334%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29966206&amp;rft_id=info%3Adoi%2F10.3233%2FJPD-181327&amp;rft.aulast=McGee&amp;rft.aufirst=DJ&amp;rft.au=Lu%2C+XH&amp;rft.au=Disbrow%2C+EA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6130334&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-lesage-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-lesage_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-lesage_57-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-lesage_57-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-lesage_57-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-lesage_57-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLesageBrice2009" class="citation journal cs1">Lesage S, Brice A (April 2009). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fhmg%2Fddp012">"Parkinson's disease: from monogenic forms to genetic susceptibility factors"</a>. <i>Human Molecular Genetics</i>. <b>18</b> (R1): R48-59. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fhmg%2Fddp012">10.1093/hmg/ddp012</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19297401">19297401</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Molecular+Genetics&amp;rft.atitle=Parkinson%27s+disease%3A+from+monogenic+forms+to+genetic+susceptibility+factors&amp;rft.volume=18&amp;rft.issue=R1&amp;rft.pages=R48-59&amp;rft.date=2009-04&amp;rft_id=info%3Adoi%2F10.1093%2Fhmg%2Fddp012&amp;rft_id=info%3Apmid%2F19297401&amp;rft.aulast=Lesage&amp;rft.aufirst=S&amp;rft.au=Brice%2C+A&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fhmg%252Fddp012&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:8-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-:8_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:8_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDengWangJankovic2018" class="citation journal cs1">Deng H, Wang P, Jankovic J (March 2018). <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29288112">"The genetics of Parkinson disease"</a>. <i>Ageing Research Reviews</i>. <b>42</b>: 72–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.arr.2017.12.007">10.1016/j.arr.2017.12.007</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29288112">29288112</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:28246244">28246244</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ageing+Research+Reviews&amp;rft.atitle=The+genetics+of+Parkinson+disease&amp;rft.volume=42&amp;rft.pages=72-85&amp;rft.date=2018-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A28246244%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29288112&amp;rft_id=info%3Adoi%2F10.1016%2Fj.arr.2017.12.007&amp;rft.aulast=Deng&amp;rft.aufirst=H&amp;rft.au=Wang%2C+P&amp;rft.au=Jankovic%2C+J&amp;rft_id=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F29288112&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-59">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPuschmann2017" class="citation journal cs1">Puschmann A (September 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5522513">"New Genes Causing Hereditary Parkinson's Disease or Parkinsonism"</a>. <i>Current Neurology and Neuroscience Reports</i>. <b>17</b> (9): 66. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs11910-017-0780-8">10.1007/s11910-017-0780-8</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5522513">5522513</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28733970">28733970</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neurology+and+Neuroscience+Reports&amp;rft.atitle=New+Genes+Causing+Hereditary+Parkinson%27s+Disease+or+Parkinsonism&amp;rft.volume=17&amp;rft.issue=9&amp;rft.pages=66&amp;rft.date=2017-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5522513%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28733970&amp;rft_id=info%3Adoi%2F10.1007%2Fs11910-017-0780-8&amp;rft.aulast=Puschmann&amp;rft.aufirst=A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5522513&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChenCenZhengPan2019" class="citation journal cs1">Chen Y, Cen Z, Zheng X, Pan Q, Chen X, Zhu L,  et&#160;al. (June 2019). <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30964957">"LRP10 in autosomal-dominant Parkinson's disease"</a>. <i>Movement Disorders</i>. <b>34</b> (6): 912–916. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.27693">10.1002/mds.27693</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30964957">30964957</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:106408549">106408549</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=LRP10+in+autosomal-dominant+Parkinson%27s+disease&amp;rft.volume=34&amp;rft.issue=6&amp;rft.pages=912-916&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A106408549%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30964957&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.27693&amp;rft.aulast=Chen&amp;rft.aufirst=Y&amp;rft.au=Cen%2C+Z&amp;rft.au=Zheng%2C+X&amp;rft.au=Pan%2C+Q&amp;rft.au=Chen%2C+X&amp;rft.au=Zhu%2C+L&amp;rft.au=Chen%2C+S&amp;rft.au=Wu%2C+H&amp;rft.au=Xie%2C+F&amp;rft.au=Wang%2C+H&amp;rft.au=Yang%2C+D&amp;rft.au=Wang%2C+L&amp;rft.au=Zhang%2C+B&amp;rft.au=Luo%2C+W&amp;rft_id=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F30964957&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Stoker2018-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-Stoker2018_61-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFStokerTorsneyBarker2018" class="citation book cs1">Stoker TB, Torsney KM, Barker RA (2018). "Pathological mechanisms and clinical aspects of GBA1 mutation-associated Parkinson's disease.".  In Stoker TB, Greenland JC (eds.). <i>Parkinson's Disease: Pathogenesis and clinical aspects</i>. Brisbane: Codon Publications.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Pathological+mechanisms+and+clinical+aspects+of+GBA1+mutation-associated+Parkinson%27s+disease.&amp;rft.btitle=Parkinson%27s+Disease%3A+Pathogenesis+and+clinical+aspects.&amp;rft.place=Brisbane&amp;rft.pub=Codon+Publications&amp;rft.date=2018&amp;rft.aulast=Stoker&amp;rft.aufirst=TB&amp;rft.au=Torsney%2C+KM&amp;rft.au=Barker%2C+RA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Abugable2019-62"><span class="mw-cite-backlink">^ <a href="#cite_ref-Abugable2019_62-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Abugable2019_62-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAbugableMorrisPalminha2019" class="citation journal cs1">Abugable AA, Morris JL, Palminha NM,  et&#160;al. (September 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dnarep.2019.102669">"DNA repair and neurological disease: From molecular understanding to the development of diagnostics and model organisms"</a>. <i>DNA Repair</i>. <b>81</b>: 102669. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dnarep.2019.102669">10.1016/j.dnarep.2019.102669</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31331820">31331820</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=DNA+Repair&amp;rft.atitle=DNA+repair+and+neurological+disease%3A+From+molecular+understanding+to+the+development+of+diagnostics+and+model+organisms&amp;rft.volume=81&amp;rft.pages=102669&amp;rft.date=2019-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.dnarep.2019.102669&amp;rft_id=info%3Apmid%2F31331820&amp;rft.aulast=Abugable&amp;rft.aufirst=AA&amp;rft.au=Morris%2C+JL&amp;rft.au=Palminha%2C+NM&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.dnarep.2019.102669&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18398010-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18398010_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18398010_63-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18398010_63-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18398010_63-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDavie2008" class="citation journal cs1">Davie CA (2008). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldn013">"A review of Parkinson's disease"</a>. <i>British Medical Bulletin</i>. <b>86</b> (1): 109–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbmb%2Fldn013">10.1093/bmb/ldn013</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18398010">18398010</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Bulletin&amp;rft.atitle=A+review+of+Parkinson%27s+disease&amp;rft.volume=86&amp;rft.issue=1&amp;rft.pages=109-27&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1093%2Fbmb%2Fldn013&amp;rft_id=info%3Apmid%2F18398010&amp;rft.aulast=Davie&amp;rft.aufirst=CA&amp;rft_id=%2F%2Fdoi.org%2F10.1093%252Fbmb%252Fldn013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid25904081-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25904081_64-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKaliaLang2015" class="citation journal cs1">Kalia LV, Lang AE (August 2015). "Parkinson's disease". <i>Lancet</i>. <b>386</b> (9996): 896–912. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0140-6736%2814%2961393-3">10.1016/S0140-6736(14)61393-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25904081">25904081</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5502904">5502904</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=Parkinson%27s+disease&amp;rft.volume=386&amp;rft.issue=9996&amp;rft.pages=896-912&amp;rft.date=2015-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5502904%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25904081&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2814%2961393-3&amp;rft.aulast=Kalia&amp;rft.aufirst=LV&amp;rft.au=Lang%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGan-OrDionRouleau2015" class="citation journal cs1">Gan-Or Z, Dion PA, Rouleau GA (2 September 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4590678">"Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease"</a>. <i>Autophagy</i>. <b>11</b> (9): 1443–57. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F15548627.2015.1067364">10.1080/15548627.2015.1067364</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4590678">4590678</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26207393">26207393</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Autophagy&amp;rft.atitle=Genetic+perspective+on+the+role+of+the+autophagy-lysosome+pathway+in+Parkinson+disease&amp;rft.volume=11&amp;rft.issue=9&amp;rft.pages=1443-57&amp;rft.date=2015-09-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4590678%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26207393&amp;rft_id=info%3Adoi%2F10.1080%2F15548627.2015.1067364&amp;rft.aulast=Gan-Or&amp;rft.aufirst=Z&amp;rft.au=Dion%2C+PA&amp;rft.au=Rouleau%2C+GA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4590678&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGuilarteGonzales2015" class="citation journal cs1">Guilarte TR, Gonzales KK (August 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4607750">"Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence"</a>. <i>Toxicological Sciences</i>. <b>146</b> (2): 204–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Ftoxsci%2Fkfv099">10.1093/toxsci/kfv099</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4607750">4607750</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26220508">26220508</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Toxicological+Sciences&amp;rft.atitle=Manganese-Induced+Parkinsonism+Is+Not+Idiopathic+Parkinson%27s+Disease%3A+Environmental+and+Genetic+Evidence&amp;rft.volume=146&amp;rft.issue=2&amp;rft.pages=204-12&amp;rft.date=2015-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4607750%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26220508&amp;rft_id=info%3Adoi%2F10.1093%2Ftoxsci%2Fkfv099&amp;rft.aulast=Guilarte&amp;rft.aufirst=TR&amp;rft.au=Gonzales%2C+KK&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4607750&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:0-67"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_67-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_67-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:0_67-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:0_67-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-:0_67-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-:0_67-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-:0_67-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-:0_67-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-:0_67-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-:0_67-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSimonGreenbergAminoff2017" class="citation book cs1">Simon RP, Greenberg D, Aminoff MJ (2017). <i>Clinical Neurology</i> (10th&#160;ed.). The United States of America: McGraw-Hill. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-259-86172-7" title="Special:BookSources/978-1-259-86172-7"><bdi>978-1-259-86172-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Clinical+Neurology&amp;rft.place=The+United+States+of+America&amp;rft.edition=10th&amp;rft.pub=McGraw-Hill&amp;rft.date=2017&amp;rft.isbn=978-1-259-86172-7&amp;rft.aulast=Simon&amp;rft.aufirst=RP&amp;rft.au=Greenberg%2C+D&amp;rft.au=Aminoff%2C+MJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKwakyePaolielloMukhopadhyayBowman2015" class="citation journal cs1">Kwakye GF, Paoliello MM, Mukhopadhyay S, Bowman AB, Aschner M (July 2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4515672">"Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features"</a>. <i>International Journal of Environmental Research and Public Health</i>. <b>12</b> (7): 7519–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fijerph120707519">10.3390/ijerph120707519</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4515672">4515672</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26154659">26154659</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Environmental+Research+and+Public+Health&amp;rft.atitle=Manganese-Induced+Parkinsonism+and+Parkinson%27s+Disease%3A+Shared+and+Distinguishable+Features&amp;rft.volume=12&amp;rft.issue=7&amp;rft.pages=7519-40&amp;rft.date=2015-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4515672%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26154659&amp;rft_id=info%3Adoi%2F10.3390%2Fijerph120707519&amp;rft.aulast=Kwakye&amp;rft.aufirst=GF&amp;rft.au=Paoliello%2C+MM&amp;rft.au=Mukhopadhyay%2C+S&amp;rft.au=Bowman%2C+AB&amp;rft.au=Aschner%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4515672&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKimKang2010" class="citation journal cs1">Kim EA, Kang SK (December 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3023358">"Occupational neurological disorders in Korea"</a>. <i>Journal of Korean Medical Science</i>. <b>25</b> (Suppl): S26-35. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3346%2Fjkms.2010.25.S.S26">10.3346/jkms.2010.25.S.S26</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3023358">3023358</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21258587">21258587</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Korean+Medical+Science&amp;rft.atitle=Occupational+neurological+disorders+in+Korea&amp;rft.volume=25&amp;rft.issue=Suppl&amp;rft.pages=S26-35&amp;rft.date=2010-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3023358%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21258587&amp;rft_id=info%3Adoi%2F10.3346%2Fjkms.2010.25.S.S26&amp;rft.aulast=Kim&amp;rft.aufirst=EA&amp;rft.au=Kang%2C+SK&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3023358&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLangston2017" class="citation journal cs1">Langston JW (6 March 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5345642">"The MPTP Story"</a>. <i>Journal of Parkinson's Disease</i>. <b>7</b> (s1): S11–S19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJPD-179006">10.3233/JPD-179006</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5345642">5345642</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28282815">28282815</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Parkinson%27s+Disease&amp;rft.atitle=The+MPTP+Story&amp;rft.volume=7&amp;rft.issue=s1&amp;rft.pages=S11-S19&amp;rft.date=2017-03-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5345642%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28282815&amp;rft_id=info%3Adoi%2F10.3233%2FJPD-179006&amp;rft.aulast=Langston&amp;rft.aufirst=JW&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5345642&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSongXuZhouZhang2017" class="citation journal cs1">Song L, Xu MB, Zhou XL, Zhang DP, Zhang SL, Zheng GQ (2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5366755">"A Preclinical Systematic Review of Ginsenoside-Rg1 in Experimental Parkinson's Disease"</a>. <i>Oxidative Medicine and Cellular Longevity</i>. <b>2017</b>: 2163053. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2017%2F2163053">10.1155/2017/2163053</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5366755">5366755</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28386306">28386306</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oxidative+Medicine+and+Cellular+Longevity&amp;rft.atitle=A+Preclinical+Systematic+Review+of+Ginsenoside-Rg1+in+Experimental+Parkinson%27s+Disease&amp;rft.volume=2017&amp;rft.pages=2163053&amp;rft.date=2017&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5366755%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28386306&amp;rft_id=info%3Adoi%2F10.1155%2F2017%2F2163053&amp;rft.aulast=Song&amp;rft.aufirst=L&amp;rft.au=Xu%2C+MB&amp;rft.au=Zhou%2C+XL&amp;rft.au=Zhang%2C+DP&amp;rft.au=Zhang%2C+SL&amp;rft.au=Zheng%2C+GQ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5366755&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChahineSternChen-Plotkin2014" class="citation journal cs1">Chahine LM, Stern MB, Chen-Plotkin A (January 2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4070332">"Blood-based biomarkers for Parkinson's disease"</a>. <i>Parkinsonism &amp; Related Disorders</i>. <b>20</b> (Suppl 1): S99–103. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1353-8020%2813%2970025-7">10.1016/S1353-8020(13)70025-7</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4070332">4070332</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24262199">24262199</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Blood-based+biomarkers+for+Parkinson%27s+disease&amp;rft.volume=20&amp;rft.issue=Suppl+1&amp;rft.pages=S99-103&amp;rft.date=2014-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4070332%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24262199&amp;rft_id=info%3Adoi%2F10.1016%2FS1353-8020%2813%2970025-7&amp;rft.aulast=Chahine&amp;rft.aufirst=LM&amp;rft.au=Stern%2C+MB&amp;rft.au=Chen-Plotkin%2C+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4070332&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid205063122-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid205063122_73-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFNuytemansTheunsCrutsVan_Broeckhoven2010" class="citation journal cs1">Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C (July 2010) [18 May 2010]. <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3056147">"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update"</a>. <i>Human Mutation</i>. <b>31</b> (7): 763–80. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhumu.21277">10.1002/humu.21277</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3056147">3056147</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20506312">20506312</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Mutation&amp;rft.atitle=Genetic+etiology+of+Parkinson+disease+associated+with+mutations+in+the+SNCA%2C+PARK2%2C+PINK1%2C+PARK7%2C+and+LRRK2+genes%3A+a+mutation+update&amp;rft.volume=31&amp;rft.issue=7&amp;rft.pages=763-80&amp;rft.date=2010-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056147%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20506312&amp;rft_id=info%3Adoi%2F10.1002%2Fhumu.21277&amp;rft.aulast=Nuytemans&amp;rft.aufirst=K&amp;rft.au=Theuns%2C+J&amp;rft.au=Cruts%2C+M&amp;rft.au=Van+Broeckhoven%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3056147&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid191737622-74"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid191737622_74-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid191737622_74-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAarslandLondosBallard2009" class="citation journal cs1">Aarsland D, Londos E, Ballard C (April 2009) [28 January 2009]. "Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity". <i>International Psychogeriatrics</i>. <b>21</b> (2): 216–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS1041610208008612">10.1017/S1041610208008612</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19173762">19173762</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5433020">5433020</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Psychogeriatrics&amp;rft.atitle=Parkinson%27s+disease+dementia+and+dementia+with+Lewy+bodies%3A+different+aspects+of+one+entity&amp;rft.volume=21&amp;rft.issue=2&amp;rft.pages=216-9&amp;rft.date=2009-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5433020%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19173762&amp;rft_id=info%3Adoi%2F10.1017%2FS1041610208008612&amp;rft.aulast=Aarsland&amp;rft.aufirst=D&amp;rft.au=Londos%2C+E&amp;rft.au=Ballard%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGuptaKuruvilla2011" class="citation journal cs1">Gupta D, Kuruvilla A (December 2011). <a rel="nofollow" class="external text" href="https://pmj.bmj.com/content/87/1034/829">"Vascular parkinsonism: what makes it different?"</a>. <i>Postgraduate Medical Journal</i>. <b>87</b> (1034): 829–36. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fpostgradmedj-2011-130051">10.1136/postgradmedj-2011-130051</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22121251">22121251</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:29227069">29227069</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Postgraduate+Medical+Journal&amp;rft.atitle=Vascular+parkinsonism%3A+what+makes+it+different%3F&amp;rft.volume=87&amp;rft.issue=1034&amp;rft.pages=829-36&amp;rft.date=2011-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29227069%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22121251&amp;rft_id=info%3Adoi%2F10.1136%2Fpostgradmedj-2011-130051&amp;rft.aulast=Gupta&amp;rft.aufirst=D&amp;rft.au=Kuruvilla%2C+A&amp;rft_id=https%3A%2F%2Fpmj.bmj.com%2Fcontent%2F87%2F1034%2F829&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMiguel-PugaVillafuerteSalas-PachecoArias-Carrión2017" class="citation journal cs1">Miguel-Puga A, Villafuerte G, Salas-Pacheco J, Arias-Carrión O (22 September 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5614922">"Therapeutic Interventions for Vascular Parkinsonism: A Systematic Review and Meta-analysis"</a>. <i>Frontiers in Neurology</i>. <b>8</b>: 481. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffneur.2017.00481">10.3389/fneur.2017.00481</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5614922">5614922</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29018399">29018399</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neurology&amp;rft.atitle=Therapeutic+Interventions+for+Vascular+Parkinsonism%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=8&amp;rft.pages=481&amp;rft.date=2017-09-22&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5614922%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29018399&amp;rft_id=info%3Adoi%2F10.3389%2Ffneur.2017.00481&amp;rft.aulast=Miguel-Puga&amp;rft.aufirst=A&amp;rft.au=Villafuerte%2C+G&amp;rft.au=Salas-Pacheco%2C+J&amp;rft.au=Arias-Carri%C3%B3n%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5614922&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBurréSharmaSüdhof2018" class="citation journal cs1">Burré J, Sharma M, Südhof TC (March 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5519445">"Cell Biology and Pathophysiology of α-Synuclein"</a>. <i>Cold Spring Harbor Perspectives in Medicine</i>. <b>8</b> (3): a024091. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1101%2Fcshperspect.a024091">10.1101/cshperspect.a024091</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5519445">5519445</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28108534">28108534</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cold+Spring+Harbor+Perspectives+in+Medicine&amp;rft.atitle=Cell+Biology+and+Pathophysiology+of+%CE%B1-Synuclein&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=a024091&amp;rft.date=2018-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5519445%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28108534&amp;rft_id=info%3Adoi%2F10.1101%2Fcshperspect.a024091&amp;rft.aulast=Burr%C3%A9&amp;rft.aufirst=J&amp;rft.au=Sharma%2C+M&amp;rft.au=S%C3%BCdhof%2C+TC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5519445&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Jankovic_book-Neuropathology-78"><span class="mw-cite-backlink">^ <a href="#cite_ref-Jankovic_book-Neuropathology_78-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Jankovic_book-Neuropathology_78-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDickson2007" class="citation book cs1">Dickson DV (2007). "Neuropathology of movement disorders".  In Tolosa E, Jankovic JJ (eds.). <i>Parkinson's disease and movement disorders</i>. Hagerstown, MD: Lippincott Williams &amp; Wilkins. pp.&#160;271–83. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-7881-7" title="Special:BookSources/978-0-7817-7881-7"><bdi>978-0-7817-7881-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Neuropathology+of+movement+disorders&amp;rft.btitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.place=Hagerstown%2C+MD&amp;rft.pages=271-83&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2007&amp;rft.isbn=978-0-7817-7881-7&amp;rft.aulast=Dickson&amp;rft.aufirst=DV&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20011063-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20011063_79-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJubaultBrambatiDegrootKullmann2009" class="citation journal cs1">Jubault T, Brambati SM, Degroot C, Kullmann B, Strafella AP, Lafontaine AL, Chouinard S, Monchi O (December 2009).  <a href="/wiki/Howard_E._Gendelman" title="Howard E. Gendelman">Gendelman HE</a> (ed.). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2784293">"Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI"</a>. <i>PLOS ONE</i>. <b>4</b> (12): e8247. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2009PLoSO...4.8247J">2009PLoSO...4.8247J</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0008247">10.1371/journal.pone.0008247</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2784293">2784293</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20011063">20011063</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Regional+brain+stem+atrophy+in+idiopathic+Parkinson%27s+disease+detected+by+anatomical+MRI&amp;rft.volume=4&amp;rft.issue=12&amp;rft.pages=e8247&amp;rft.date=2009-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2784293%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20011063&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0008247&amp;rft_id=info%3Abibcode%2F2009PLoSO...4.8247J&amp;rft.aulast=Jubault&amp;rft.aufirst=T&amp;rft.au=Brambati%2C+SM&amp;rft.au=Degroot%2C+C&amp;rft.au=Kullmann%2C+B&amp;rft.au=Strafella%2C+AP&amp;rft.au=Lafontaine%2C+AL&amp;rft.au=Chouinard%2C+S&amp;rft.au=Monchi%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2784293&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18781672-80"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18781672_80-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18781672_80-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18781672_80-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid18781672_80-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid18781672_80-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid18781672_80-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFObesoRodríguez-OrozBenitez-TeminoBlesa2008" class="citation journal cs1">Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M (2008). "Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease". <i>Movement Disorders</i>. <b>23</b> (Suppl 3): S548–59. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.22062">10.1002/mds.22062</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18781672">18781672</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13186083">13186083</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Functional+organization+of+the+basal+ganglia%3A+therapeutic+implications+for+Parkinson%27s+disease&amp;rft.volume=23&amp;rft.issue=Suppl+3&amp;rft.pages=S548-59&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13186083%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18781672&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22062&amp;rft.aulast=Obeso&amp;rft.aufirst=JA&amp;rft.au=Rodr%C3%ADguez-Oroz%2C+MC&amp;rft.au=Benitez-Temino%2C+B&amp;rft.au=Blesa%2C+FJ&amp;rft.au=Guridi%2C+J&amp;rft.au=Marin%2C+C&amp;rft.au=Rodriguez%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20495568-81"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20495568_81-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid20495568_81-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFObesoRodriguez-OrozGoetz2010" class="citation journal cs1">Obeso JA, Rodriguez-Oroz MC, Goetz CG,  et&#160;al. (June 2010). "Missing pieces in the Parkinson's disease puzzle". <i>Nature Medicine</i>. <b>16</b> (6): 653–61. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnm.2165">10.1038/nm.2165</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20495568">20495568</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3146438">3146438</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=Missing+pieces+in+the+Parkinson%27s+disease+puzzle&amp;rft.volume=16&amp;rft.issue=6&amp;rft.pages=653-61&amp;rft.date=2010-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3146438%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20495568&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.2165&amp;rft.aulast=Obeso&amp;rft.aufirst=JA&amp;rft.au=Rodriguez-Oroz%2C+MC&amp;rft.au=Goetz%2C+CG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20563819-82"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20563819_82-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20563819_82-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20563819_82-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSchulz-Schaeffer2010" class="citation journal cs1">Schulz-Schaeffer WJ (August 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2892607">"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia"</a>. <i>Acta Neuropathologica</i>. <b>120</b> (2): 131–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00401-010-0711-0">10.1007/s00401-010-0711-0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2892607">2892607</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20563819">20563819</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica&amp;rft.atitle=The+synaptic+pathology+of+alpha-synuclein+aggregation+in+dementia+with+Lewy+bodies%2C+Parkinson%27s+disease+and+Parkinson%27s+disease+dementia&amp;rft.volume=120&amp;rft.issue=2&amp;rft.pages=131-43&amp;rft.date=2010-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2892607%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20563819&amp;rft_id=info%3Adoi%2F10.1007%2Fs00401-010-0711-0&amp;rft.aulast=Schulz-Schaeffer&amp;rft.aufirst=WJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2892607&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20082992-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20082992_83-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHirsch2009" class="citation journal cs1">Hirsch EC (December 2009). "Iron transport in Parkinson's disease". <i>Parkinsonism &amp; Related Disorders</i>. <b>15</b> (Suppl 3): S209–11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1353-8020%2809%2970816-8">10.1016/S1353-8020(09)70816-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20082992">20082992</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Iron+transport+in+Parkinson%27s+disease&amp;rft.volume=15&amp;rft.issue=Suppl+3&amp;rft.pages=S209-11&amp;rft.date=2009-12&amp;rft_id=info%3Adoi%2F10.1016%2FS1353-8020%2809%2970816-8&amp;rft_id=info%3Apmid%2F20082992&amp;rft.aulast=Hirsch&amp;rft.aufirst=EC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nice-Diagnosis-84"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-Diagnosis_84-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-Diagnosis_84-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2006" class="citation book cs1">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Diagnosing Parkinson's Disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;29–47. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-86016-283-1" title="Special:BookSources/978-1-86016-283-1"><bdi>978-1-86016-283-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100924153546/http://guidance.nice.org.uk/CG35/Guidance/pdf/English">Archived</a> from the original on 24 September 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Diagnosing+Parkinson%27s+Disease&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.place=London&amp;rft.pages=29-47&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2006&amp;rft.isbn=978-1-86016-283-1&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid12464118-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid12464118_85-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPoeweWenning2002" class="citation journal cs1">Poewe W, Wenning G (November 2002). "The differential diagnosis of Parkinson's disease". <i>European Journal of Neurology</i>. <b>9</b> (Suppl 3): 23–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1468-1331.9.s3.3.x">10.1046/j.1468-1331.9.s3.3.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12464118">12464118</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=The+differential+diagnosis+of+Parkinson%27s+disease&amp;rft.volume=9&amp;rft.issue=Suppl+3&amp;rft.pages=23-30&amp;rft.date=2002-11&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1468-1331.9.s3.3.x&amp;rft_id=info%3Apmid%2F12464118&amp;rft.aulast=Poewe&amp;rft.aufirst=W&amp;rft.au=Wenning%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGibbLees1988" class="citation journal cs1">Gibb WR, Lees AJ (June 1988). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1033142">"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease"</a>. <i>Journal of Neurology, Neurosurgery, and Psychiatry</i>. <b>51</b> (6): 745–52. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fjnnp.51.6.745">10.1136/jnnp.51.6.745</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1033142">1033142</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/2841426">2841426</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology%2C+Neurosurgery%2C+and+Psychiatry&amp;rft.atitle=The+relevance+of+the+Lewy+body+to+the+pathogenesis+of+idiopathic+Parkinson%27s+disease&amp;rft.volume=51&amp;rft.issue=6&amp;rft.pages=745-52&amp;rft.date=1988-06&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1033142%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F2841426&amp;rft_id=info%3Adoi%2F10.1136%2Fjnnp.51.6.745&amp;rft.aulast=Gibb&amp;rft.aufirst=WR&amp;rft.au=Lees%2C+AJ&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1033142&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMustafaFesselBarwiseShannon2012" class="citation journal cs1">Mustafa HI, Fessel JP, Barwise J, Shannon JR, Raj SR, Diedrich A,  et&#160;al. (January 2012). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3296831">"Dysautonomia: perioperative implications"</a>. <i>Anesthesiology</i>. <b>116</b> (1): 205–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FALN.0b013e31823db712">10.1097/ALN.0b013e31823db712</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3296831">3296831</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22143168">22143168</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Anesthesiology&amp;rft.atitle=Dysautonomia%3A+perioperative+implications&amp;rft.volume=116&amp;rft.issue=1&amp;rft.pages=205-15&amp;rft.date=2012-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3296831%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F22143168&amp;rft_id=info%3Adoi%2F10.1097%2FALN.0b013e31823db712&amp;rft.aulast=Mustafa&amp;rft.aufirst=HI&amp;rft.au=Fessel%2C+JP&amp;rft.au=Barwise%2C+J&amp;rft.au=Shannon%2C+JR&amp;rft.au=Raj%2C+SR&amp;rft.au=Diedrich%2C+A&amp;rft.au=Biaggioni%2C+I&amp;rft.au=Robertson%2C+D&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3296831&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRizzoCopettiArcutiMartino2016" class="citation journal cs1">Rizzo G, Copetti M, Arcuti S, Martino D, Fontana A, Logroscino G (February 2016). "Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis". <i>Neurology</i>. <b>86</b> (6): 566–76. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000002350">10.1212/WNL.0000000000002350</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26764028">26764028</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207110404">207110404</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Accuracy+of+clinical+diagnosis+of+Parkinson+disease%3A+A+systematic+review+and+meta-analysis&amp;rft.volume=86&amp;rft.issue=6&amp;rft.pages=566-76&amp;rft.date=2016-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207110404%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26764028&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000002350&amp;rft.aulast=Rizzo&amp;rft.aufirst=G&amp;rft.au=Copetti%2C+M&amp;rft.au=Arcuti%2C+S&amp;rft.au=Martino%2C+D&amp;rft.au=Fontana%2C+A&amp;rft.au=Logroscino%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20351351-89"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20351351_89-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20351351_89-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20351351_89-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid20351351_89-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrooks2010" class="citation journal cs1">Brooks DJ (April 2010). <a rel="nofollow" class="external text" href="https://doi.org/10.2967%2Fjnumed.108.059998">"Imaging approaches to Parkinson disease"</a>. <i>Journal of Nuclear Medicine</i>. <b>51</b> (4): 596–609. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2967%2Fjnumed.108.059998">10.2967/jnumed.108.059998</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20351351">20351351</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Nuclear+Medicine&amp;rft.atitle=Imaging+approaches+to+Parkinson+disease&amp;rft.volume=51&amp;rft.issue=4&amp;rft.pages=596-609&amp;rft.date=2010-04&amp;rft_id=info%3Adoi%2F10.2967%2Fjnumed.108.059998&amp;rft_id=info%3Apmid%2F20351351&amp;rft.aulast=Brooks&amp;rft.aufirst=DJ&amp;rft_id=%2F%2Fdoi.org%2F10.2967%252Fjnumed.108.059998&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSchwarzAfzalMorganBajaj2014" class="citation journal cs1">Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP (2014). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3977922">"The 'swallow tail' appearance of the healthy nigrosome – a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T"</a>. <i>PLOS ONE</i>. <b>9</b> (4): e93814. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2014PLoSO...993814S">2014PLoSO...993814S</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0093814">10.1371/journal.pone.0093814</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3977922">3977922</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24710392">24710392</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=The+%27swallow+tail%27+appearance+of+the+healthy+nigrosome+%E2%80%93+a+new+accurate+test+of+Parkinson%27s+disease%3A+a+case-control+and+retrospective+cross-sectional+MRI+study+at+3T&amp;rft.volume=9&amp;rft.issue=4&amp;rft.pages=e93814&amp;rft.date=2014&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3977922%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24710392&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0093814&amp;rft_id=info%3Abibcode%2F2014PLoSO...993814S&amp;rft.aulast=Schwarz&amp;rft.aufirst=ST&amp;rft.au=Afzal%2C+M&amp;rft.au=Morgan%2C+PS&amp;rft.au=Bajaj%2C+N&amp;rft.au=Gowland%2C+PA&amp;rft.au=Auer%2C+DP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3977922&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-91">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMahlknechtKrismerPoeweSeppi2017" class="citation journal cs1">Mahlknecht P, Krismer F, Poewe W, Seppi K (April 2017). "Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease". <i>Movement Disorders</i>. <b>32</b> (4): 619–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.26932">10.1002/mds.26932</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28151553">28151553</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:7730034">7730034</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Meta-analysis+of+dorsolateral+nigral+hyperintensity+on+magnetic+resonance+imaging+as+a+marker+for+Parkinson%27s+disease&amp;rft.volume=32&amp;rft.issue=4&amp;rft.pages=619-23&amp;rft.date=2017-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A7730034%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28151553&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.26932&amp;rft.aulast=Mahlknecht&amp;rft.aufirst=P&amp;rft.au=Krismer%2C+F&amp;rft.au=Poewe%2C+W&amp;rft.au=Seppi%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-92">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFChoBaeKim2020" class="citation journal cs1">Cho SJ, Bae YJ, Kim JM,  et&#160;al. (September 2020). "Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis". <i>European Radiology</i>. <b>30</b> (10): 1268–1280. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00330-020-07240-7">10.1007/s00330-020-07240-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32886201">32886201</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:221478854">221478854</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Radiology&amp;rft.atitle=Diagnostic+performance+of+neuromelanin-sensitive+magnetic+resonance+imaging+for+patients+with+Parkinson%27s+disease+and+factor+analysis+for+its+heterogeneity%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=30&amp;rft.issue=10&amp;rft.pages=1268-1280&amp;rft.date=2020-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A221478854%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32886201&amp;rft_id=info%3Adoi%2F10.1007%2Fs00330-020-07240-7&amp;rft.aulast=Cho&amp;rft.aufirst=SJ&amp;rft.au=Bae%2C+YJ&amp;rft.au=Kim%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSuwijnvan_Boheemende_HaanTissingh2015" class="citation journal cs1">Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4385258">"The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review"</a>. <i>EJNMMI Research</i>. <b>5</b>: 12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs13550-015-0087-1">10.1186/s13550-015-0087-1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4385258">4385258</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25853018">25853018</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=EJNMMI+Research&amp;rft.atitle=The+diagnostic+accuracy+of+dopamine+transporter+SPECT+imaging+to+detect+nigrostriatal+cell+loss+in+patients+with+Parkinson%27s+disease+or+clinically+uncertain+parkinsonism%3A+a+systematic+review&amp;rft.volume=5&amp;rft.pages=12&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4385258%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F25853018&amp;rft_id=info%3Adoi%2F10.1186%2Fs13550-015-0087-1&amp;rft.aulast=Suwijn&amp;rft.aufirst=SR&amp;rft.au=van+Boheemen%2C+CJ&amp;rft.au=de+Haan%2C+RJ&amp;rft.au=Tissingh%2C+G&amp;rft.au=Booij%2C+J&amp;rft.au=de+Bie%2C+RM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4385258&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-94"><span class="mw-cite-backlink"><b><a href="#cite_ref-94">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022454Orig1s000Lbl.pdf">"DaTSCAN Approval Letter"</a> <span class="cs1-format">(PDF)</span>. <i>FDA.gov</i>. Food and Drug Administration<span class="reference-accessdate">. Retrieved <span class="nowrap">22 March</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FDA.gov&amp;rft.atitle=DaTSCAN+Approval+Letter&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2011%2F022454Orig1s000Lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:11-95"><span class="mw-cite-backlink">^ <a href="#cite_ref-:11_95-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:11_95-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:11_95-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:11_95-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFStokerGreenlandBarker2018" class="citation book cs1">Stoker TB, Greenland JC, Barker RA (December 2018). <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30702835/"><i>The Differential Diagnosis of Parkinson's Disease</i></a>. Codon Publications. pp.&#160;109–128. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.15586%2Fcodonpublications.parkinsonsdisease.2018.ch6">10.15586/codonpublications.parkinsonsdisease.2018.ch6</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-9944381-6-4" title="Special:BookSources/978-0-9944381-6-4"><bdi>978-0-9944381-6-4</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30702835">30702835</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:80908095">80908095</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Differential+Diagnosis+of+Parkinson%27s+Disease&amp;rft.pages=109-128&amp;rft.pub=Codon+Publications&amp;rft.date=2018-12&amp;rft_id=info%3Adoi%2F10.15586%2Fcodonpublications.parkinsonsdisease.2018.ch6&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A80908095%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30702835&amp;rft.isbn=978-0-9944381-6-4&amp;rft.aulast=Stoker&amp;rft.aufirst=TB&amp;rft.au=Greenland%2C+JC&amp;rft.au=Barker%2C+RA&amp;rft_id=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F30702835%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-96"><span class="mw-cite-backlink"><b><a href="#cite_ref-96">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLevinKurzArzbergerGiese2016" class="citation journal cs1">Levin J, Kurz A, Arzberger T, Giese A, Höglinger GU (February 2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4782269">"The Differential Diagnosis and Treatment of Atypical Parkinsonism"</a>. <i>Deutsches Ärzteblatt International</i>. <b>113</b> (5): 61–9. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3238%2Farztebl.2016.0061">10.3238/arztebl.2016.0061</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4782269">4782269</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26900156">26900156</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Deutsches+%C3%84rzteblatt+International&amp;rft.atitle=The+Differential+Diagnosis+and+Treatment+of+Atypical+Parkinsonism&amp;rft.volume=113&amp;rft.issue=5&amp;rft.pages=61-9&amp;rft.date=2016-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4782269%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26900156&amp;rft_id=info%3Adoi%2F10.3238%2Farztebl.2016.0061&amp;rft.aulast=Levin&amp;rft.aufirst=J&amp;rft.au=Kurz%2C+A&amp;rft.au=Arzberger%2C+T&amp;rft.au=Giese%2C+A&amp;rft.au=H%C3%B6glinger%2C+GU&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4782269&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Greenland2018-97"><span class="mw-cite-backlink"><b><a href="#cite_ref-Greenland2018_97-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGreenlandStoker2018" class="citation book cs1">Greenland J, Stoker TB (2018). <i>Parkinson's Disease: Pathogenesis and Clinical Aspects</i>. Codon Publications. pp.&#160;109–28. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-9944381-6-4" title="Special:BookSources/978-0-9944381-6-4"><bdi>978-0-9944381-6-4</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Parkinson%27s+Disease%3A+Pathogenesis+and+Clinical+Aspects&amp;rft.pages=109-28&amp;rft.pub=Codon+Publications&amp;rft.date=2018&amp;rft.isbn=978-0-9944381-6-4&amp;rft.aulast=Greenland&amp;rft.aufirst=J&amp;rft.au=Stoker%2C+TB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20182023-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20182023_98-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCostaLunetSantosSantos2010" class="citation journal cs1">Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010). <a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJAD-2010-091525">"Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies"</a>. <i>Journal of Alzheimer's Disease</i>. <b>20</b> (Suppl 1): S221–38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJAD-2010-091525">10.3233/JAD-2010-091525</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20182023">20182023</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Alzheimer%27s+Disease&amp;rft.atitle=Caffeine+exposure+and+the+risk+of+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis+of+observational+studies&amp;rft.volume=20&amp;rft.issue=Suppl+1&amp;rft.pages=S221-38&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.3233%2FJAD-2010-091525&amp;rft_id=info%3Apmid%2F20182023&amp;rft.aulast=Costa&amp;rft.aufirst=J&amp;rft.au=Lunet%2C+N&amp;rft.au=Santos%2C+C&amp;rft.au=Santos%2C+J&amp;rft.au=Vaz-Carneiro%2C+A&amp;rft_id=%2F%2Fdoi.org%2F10.3233%252FJAD-2010-091525&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Gagne-2010-99"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gagne-2010_99-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGagnePower2010" class="citation journal cs1">Gagne JJ, Power MC (March 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2848103">"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis"</a>. <i>Neurology</i>. <b>74</b> (12): 995–1002. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0b013e3181d5a4a3">10.1212/WNL.0b013e3181d5a4a3</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2848103">2848103</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20308684">20308684</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Anti-inflammatory+drugs+and+risk+of+Parkinson+disease%3A+a+meta-analysis&amp;rft.volume=74&amp;rft.issue=12&amp;rft.pages=995-1002&amp;rft.date=2010-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2848103%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20308684&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0b013e3181d5a4a3&amp;rft.aulast=Gagne&amp;rft.aufirst=JJ&amp;rft.au=Power%2C+MC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2848103&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:3-100"><span class="mw-cite-backlink">^ <a href="#cite_ref-:3_100-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:3_100-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFConnollyLang2014" class="citation journal cs1">Connolly BS, Lang AE (30 April 2014). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/282b19727fa648f2fdc92597a40713d3708ae092">"Pharmacological treatment of Parkinson disease: a review"</a>. <i>JAMA</i>. <b>311</b> (16): 1670–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2014.3654">10.1001/jama.2014.3654</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24756517">24756517</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:205058847">205058847</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Pharmacological+treatment+of+Parkinson+disease%3A+a+review&amp;rft.volume=311&amp;rft.issue=16&amp;rft.pages=1670-83&amp;rft.date=2014-04-30&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A205058847%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F24756517&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2014.3654&amp;rft.aulast=Connolly&amp;rft.aufirst=BS&amp;rft.au=Lang%2C+AE&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F282b19727fa648f2fdc92597a40713d3708ae092&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:4-101"><span class="mw-cite-backlink">^ <a href="#cite_ref-:4_101-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:4_101-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOlanowStocchiLang2011" class="citation book cs1">Olanow CW, Stocchi F, Lang AE (2011). "The non-motor and non-dopaminergic features of PD". <i>Parkinson's Disease: Non-Motor and Non-Dopaminergic Features</i>. Wiley-Blackwell. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1405191852" title="Special:BookSources/978-1405191852"><bdi>978-1405191852</bdi></a>. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/743205140">743205140</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=The+non-motor+and+non-dopaminergic+features+of+PD&amp;rft.btitle=Parkinson%27s+Disease%3A+Non-Motor+and+Non-Dopaminergic+Features&amp;rft.pub=Wiley-Blackwell&amp;rft.date=2011&amp;rft_id=info%3Aoclcnum%2F743205140&amp;rft.isbn=978-1405191852&amp;rft.aulast=Olanow&amp;rft.aufirst=CW&amp;rft.au=Stocchi%2C+F&amp;rft.au=Lang%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nice-pharma-102"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-pharma_102-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Nice-pharma_102-15"><sup><i><b>p</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2006" class="citation book cs1">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Symptomatic pharmacological therapy in Parkinson's disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;59–100. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-86016-283-1" title="Special:BookSources/978-1-86016-283-1"><bdi>978-1-86016-283-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100924153546/http://guidance.nice.org.uk/CG35/Guidance/pdf/English">Archived</a> from the original on 24 September 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Symptomatic+pharmacological+therapy+in+Parkinson%27s+disease&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.place=London&amp;rft.pages=59-100&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2006&amp;rft.isbn=978-1-86016-283-1&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFZhangTan2016" class="citation journal cs1">Zhang J, Tan LC (2016). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4876591">"Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist"</a>. <i>Current Neuropharmacology</i>. <b>14</b> (4): 356–63. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1570159X14666151208114634">10.2174/1570159X14666151208114634</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4876591">4876591</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26644151">26644151</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neuropharmacology&amp;rft.atitle=Revisiting+the+Medical+Management+of+Parkinson%27s+Disease%3A+Levodopa+versus+Dopamine+Agonist&amp;rft.volume=14&amp;rft.issue=4&amp;rft.pages=356-63&amp;rft.date=2016&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4876591%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26644151&amp;rft_id=info%3Adoi%2F10.2174%2F1570159X14666151208114634&amp;rft.aulast=Zhang&amp;rft.aufirst=J&amp;rft.au=Tan%2C+LC&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4876591&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Pedrosa2013-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-Pedrosa2013_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Pedrosa2013_104-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPedrosaTimmermann2013" class="citation journal cs1">Pedrosa DJ, Timmermann L (2013). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3592512">"Review: management of Parkinson's disease"</a>. <i>Neuropsychiatric Disease and Treatment</i> (Review). <b>9</b>: 321–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FNDT.S32302">10.2147/NDT.S32302</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3592512">3592512</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23487540">23487540</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuropsychiatric+Disease+and+Treatment&amp;rft.atitle=Review%3A+management+of+Parkinson%27s+disease&amp;rft.volume=9&amp;rft.pages=321-40&amp;rft.date=2013&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3592512%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23487540&amp;rft_id=info%3Adoi%2F10.2147%2FNDT.S32302&amp;rft.aulast=Pedrosa&amp;rft.aufirst=DJ&amp;rft.au=Timmermann%2C+L&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3592512&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nice-palliative-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-Nice-palliative_105-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2006" class="citation book cs1">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Palliative care in Parkinson's disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;147–51. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-86016-283-1" title="Special:BookSources/978-1-86016-283-1"><bdi>978-1-86016-283-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100924153546/http://guidance.nice.org.uk/CG35/Guidance/pdf/English">Archived</a> from the original on 24 September 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Palliative+care+in+Parkinson%27s+disease&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.place=London&amp;rft.pages=147-51&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2006&amp;rft.isbn=978-1-86016-283-1&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOrgetaMcDonaldPoliakoffHindle2020" class="citation journal cs1">Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I (February 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7043362">"Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease"</a>. <i>The Cochrane Database of Systematic Reviews</i>. <b>2020</b> (2): CD011961. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.cd011961.pub2">10.1002/14651858.cd011961.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7043362">7043362</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32101639">32101639</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Cognitive+training+interventions+for+dementia+and+mild+cognitive+impairment+in+Parkinson%27s+disease&amp;rft.volume=2020&amp;rft.issue=2&amp;rft.pages=CD011961&amp;rft.date=2020-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7043362%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32101639&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.cd011961.pub2&amp;rft.aulast=Orgeta&amp;rft.aufirst=V&amp;rft.au=McDonald%2C+KR&amp;rft.au=Poliakoff%2C+E&amp;rft.au=Hindle%2C+JV&amp;rft.au=Clare%2C+L&amp;rft.au=Leroi%2C+I&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7043362&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMaria2017" class="citation book cs1">Maria N (2017). <i>Levodopa pharmacokinetics – from stomach to brain A study on patients with Parkinson's disease</i>. Linköping: Linköping University Electronic Press. p.&#160;10. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-9176855577" title="Special:BookSources/978-9176855577"><bdi>978-9176855577</bdi></a>. <a href="/wiki/OCLC_(identifier)" class="mw-redirect" title="OCLC (identifier)">OCLC</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/oclc/993068595">993068595</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Levodopa+pharmacokinetics+%E2%80%93+from+stomach+to+brain+A+study+on+patients+with+Parkinson%27s+disease.&amp;rft.place=Link%C3%B6ping&amp;rft.pages=10&amp;rft.pub=Link%C3%B6ping+University+Electronic+Press&amp;rft.date=2017&amp;rft_id=info%3Aoclcnum%2F993068595&amp;rft.isbn=978-9176855577&amp;rft.aulast=Maria&amp;rft.aufirst=N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Oertel2017-108"><span class="mw-cite-backlink">^ <a href="#cite_ref-Oertel2017_108-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Oertel2017_108-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOertel2017" class="citation journal cs1">Oertel WH (13 March 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5357034">"Recent advances in treating Parkinson's disease"</a>. <i>F1000Research</i> (Review). <b>6</b>: 260. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12688%2Ff1000research.10100.1">10.12688/f1000research.10100.1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5357034">5357034</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28357055">28357055</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=F1000Research&amp;rft.atitle=Recent+advances+in+treating+Parkinson%27s+disease&amp;rft.volume=6&amp;rft.pages=260&amp;rft.date=2017-03-13&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5357034%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28357055&amp;rft_id=info%3Adoi%2F10.12688%2Ff1000research.10100.1&amp;rft.aulast=Oertel&amp;rft.aufirst=WH&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5357034&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAquinoFox2015" class="citation journal cs1">Aquino CC, Fox SH (January 2015). "Clinical spectrum of levodopa-induced complications". <i>Movement Disorders</i>. <b>30</b> (1): 80–89. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.26125">10.1002/mds.26125</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25488260">25488260</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22301199">22301199</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Clinical+spectrum+of+levodopa-induced+complications&amp;rft.volume=30&amp;rft.issue=1&amp;rft.pages=80-89&amp;rft.date=2015-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22301199%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25488260&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.26125&amp;rft.aulast=Aquino&amp;rft.aufirst=CC&amp;rft.au=Fox%2C+SH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTambascoRomoliCalabresi2018" class="citation journal cs1">Tambasco N, Romoli M, Calabresi P (2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6187751">"Levodopa in Parkinson's Disease: Current Status and Future Developments"</a>. <i>Current Neuropharmacology</i>. <b>16</b> (8): 1239–1252. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1570159X15666170510143821">10.2174/1570159X15666170510143821</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6187751">6187751</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28494719">28494719</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neuropharmacology&amp;rft.atitle=Levodopa+in+Parkinson%27s+Disease%3A+Current+Status+and+Future+Developments&amp;rft.volume=16&amp;rft.issue=8&amp;rft.pages=1239-1252&amp;rft.date=2018&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6187751%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28494719&amp;rft_id=info%3Adoi%2F10.2174%2F1570159X15666170510143821&amp;rft.aulast=Tambasco&amp;rft.aufirst=N&amp;rft.au=Romoli%2C+M&amp;rft.au=Calabresi%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6187751&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:2-111"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_111-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_111-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:2_111-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAkhtarYarGroverNath2020" class="citation journal cs1">Akhtar MJ, Yar MS, Grover G, Nath R (January 2020). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bioorg.2019.103418">"Neurological and psychiatric management using COMT inhibitors: A review"</a>. <i>Bioorganic Chemistry</i>. <b>94</b>: 103418. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.bioorg.2019.103418">10.1016/j.bioorg.2019.103418</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31708229">31708229</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bioorganic+Chemistry&amp;rft.atitle=Neurological+and+psychiatric+management+using+COMT+inhibitors%3A+A+review&amp;rft.volume=94&amp;rft.pages=103418&amp;rft.date=2020-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bioorg.2019.103418&amp;rft_id=info%3Apmid%2F31708229&amp;rft.aulast=Akhtar&amp;rft.aufirst=MJ&amp;rft.au=Yar%2C+MS&amp;rft.au=Grover%2C+G&amp;rft.au=Nath%2C+R&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.bioorg.2019.103418&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-112">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/emc/product/3902">"Tasmar 100 mg Tablets – Summary of Product Characteristics (SmPC) – (emc)"</a>. <i>www.medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.medicines.org.uk&amp;rft.atitle=Tasmar+100+mg+Tablets+%E2%80%93+Summary+of+Product+Characteristics+%28SmPC%29+%E2%80%93+%28emc%29&amp;rft_id=https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F3902&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-113">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFScott2016" class="citation journal cs1">Scott LJ (September 2016). "Opicapone: A Review in Parkinson's Disease". <i>Drugs</i>. <b>76</b> (13): 1293–1300. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs40265-016-0623-y">10.1007/s40265-016-0623-y</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27498199">27498199</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5787752">5787752</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Drugs&amp;rft.atitle=Opicapone%3A+A+Review+in+Parkinson%27s+Disease&amp;rft.volume=76&amp;rft.issue=13&amp;rft.pages=1293-1300&amp;rft.date=2016-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5787752%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27498199&amp;rft_id=info%3Adoi%2F10.1007%2Fs40265-016-0623-y&amp;rft.aulast=Scott&amp;rft.aufirst=LJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-114">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWatkins2000" class="citation journal cs1">Watkins P (2000). <a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11147510">"COMT inhibitors and liver toxicity"</a>. <i>Neurology</i>. <b>55</b> (11 Suppl 4): S51-2, discussion S53-6. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11147510">11147510</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=COMT+inhibitors+and+liver+toxicity&amp;rft.volume=55&amp;rft.issue=11+Suppl+4&amp;rft.pages=S51-2%2C+discussion+S53-6&amp;rft.date=2000&amp;rft_id=info%3Apmid%2F11147510&amp;rft.aulast=Watkins&amp;rft.aufirst=P&amp;rft_id=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F11147510&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-115">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/emc/product/1632">"Comtess 200 mg film-coated Tablets – Summary of Product Characteristics (SmPC) – (emc)"</a>. <i>www.medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.medicines.org.uk&amp;rft.atitle=Comtess+200+mg+film-coated+Tablets+%E2%80%93+Summary+of+Product+Characteristics+%28SmPC%29+%E2%80%93+%28emc%29&amp;rft_id=https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F1632&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-116"><span class="mw-cite-backlink"><b><a href="#cite_ref-116">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/emc/product/6517/smpc">"Stalevo 150 mg/37.5 mg/200 mg Film-coated Tablets – Summary of Product Characteristics (SmPC) – (emc)"</a>. <i>www.medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.medicines.org.uk&amp;rft.atitle=Stalevo+150+mg%2F37.5+mg%2F200+mg+Film-coated+Tablets+%E2%80%93+Summary+of+Product+Characteristics+%28SmPC%29+%E2%80%93+%28emc%29&amp;rft_id=https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F6517%2Fsmpc&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-117"><span class="mw-cite-backlink"><b><a href="#cite_ref-117">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.medicines.org.uk/emc/product/7386">"Ongentys 50 mg hard capsules – Summary of Product Characteristics (SmPC) – (emc)"</a>. <i>www.medicines.org.uk</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.medicines.org.uk&amp;rft.atitle=Ongentys+50+mg+hard+capsules+%E2%80%93+Summary+of+Product+Characteristics+%28SmPC%29+%E2%80%93+%28emc%29&amp;rft_id=https%3A%2F%2Fwww.medicines.org.uk%2Femc%2Fproduct%2F7386&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-118">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGoldenberg2008" class="citation journal cs1">Goldenberg MM (October 2008). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2730785">"Medical management of Parkinson's disease"</a>. <i>P &amp; T</i>. <b>33</b> (10): 590–606. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2730785">2730785</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19750042">19750042</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=P+%26+T&amp;rft.atitle=Medical+management+of+Parkinson%27s+disease&amp;rft.volume=33&amp;rft.issue=10&amp;rft.pages=590-606&amp;rft.date=2008-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2730785%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19750042&amp;rft.aulast=Goldenberg&amp;rft.aufirst=MM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2730785&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20123548-119"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20123548_119-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCeravoloFrosiniRossiBonuccelli2009" class="citation journal cs1">Ceravolo R, Frosini D, Rossi C, Bonuccelli U (December 2009). "Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management". <i>Parkinsonism &amp; Related Disorders</i>. <b>15</b> (Suppl 4): S111–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1353-8020%2809%2970847-8">10.1016/S1353-8020(09)70847-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20123548">20123548</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Impulse+control+disorders+in+Parkinson%27s+disease%3A+definition%2C+epidemiology%2C+risk+factors%2C+neurobiology+and+management&amp;rft.volume=15&amp;rft.issue=Suppl+4&amp;rft.pages=S111-15&amp;rft.date=2009-12&amp;rft_id=info%3Adoi%2F10.1016%2FS1353-8020%2809%2970847-8&amp;rft_id=info%3Apmid%2F20123548&amp;rft.aulast=Ceravolo&amp;rft.aufirst=R&amp;rft.au=Frosini%2C+D&amp;rft.au=Rossi%2C+C&amp;rft.au=Bonuccelli%2C+U&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Jankovic_book-Pharma-120"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jankovic_book-Pharma_120-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTolosaKatzenschlager2007" class="citation book cs1">Tolosa E, Katzenschlager R (2007). "Pharmacological management of Parkinson's disease".  In Tolosa E, Jankovic JJ (eds.). <i>Parkinson's disease and movement disorders</i>. Hagerstwon, MD: Lippincott Williams &amp; Wilkins. pp.&#160;110–45. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-7817-7881-7" title="Special:BookSources/978-0-7817-7881-7"><bdi>978-0-7817-7881-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Pharmacological+management+of+Parkinson%27s+disease&amp;rft.btitle=Parkinson%27s+disease+and+movement+disorders&amp;rft.place=Hagerstwon%2C+MD&amp;rft.pages=110-45&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft.date=2007&amp;rft.isbn=978-0-7817-7881-7&amp;rft.aulast=Tolosa&amp;rft.aufirst=E&amp;rft.au=Katzenschlager%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:10-121"><span class="mw-cite-backlink">^ <a href="#cite_ref-:10_121-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:10_121-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:10_121-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFAlborghettiNicoletti2019" class="citation journal cs1">Alborghetti M, Nicoletti F (2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7052841">"Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside"</a>. <i>Current Neuropharmacology</i>. <b>17</b> (9): 861–873. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1570159X16666180830100754">10.2174/1570159X16666180830100754</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7052841">7052841</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30160213">30160213</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Neuropharmacology&amp;rft.atitle=Different+Generations+of+Type-B+Monoamine+Oxidase+Inhibitors+in+Parkinson%27s+Disease%3A+From+Bench+to+Bedside&amp;rft.volume=17&amp;rft.issue=9&amp;rft.pages=861-873&amp;rft.date=2019&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7052841%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30160213&amp;rft_id=info%3Adoi%2F10.2174%2F1570159X16666180830100754&amp;rft.aulast=Alborghetti&amp;rft.aufirst=M&amp;rft.au=Nicoletti%2C+F&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7052841&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-122">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFIvesStoweMarroCounsell2004" class="citation journal cs1">Ives NJ, Stowe RL, Marro J, Counsell C, Macleod A, Clarke CE,  et&#160;al. (September 2004). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC516655">"Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients"</a>. <i>BMJ</i>. <b>329</b> (7466): 593. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.38184.606169.AE">10.1136/bmj.38184.606169.AE</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC516655">516655</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15310558">15310558</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Monoamine+oxidase+type+B+inhibitors+in+early+Parkinson%27s+disease%3A+meta-analysis+of+17+randomised+trials+involving+3525+patients&amp;rft.volume=329&amp;rft.issue=7466&amp;rft.pages=593&amp;rft.date=2004-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC516655%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15310558&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.38184.606169.AE&amp;rft.aulast=Ives&amp;rft.aufirst=NJ&amp;rft.au=Stowe%2C+RL&amp;rft.au=Marro%2C+J&amp;rft.au=Counsell%2C+C&amp;rft.au=Macleod%2C+A&amp;rft.au=Clarke%2C+CE&amp;rft.au=Gray%2C+R&amp;rft.au=Wheatley%2C+K&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC516655&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-123">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCrosbyDeaneClarke2003" class="citation journal cs1">Crosby N, Deane KH, Clarke CE (2003). "Amantadine in Parkinson's disease". <i>The Cochrane Database of Systematic Reviews</i> (1): CD003468. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD003468">10.1002/14651858.CD003468</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12535476">12535476</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Amantadine+in+Parkinson%27s+disease&amp;rft.issue=1&amp;rft.pages=CD003468&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD003468&amp;rft_id=info%3Apmid%2F12535476&amp;rft.aulast=Crosby&amp;rft.aufirst=N&amp;rft.au=Deane%2C+KH&amp;rft.au=Clarke%2C+CE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nice-NonMotor-124"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-NonMotor_124-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-NonMotor_124-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2006" class="citation book cs1">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Non-motor features of Parkinson's disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;113–33. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-86016-283-1" title="Special:BookSources/978-1-86016-283-1"><bdi>978-1-86016-283-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100924153546/http://guidance.nice.org.uk/CG35/Guidance/pdf/English">Archived</a> from the original on 24 September 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Non-motor+features+of+Parkinson%27s+disease&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.place=London&amp;rft.pages=113-33&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2006&amp;rft.isbn=978-1-86016-283-1&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19559160-125"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19559160_125-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHasnainViewegBaronBeatty-Brooks2009" class="citation journal cs1">Hasnain M, Vieweg WV, Baron MS, Beatty-Brooks M, Fernandez A, Pandurangi AK (July 2009). "Pharmacological management of psychosis in elderly patients with parkinsonism". <i>The American Journal of Medicine</i>. <b>122</b> (7): 614–22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.amjmed.2009.01.025">10.1016/j.amjmed.2009.01.025</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19559160">19559160</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Medicine&amp;rft.atitle=Pharmacological+management+of+psychosis+in+elderly+patients+with+parkinsonism&amp;rft.volume=122&amp;rft.issue=7&amp;rft.pages=614-22&amp;rft.date=2009-07&amp;rft_id=info%3Adoi%2F10.1016%2Fj.amjmed.2009.01.025&amp;rft_id=info%3Apmid%2F19559160&amp;rft.aulast=Hasnain&amp;rft.aufirst=M&amp;rft.au=Vieweg%2C+WV&amp;rft.au=Baron%2C+MS&amp;rft.au=Beatty-Brooks%2C+M&amp;rft.au=Fernandez%2C+A&amp;rft.au=Pandurangi%2C+AK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation pressrelease cs1"><a rel="nofollow" class="external text" href="https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm498442.htm">"FDA approves first drug to treat hallucinations and delusions associated with Parkinson's disease"</a>. <i>www.fda.gov</i> (Press release). 29 April 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">12 October</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+first+drug+to+treat+hallucinations+and+delusions+associated+with+Parkinson%27s+disease&amp;rft.date=2016-04-29&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fnewsevents%2Fnewsroom%2Fpressannouncements%2Fucm498442.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Elbers2015-127"><span class="mw-cite-backlink">^ <a href="#cite_ref-Elbers2015_127-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Elbers2015_127-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFElbersVerhoefvan_WegenBerendse2015" class="citation journal cs1">Elbers RG, Verhoef J, van Wegen EE, Berendse HW, Kwakkel G (October 2015). "Interventions for fatigue in Parkinson's disease". <i>The Cochrane Database of Systematic Reviews</i> (Review) (10): CD010925. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD010925.pub2">10.1002/14651858.CD010925.pub2</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26447539">26447539</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Interventions+for+fatigue+in+Parkinson%27s+disease&amp;rft.issue=10&amp;rft.pages=CD010925&amp;rft.date=2015-10&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD010925.pub2&amp;rft_id=info%3Apmid%2F26447539&amp;rft.aulast=Elbers&amp;rft.aufirst=RG&amp;rft.au=Verhoef%2C+J&amp;rft.au=van+Wegen%2C+EE&amp;rft.au=Berendse%2C+HW&amp;rft.au=Kwakkel%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nice-surgery-128"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-surgery_128-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-surgery_128-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nice-surgery_128-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nice-surgery_128-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2006" class="citation book cs1">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Surgery for Parkinson's disease"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;101–11. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-86016-283-1" title="Special:BookSources/978-1-86016-283-1"><bdi>978-1-86016-283-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100924153546/http://guidance.nice.org.uk/CG35/Guidance/pdf/English">Archived</a> from the original on 24 September 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Surgery+for+Parkinson%27s+disease&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.place=London&amp;rft.pages=101-11&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2006&amp;rft.isbn=978-1-86016-283-1&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20937936-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20937936_129-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBronsteinTagliatiAlterman2011" class="citation journal cs1">Bronstein JM, Tagliati M, Alterman RL,  et&#160;al. (February 2011). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4523130">"Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues"</a>. <i>Archives of Neurology</i>. <b>68</b> (2): 165. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchneurol.2010.260">10.1001/archneurol.2010.260</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4523130">4523130</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20937936">20937936</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Neurology&amp;rft.atitle=Deep+brain+stimulation+for+Parkinson+disease%3A+an+expert+consensus+and+review+of+key+issues&amp;rft.volume=68&amp;rft.issue=2&amp;rft.pages=165&amp;rft.date=2011-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4523130%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F20937936&amp;rft_id=info%3Adoi%2F10.1001%2Farchneurol.2010.260&amp;rft.aulast=Bronstein&amp;rft.aufirst=JM&amp;rft.au=Tagliati%2C+M&amp;rft.au=Alterman%2C+RL&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4523130&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Dallapiazza2018-130"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dallapiazza2018_130-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDallapiazzaVlooFomenko2018" class="citation book cs1">Dallapiazza RF, Vloo PD, Fomenko A,  et&#160;al. (2018). "Considerations for Patient and Target Selection in Deep Brain Stimulation surgery for Parkinson's disease".  In Stoker TB, Greenland JC (eds.). <i>Parkinson's disease: Pathogenesis and clinical aspects</i>. Brisbane: Codon Publications.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Considerations+for+Patient+and+Target+Selection+in+Deep+Brain+Stimulation+surgery+for+Parkinson%27s+disease&amp;rft.btitle=Parkinson%27s+disease%3A+Pathogenesis+and+clinical+aspects.&amp;rft.place=Brisbane&amp;rft.pub=Codon+Publications&amp;rft.date=2018&amp;rft.aulast=Dallapiazza&amp;rft.aufirst=RF&amp;rft.au=Vloo%2C+PD&amp;rft.au=Fomenko%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-131">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFStokerGreenlandDallapiazzaDe_Vloo2018" class="citation cs2">Stoker TB, Greenland JC, Dallapiazza RF, De Vloo P, Fomenko A, Lee DJ, Hamani C, Munhoz RP, Hodaie M, Lozano AM, Fasano A, Kalia SK (2018),  Stoker TB (ed.), <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK536714/">"Considerations for Patient and Target Selection in Deep Brain Stimulation Surgery for Parkinson's Disease"</a>, <i>Parkinson's Disease: Pathogenesis and Clinical Aspects</i>, Brisbane (AU): Codon Publications, <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-9944381-6-4" title="Special:BookSources/978-0-9944381-6-4"><bdi>978-0-9944381-6-4</bdi></a>, <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30702838">30702838</a><span class="reference-accessdate">, retrieved <span class="nowrap">19 November</span> 2021</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinson%27s+Disease%3A+Pathogenesis+and+Clinical+Aspects&amp;rft.atitle=Considerations+for+Patient+and+Target+Selection+in+Deep+Brain+Stimulation+Surgery+for+Parkinson%27s+Disease&amp;rft.date=2018&amp;rft_id=info%3Apmid%2F30702838&amp;rft.isbn=978-0-9944381-6-4&amp;rft.aulast=Stoker&amp;rft.aufirst=TB&amp;rft.au=Greenland%2C+JC&amp;rft.au=Dallapiazza%2C+RF&amp;rft.au=De+Vloo%2C+P&amp;rft.au=Fomenko%2C+A&amp;rft.au=Lee%2C+DJ&amp;rft.au=Hamani%2C+C&amp;rft.au=Munhoz%2C+RP&amp;rft.au=Hodaie%2C+M&amp;rft.au=Lozano%2C+AM&amp;rft.au=Fasano%2C+A&amp;rft.au=Kalia%2C+SK&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK536714%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nice-rehab-132"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nice-rehab_132-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nice-rehab_132-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nice-rehab_132-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nice-rehab_132-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nice-rehab_132-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFThe_National_Collaborating_Centre_for_Chronic_Conditions2006" class="citation book cs1">The National Collaborating Centre for Chronic Conditions, ed. (2006). <a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG35/Guidance/pdf/English">"Other key interventions"</a>. <i>Parkinson's Disease</i>. London: Royal College of Physicians. pp.&#160;135–46. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-1-86016-283-1" title="Special:BookSources/978-1-86016-283-1"><bdi>978-1-86016-283-1</bdi></a>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100924153546/http://guidance.nice.org.uk/CG35/Guidance/pdf/English">Archived</a> from the original on 24 September 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Other+key+interventions&amp;rft.btitle=Parkinson%27s+Disease&amp;rft.place=London&amp;rft.pages=135-46&amp;rft.pub=Royal+College+of+Physicians&amp;rft.date=2006&amp;rft.isbn=978-1-86016-283-1&amp;rft_id=http%3A%2F%2Fguidance.nice.org.uk%2FCG35%2FGuidance%2Fpdf%2FEnglish&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18181210-133"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18181210_133-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18181210_133-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGoodwinRichardsTaylorTaylor2008" class="citation journal cs1">Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (April 2008). "The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis". <i>Movement Disorders</i>. <b>23</b> (5): 631–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.21922">10.1002/mds.21922</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//hdl.handle.net/10871%2F17451">10871/17451</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18181210">18181210</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:3808899">3808899</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=The+effectiveness+of+exercise+interventions+for+people+with+Parkinson%27s+disease%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=23&amp;rft.issue=5&amp;rft.pages=631-40&amp;rft.date=2008-04&amp;rft_id=info%3Ahdl%2F10871%2F17451&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A3808899%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18181210&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21922&amp;rft.aulast=Goodwin&amp;rft.aufirst=VA&amp;rft.au=Richards%2C+SH&amp;rft.au=Taylor%2C+RS&amp;rft.au=Taylor%2C+AH&amp;rft.au=Campbell%2C+JL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-134"><span class="mw-cite-backlink"><b><a href="#cite_ref-134">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDereliYaliman2010" class="citation journal cs1">Dereli EE, Yaliman A (April 2010). "Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme on quality of life in patients with Parkinson's disease". <i>Clinical Rehabilitation</i>. <b>24</b> (4): 352–62. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F0269215509358933">10.1177/0269215509358933</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20360152">20360152</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:10947269">10947269</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Rehabilitation&amp;rft.atitle=Comparison+of+the+effects+of+a+physiotherapist-supervised+exercise+programme+and+a+self-supervised+exercise+programme+on+quality+of+life+in+patients+with+Parkinson%27s+disease&amp;rft.volume=24&amp;rft.issue=4&amp;rft.pages=352-62&amp;rft.date=2010-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10947269%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20360152&amp;rft_id=info%3Adoi%2F10.1177%2F0269215509358933&amp;rft.aulast=Dereli&amp;rft.aufirst=EE&amp;rft.au=Yaliman%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-135">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJinWangLiuZhu2019" class="citation journal cs1">Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, Fan X (December 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6981975">"The Impact of Mind-body Exercises on Motor Function, Depressive Symptoms, and Quality of Life in Parkinson's Disease: A Systematic Review and Meta-analysis"</a>. <i>International Journal of Environmental Research and Public Health</i>. <b>17</b> (1): 31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fijerph17010031">10.3390/ijerph17010031</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6981975">6981975</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31861456">31861456</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Environmental+Research+and+Public+Health&amp;rft.atitle=The+Impact+of+Mind-body+Exercises+on+Motor+Function%2C+Depressive+Symptoms%2C+and+Quality+of+Life+in+Parkinson%27s+Disease%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=17&amp;rft.issue=1&amp;rft.pages=31&amp;rft.date=2019-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6981975%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31861456&amp;rft_id=info%3Adoi%2F10.3390%2Fijerph17010031&amp;rft.aulast=Jin&amp;rft.aufirst=X&amp;rft.au=Wang%2C+L&amp;rft.au=Liu%2C+S&amp;rft.au=Zhu%2C+L&amp;rft.au=Loprinzi%2C+PD&amp;rft.au=Fan%2C+X&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6981975&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-136">^</a></b></span> <span class="reference-text"><a href="#CITEREFO&#39;SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, pp.&#160;873, 876</span>
</li>
<li id="cite_note-137"><span class="mw-cite-backlink"><b><a href="#cite_ref-137">^</a></b></span> <span class="reference-text"><a href="#CITEREFO&#39;SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, p.&#160;879</span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><a href="#CITEREFO&#39;SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, p.&#160;877</span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><a href="#CITEREFO&#39;SullivanSchmitz2007">O'Sullivan &amp; Schmitz 2007</a>, p.&#160;880</span>
</li>
<li id="cite_note-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-140">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRamazzinaBernazzoliCostantino2017" class="citation journal cs1">Ramazzina I, Bernazzoli B, Costantino C (31 March 2017). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5384725">"Systematic review on strength training in Parkinson's disease: an unsolved question"</a>. <i>Clinical Interventions in Aging</i>. <b>12</b>: 619–628. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FCIA.S131903">10.2147/CIA.S131903</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC5384725">5384725</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28408811">28408811</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Interventions+in+Aging&amp;rft.atitle=Systematic+review+on+strength+training+in+Parkinson%27s+disease%3A+an+unsolved+question&amp;rft.volume=12&amp;rft.pages=619-628&amp;rft.date=2017-03-31&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5384725%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28408811&amp;rft_id=info%3Adoi%2F10.2147%2FCIA.S131903&amp;rft.aulast=Ramazzina&amp;rft.aufirst=I&amp;rft.au=Bernazzoli%2C+B&amp;rft.au=Costantino%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5384725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17117354-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17117354_141-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFoxRamigCiucciSapir2006" class="citation journal cs1">Fox CM, Ramig LO, Ciucci MR, Sapir S, McFarland DH, Farley BG (November 2006). "The science and practice of LSVT/LOUD: neural plasticity-principled approach to treating individuals with Parkinson disease and other neurological disorders". <i>Seminars in Speech and Language</i>. <b>27</b> (4): 283–99. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1055%2Fs-2006-955118">10.1055/s-2006-955118</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17117354">17117354</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Seminars+in+Speech+and+Language&amp;rft.atitle=The+science+and+practice+of+LSVT%2FLOUD%3A+neural+plasticity-principled+approach+to+treating+individuals+with+Parkinson+disease+and+other+neurological+disorders&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=283-99&amp;rft.date=2006-11&amp;rft_id=info%3Adoi%2F10.1055%2Fs-2006-955118&amp;rft_id=info%3Apmid%2F17117354&amp;rft.aulast=Fox&amp;rft.aufirst=CM&amp;rft.au=Ramig%2C+LO&amp;rft.au=Ciucci%2C+MR&amp;rft.au=Sapir%2C+S&amp;rft.au=McFarland%2C+DH&amp;rft.au=Farley%2C+BG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17636709-142"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17636709_142-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDixonDuncanJohnson2007" class="citation journal cs1">Dixon L, Duncan D, Johnson P,  et&#160;al. (July 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6991932">"Occupational therapy for patients with Parkinson's disease"</a>. <i>The Cochrane Database of Systematic Reviews</i> (3): CD002813. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.CD002813.pub2">10.1002/14651858.CD002813.pub2</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6991932">6991932</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17636709">17636709</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Occupational+therapy+for+patients+with+Parkinson%27s+disease&amp;rft.issue=3&amp;rft.pages=CD002813&amp;rft.date=2007-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6991932%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17636709&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002813.pub2&amp;rft.aulast=Dixon&amp;rft.aufirst=L&amp;rft.au=Duncan%2C+D&amp;rft.au=Johnson%2C+P&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6991932&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17531914-143"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17531914_143-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFerrellConnorCordes2007" class="citation journal cs1">Ferrell B, Connor SR, Cordes A,  et&#160;al. (June 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpainsymman.2007.02.024">"The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum"</a>. <i>Journal of Pain and Symptom Management</i>. <b>33</b> (6): 737–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpainsymman.2007.02.024">10.1016/j.jpainsymman.2007.02.024</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17531914">17531914</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pain+and+Symptom+Management&amp;rft.atitle=The+national+agenda+for+quality+palliative+care%3A+the+National+Consensus+Project+and+the+National+Quality+Forum&amp;rft.volume=33&amp;rft.issue=6&amp;rft.pages=737-44&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jpainsymman.2007.02.024&amp;rft_id=info%3Apmid%2F17531914&amp;rft.aulast=Ferrell&amp;rft.aufirst=B&amp;rft.au=Connor%2C+SR&amp;rft.au=Cordes%2C+A&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.jpainsymman.2007.02.024&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid24182372-144"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid24182372_144-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid24182372_144-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLorenzlNüblingPerrarVoltz2013" class="citation book cs1">Lorenzl S, Nübling G, Perrar KM, Voltz R (2013). "Palliative treatment of chronic neurologic disorders". <i>Ethical and Legal Issues in Neurology</i>. Handbook of Clinical Neurology. Vol.&#160;118. pp.&#160;133–39. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FB978-0-444-53501-6.00010-X">10.1016/B978-0-444-53501-6.00010-X</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0444535016" title="Special:BookSources/978-0444535016"><bdi>978-0444535016</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24182372">24182372</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Palliative+treatment+of+chronic+neurologic+disorders&amp;rft.btitle=Ethical+and+Legal+Issues+in+Neurology&amp;rft.series=Handbook+of+Clinical+Neurology&amp;rft.pages=133-39&amp;rft.date=2013&amp;rft_id=info%3Apmid%2F24182372&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-444-53501-6.00010-X&amp;rft.isbn=978-0444535016&amp;rft.aulast=Lorenzl&amp;rft.aufirst=S&amp;rft.au=N%C3%BCbling%2C+G&amp;rft.au=Perrar%2C+KM&amp;rft.au=Voltz%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22771241-145"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid22771241_145-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid22771241_145-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGhoche2012" class="citation journal cs1">Ghoche R (December 2012). "The conceptual framework of palliative care applied to advanced Parkinson's disease". <i>Parkinsonism &amp; Related Disorders</i>. <b>18</b> (Suppl 3): S2–5. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2012.06.012">10.1016/j.parkreldis.2012.06.012</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22771241">22771241</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=The+conceptual+framework+of+palliative+care+applied+to+advanced+Parkinson%27s+disease&amp;rft.volume=18&amp;rft.issue=Suppl+3&amp;rft.pages=S2-5&amp;rft.date=2012-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2012.06.012&amp;rft_id=info%3Apmid%2F22771241&amp;rft.aulast=Ghoche&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20081638-146"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid20081638_146-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid20081638_146-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid20081638_146-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWilcox2010" class="citation journal cs1">Wilcox SK (January 2010). "Extending palliative care to patients with Parkinson's disease". <i>British Journal of Hospital Medicine</i>. <b>71</b> (1): 26–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.12968%2Fhmed.2010.71.1.45969">10.12968/hmed.2010.71.1.45969</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20081638">20081638</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Hospital+Medicine&amp;rft.atitle=Extending+palliative+care+to+patients+with+Parkinson%27s+disease&amp;rft.volume=71&amp;rft.issue=1&amp;rft.pages=26-30&amp;rft.date=2010-01&amp;rft_id=info%3Adoi%2F10.12968%2Fhmed.2010.71.1.45969&amp;rft_id=info%3Apmid%2F20081638&amp;rft.aulast=Wilcox&amp;rft.aufirst=SK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid24801658-147"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24801658_147-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMoensHigginsonHarding2014" class="citation journal cs1">Moens K, Higginson IJ, Harding R (October 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpainsymman.2013.11.009">"Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic review"</a>. <i>Journal of Pain and Symptom Management</i>. <b>48</b> (4): 660–77. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jpainsymman.2013.11.009">10.1016/j.jpainsymman.2013.11.009</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24801658">24801658</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pain+and+Symptom+Management&amp;rft.atitle=Are+there+differences+in+the+prevalence+of+palliative+care-related+problems+in+people+living+with+advanced+cancer+and+eight+non-cancer+conditions%3F+A+systematic+review&amp;rft.volume=48&amp;rft.issue=4&amp;rft.pages=660-77&amp;rft.date=2014-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jpainsymman.2013.11.009&amp;rft_id=info%3Apmid%2F24801658&amp;rft.aulast=Moens&amp;rft.aufirst=K&amp;rft.au=Higginson%2C+IJ&amp;rft.au=Harding%2C+R&amp;rft_id=%2F%2Fdoi.org%2F10.1016%252Fj.jpainsymman.2013.11.009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid24195263-148"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid24195263_148-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCasey2013" class="citation journal cs1">Casey G (August 2013). "Parkinson's disease: a long and difficult journey". <i>Nursing New Zealand</i>. <b>19</b> (7): 20–24. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24195263">24195263</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nursing+New+Zealand&amp;rft.atitle=Parkinson%27s+disease%3A+a+long+and+difficult+journey&amp;rft.volume=19&amp;rft.issue=7&amp;rft.pages=20-24&amp;rft.date=2013-08&amp;rft_id=info%3Apmid%2F24195263&amp;rft.aulast=Casey&amp;rft.aufirst=G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17131223-149"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17131223_149-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-pmid17131223_149-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPoewe2006" class="citation journal cs1">Poewe W (December 2006). "The natural history of Parkinson's disease". <i>Journal of Neurology</i>. <b>253</b> (Suppl 7): vii2–vii6. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00415-006-7002-7">10.1007/s00415-006-7002-7</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17131223">17131223</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35082340">35082340</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Neurology&amp;rft.atitle=The+natural+history+of+Parkinson%27s+disease&amp;rft.volume=253&amp;rft.issue=Suppl+7&amp;rft.pages=vii2-vii6&amp;rft.date=2006-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35082340%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F17131223&amp;rft_id=info%3Adoi%2F10.1007%2Fs00415-006-7002-7&amp;rft.aulast=Poewe&amp;rft.aufirst=W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-GlobalBurden2016-150"><span class="mw-cite-backlink">^ <a href="#cite_ref-GlobalBurden2016_150-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GlobalBurden2016_150-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFeiginNicholsAlam2019" class="citation journal cs1">Feigin VL, Nichols E, Alam T,  et&#160;al. (May 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6459001">"Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016"</a>. <i>Lancet Neurol</i>. <b>18</b> (5): 459–80. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2818%2930499-X">10.1016/S1474-4422(18)30499-X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6459001">6459001</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30879893">30879893</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet+Neurol&amp;rft.atitle=Global%2C+regional%2C+and+national+burden+of+neurological+disorders%2C+1990%E2%80%932016%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2016&amp;rft.volume=18&amp;rft.issue=5&amp;rft.pages=459-80&amp;rft.date=2019-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6459001%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30879893&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2818%2930499-X&amp;rft.aulast=Feigin&amp;rft.aufirst=VL&amp;rft.au=Nichols%2C+E&amp;rft.au=Alam%2C+T&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6459001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid23225012-151"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid23225012_151-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMhyreBoydHamillMaguire-Zeiss2012" class="citation book cs1">Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA (2012). <i>Parkinson's disease</i>. Subcellular Biochemistry. Vol.&#160;65. pp.&#160;389–455. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-94-007-5416-4_16">10.1007/978-94-007-5416-4_16</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-94-007-5415-7" title="Special:BookSources/978-94-007-5415-7"><bdi>978-94-007-5415-7</bdi></a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4372387">4372387</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/23225012">23225012</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Parkinson%27s+disease&amp;rft.series=Subcellular+Biochemistry&amp;rft.pages=389-455&amp;rft.date=2012&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4372387%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F23225012&amp;rft_id=info%3Adoi%2F10.1007%2F978-94-007-5416-4_16&amp;rft.isbn=978-94-007-5415-7&amp;rft.aulast=Mhyre&amp;rft.aufirst=TR&amp;rft.au=Boyd%2C+JT&amp;rft.au=Hamill%2C+RW&amp;rft.au=Maguire-Zeiss%2C+KA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Kad2019-152"><span class="mw-cite-backlink">^ <a href="#cite_ref-Kad2019_152-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kad2019_152-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKadastik-EermeTabaAsserTaba2019" class="citation journal cs1">Kadastik-Eerme L, Taba N, Asser T, Taba P (16 April 2019). "Incidence and Mortality of Parkinson's Disease in Estonia". <i>Neuroepidemiology</i>. <b>53</b> (1–2): 63–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1159%2F000499756">10.1159/000499756</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30991384">30991384</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:119103425">119103425</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroepidemiology&amp;rft.atitle=Incidence+and+Mortality+of+Parkinson%27s+Disease+in+Estonia&amp;rft.volume=53&amp;rft.issue=1%E2%80%932&amp;rft.pages=63-72&amp;rft.date=2019-04-16&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A119103425%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30991384&amp;rft_id=info%3Adoi%2F10.1159%2F000499756&amp;rft.aulast=Kadastik-Eerme&amp;rft.aufirst=L&amp;rft.au=Taba%2C+N&amp;rft.au=Asser%2C+T&amp;rft.au=Taba%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-153"><span class="mw-cite-backlink"><b><a href="#cite_ref-153">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLiMaCuiHe2019" class="citation journal cs1">Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, Chen S (31 July 2019). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6668186">"Parkinson's disease in China: a forty-year growing track of bedside work"</a>. <i>Translational Neurodegeneration</i>. <b>8</b> (1): 22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs40035-019-0162-z">10.1186/s40035-019-0162-z</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6668186">6668186</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31384434">31384434</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Translational+Neurodegeneration&amp;rft.atitle=Parkinson%27s+disease+in+China%3A+a+forty-year+growing+track+of+bedside+work&amp;rft.volume=8&amp;rft.issue=1&amp;rft.pages=22&amp;rft.date=2019-07-31&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6668186%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31384434&amp;rft_id=info%3Adoi%2F10.1186%2Fs40035-019-0162-z&amp;rft.aulast=Li&amp;rft.aufirst=G&amp;rft.au=Ma%2C+J&amp;rft.au=Cui%2C+S&amp;rft.au=He%2C+Y&amp;rft.au=Xiao%2C+Q&amp;rft.au=Liu%2C+J&amp;rft.au=Chen%2C+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6668186&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-154"><span class="mw-cite-backlink"><b><a href="#cite_ref-154">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDorseyShererOkunBloem" class="citation journal cs1">Dorsey ER, Sherer T, Okun MS, Bloem BR. <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6311367">"The Emerging Evidence of the Parkinson Pandemic"</a>. <i>Journal of Parkinson's Disease</i>. <b>8</b> (s1): S3–S8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJPD-181474">10.3233/JPD-181474</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6311367">6311367</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30584159">30584159</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Parkinson%27s+Disease&amp;rft.atitle=The+Emerging+Evidence+of+the+Parkinson+Pandemic&amp;rft.volume=8&amp;rft.issue=s1&amp;rft.pages=S3-S8&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6311367%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30584159&amp;rft_id=info%3Adoi%2F10.3233%2FJPD-181474&amp;rft.aulast=Dorsey&amp;rft.aufirst=ER&amp;rft.au=Sherer%2C+T&amp;rft.au=Okun%2C+MS&amp;rft.au=Bloem%2C+BR&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6311367&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid15568171-155"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid15568171_155-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid15568171_155-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid15568171_155-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGarcía_Ruiz2004" class="citation journal cs1 cs1-prop-foreign-lang-source">García Ruiz PJ (December 2004). <a rel="nofollow" class="external text" href="https://www.researchgate.net/publication/8159672">"Prehistoria de la enfermedad de Parkinson"</a> &#91;Prehistory of Parkinson's disease&#93;. <i>Neurologia</i> (in Spanish). <b>19</b> (10): 735–37. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15568171">15568171</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurologia&amp;rft.atitle=Prehistoria+de+la+enfermedad+de+Parkinson&amp;rft.volume=19&amp;rft.issue=10&amp;rft.pages=735-37&amp;rft.date=2004-12&amp;rft_id=info%3Apmid%2F15568171&amp;rft.aulast=Garc%C3%ADa+Ruiz&amp;rft.aufirst=PJ&amp;rft_id=https%3A%2F%2Fwww.researchgate.net%2Fpublication%2F8159672&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span>. The article mistakenly refers to Job 34:19 instead of Job 33:19.</span>
</li>
<li id="cite_note-pmid19892136-156"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid19892136_156-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid19892136_156-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLanska2010" class="citation book cs1">Lanska DJ (2010). <i>Chapter 33: the history of movement disorders</i>. Handbook of Clinical Neurology. Vol.&#160;95. pp.&#160;501–46. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0072-9752%2808%2902133-7">10.1016/S0072-9752(08)02133-7</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0444520098" title="Special:BookSources/978-0444520098"><bdi>978-0444520098</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19892136">19892136</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Chapter+33%3A+the+history+of+movement+disorders&amp;rft.series=Handbook+of+Clinical+Neurology&amp;rft.pages=501-46&amp;rft.date=2010&amp;rft_id=info%3Apmid%2F19892136&amp;rft_id=info%3Adoi%2F10.1016%2FS0072-9752%2808%2902133-7&amp;rft.isbn=978-0444520098&amp;rft.aulast=Lanska&amp;rft.aufirst=DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid9380070-157"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9380070_157-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKoehlerKeyser1997" class="citation journal cs1">Koehler PJ, Keyser A (September 1997). "Tremor in Latin texts of Dutch physicians: 16th-18th centuries". <i>Movement Disorders</i>. <b>12</b> (5): 798–806. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.870120531">10.1002/mds.870120531</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9380070">9380070</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:310819">310819</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Tremor+in+Latin+texts+of+Dutch+physicians%3A+16th-18th+centuries&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=798-806&amp;rft.date=1997-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A310819%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9380070&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.870120531&amp;rft.aulast=Koehler&amp;rft.aufirst=PJ&amp;rft.au=Keyser%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid9399240-158"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9399240_158-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLouis1997" class="citation journal cs1">Louis ED (November 1997). "The shaking palsy, the first forty-five years: a journey through the British literature". <i>Movement Disorders</i>. <b>12</b> (6): 1068–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.870120638">10.1002/mds.870120638</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9399240">9399240</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34630080">34630080</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=The+shaking+palsy%2C+the+first+forty-five+years%3A+a+journey+through+the+British+literature&amp;rft.volume=12&amp;rft.issue=6&amp;rft.pages=1068-72&amp;rft.date=1997-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34630080%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9399240&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.870120638&amp;rft.aulast=Louis&amp;rft.aufirst=ED&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18781671-159"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid18781671_159-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid18781671_159-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid18781671_159-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFahn2008" class="citation journal cs1">Fahn S (2008). "The history of dopamine and levodopa in the treatment of Parkinson's disease". <i>Movement Disorders</i>. <b>23</b> (Suppl 3): S497–508. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.22028">10.1002/mds.22028</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18781671">18781671</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:45572523">45572523</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=The+history+of+dopamine+and+levodopa+in+the+treatment+of+Parkinson%27s+disease&amp;rft.volume=23&amp;rft.issue=Suppl+3&amp;rft.pages=S497-508&amp;rft.date=2008&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A45572523%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18781671&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22028&amp;rft.aulast=Fahn&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid9361073-160"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid9361073_160-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGuridiLozano1997" class="citation journal cs1">Guridi J, Lozano AM (November 1997). "A brief history of pallidotomy". <i>Neurosurgery</i>. <b>41</b> (5): 1169–80, discussion 1180–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00006123-199711000-00029">10.1097/00006123-199711000-00029</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9361073">9361073</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurosurgery&amp;rft.atitle=A+brief+history+of+pallidotomy&amp;rft.volume=41&amp;rft.issue=5&amp;rft.pages=1169-80%2C+discussion+1180-83&amp;rft.date=1997-11&amp;rft_id=info%3Adoi%2F10.1097%2F00006123-199711000-00029&amp;rft_id=info%3Apmid%2F9361073&amp;rft.aulast=Guridi&amp;rft.aufirst=J&amp;rft.au=Lozano%2C+AM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-161"><span class="mw-cite-backlink"><b><a href="#cite_ref-161">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHornykiewicz2002" class="citation journal cs1">Hornykiewicz O (2002). "L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent". <i>Amino Acids</i>. <b>23</b> (1–3): 65–70. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00726-001-0111-9">10.1007/s00726-001-0111-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12373520">12373520</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25117208">25117208</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Amino+Acids&amp;rft.atitle=L-DOPA%3A+from+a+biologically+inactive+amino+acid+to+a+successful+therapeutic+agent&amp;rft.volume=23&amp;rft.issue=1%E2%80%933&amp;rft.pages=65-70&amp;rft.date=2002&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25117208%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12373520&amp;rft_id=info%3Adoi%2F10.1007%2Fs00726-001-0111-9&amp;rft.aulast=Hornykiewicz&amp;rft.aufirst=O&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18684199-162"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18684199_162-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCoffey2009" class="citation journal cs1">Coffey RJ (March 2009). "Deep brain stimulation devices: a brief technical history and review". <i>Artificial Organs</i>. <b>33</b> (3): 208–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1525-1594.2008.00620.x">10.1111/j.1525-1594.2008.00620.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18684199">18684199</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Artificial+Organs&amp;rft.atitle=Deep+brain+stimulation+devices%3A+a+brief+technical+history+and+review&amp;rft.volume=33&amp;rft.issue=3&amp;rft.pages=208-20&amp;rft.date=2009-03&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1525-1594.2008.00620.x&amp;rft_id=info%3Apmid%2F18684199&amp;rft.aulast=Coffey&amp;rft.aufirst=RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid17702630-163"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid17702630_163-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid17702630_163-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid17702630_163-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-pmid17702630_163-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-pmid17702630_163-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFFindley2007" class="citation journal cs1 cs1-prop-long-vol">Findley LJ (September 2007). "The economic impact of Parkinson's disease". <i>Parkinsonism &amp; Related Disorders</i>. 13 Suppl (Suppl): S8–12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2007.06.003">10.1016/j.parkreldis.2007.06.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17702630">17702630</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=The+economic+impact+of+Parkinson%27s+disease&amp;rft.volume=13+Suppl&amp;rft.issue=Suppl&amp;rft.pages=S8-12&amp;rft.date=2007-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2007.06.003&amp;rft_id=info%3Apmid%2F17702630&amp;rft.aulast=Findley&amp;rft.aufirst=LJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-tulip-164"><span class="mw-cite-backlink"><b><a href="#cite_ref-tulip_164-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110514151652/http://www.gsk.com/infocus/parkinsons.htm">"Parkinson's – 'the shaking palsy'<span class="cs1-kern-right"></span>"</a>. GlaxoSmithKline. 1 April 2009. Archived from <a rel="nofollow" class="external text" href="http://www.gsk.com/infocus/parkinsons.htm">the original</a> on 14 May 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Parkinson%27s+%E2%80%93+%27the+shaking+palsy%27&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2009-04-01&amp;rft_id=http%3A%2F%2Fwww.gsk.com%2Finfocus%2Fparkinsons.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-urlNational_Parkinson_Foundation_–_Mission-165"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlNational_Parkinson_Foundation_–_Mission_165-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20101221103201/http://parkinson.org/About-Us/Mission">"National Parkinson Foundation – Mission"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.parkinson.org/About-Us/Mission">the original</a> on 21 December 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">28 March</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=National+Parkinson+Foundation+%E2%80%93+Mission&amp;rft_id=http%3A%2F%2Fwww.parkinson.org%2FAbout-Us%2FMission&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-166"><span class="mw-cite-backlink"><b><a href="#cite_ref-166">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation magazine cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110220012106/http://www.time.com/time/magazine/article/0,9171,828597,00.html">"Education: Joy in Giving"</a>. <i>Time</i>. 18 January 1960. Archived from <a rel="nofollow" class="external text" href="http://www.time.com/time/magazine/article/0,9171,828597,00.html">the original</a> on 20 February 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Time&amp;rft.atitle=Education%3A+Joy+in+Giving&amp;rft.date=1960-01-18&amp;rft_id=http%3A%2F%2Fwww.time.com%2Ftime%2Fmagazine%2Farticle%2F0%2C9171%2C828597%2C00.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-167"><span class="mw-cite-backlink"><b><a href="#cite_ref-167">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110515204903/http://www.pdf.org/en/about_pdf">"About PDF"</a>. Parkinson's Disease Foundation. Archived from <a rel="nofollow" class="external text" href="http://www.pdf.org/en/about_pdf">the original</a> on 15 May 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">24 July</span> 2016</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=About+PDF&amp;rft.pub=Parkinson%27s+Disease+Foundation&amp;rft_id=http%3A%2F%2Fwww.pdf.org%2Fen%2Fabout_pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-168"><span class="mw-cite-backlink"><b><a href="#cite_ref-168">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120510165933/http://www.apdaparkinson.org/userND/index.asp">"American Parkinson Disease Association: Home"</a>. American Parkinson Disease Association. Archived from <a rel="nofollow" class="external text" href="http://www.apdaparkinson.org/userND/index.asp">the original</a> on 10 May 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=American+Parkinson+Disease+Association%3A+Home&amp;rft.pub=American+Parkinson+Disease+Association&amp;rft_id=http%3A%2F%2Fwww.apdaparkinson.org%2FuserND%2Findex.asp&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-169"><span class="mw-cite-backlink"><b><a href="#cite_ref-169">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.epda.eu.com/about-us/">"About EPDA"</a>. European Parkinson's Disease Association. 2010. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20100815232300/http://www.epda.eu.com/about-us/">Archived</a> from the original on 15 August 2010<span class="reference-accessdate">. Retrieved <span class="nowrap">9 August</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=About+EPDA&amp;rft.pub=European+Parkinson%27s+Disease+Association&amp;rft.date=2010&amp;rft_id=http%3A%2F%2Fwww.epda.eu.com%2Fabout-us%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-MJF_guardian-170"><span class="mw-cite-backlink">^ <a href="#cite_ref-MJF_guardian_170-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MJF_guardian_170-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MJF_guardian_170-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrockes2009" class="citation news cs1">Brockes E (11 April 2009). <a rel="nofollow" class="external text" href="https://www.theguardian.com/lifeandstyle/2009/apr/11/michael-j-fox-parkinsons">"<span class="cs1-kern-left"></span>'It's the gift that keeps on taking'<span class="cs1-kern-right"></span>"</a>. <i>The Guardian</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20131008000425/http://www.theguardian.com/lifeandstyle/2009/apr/11/michael-j-fox-parkinsons">Archived</a> from the original on 8 October 2013<span class="reference-accessdate">. Retrieved <span class="nowrap">25 October</span> 2010</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=%27It%27s+the+gift+that+keeps+on+taking%27&amp;rft.date=2009-04-11&amp;rft.aulast=Brockes&amp;rft.aufirst=E&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Flifeandstyle%2F2009%2Fapr%2F11%2Fmichael-j-fox-parkinsons&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-doctorate_Fox-171"><span class="mw-cite-backlink"><b><a href="#cite_ref-doctorate_Fox_171-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110930040553/http://ki.se/ki/jsp/polopoly.jsp?d=25844&amp;a=96573&amp;l=en&amp;newsdep=25844">"Michael J. Fox to be made honorary doctor at Karolinska Institutet"</a>. Karolinska Institutet. 5 March 2010. Archived from <a rel="nofollow" class="external text" href="http://ki.se/ki/jsp/polopoly.jsp?d=25844&amp;a=96573&amp;l=en&amp;newsdep=25844">the original</a> on 30 September 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Michael+J.+Fox+to+be+made+honorary+doctor+at+Karolinska+Institutet&amp;rft.date=2010-03-05&amp;rft_id=http%3A%2F%2Fki.se%2Fki%2Fjsp%2Fpolopoly.jsp%3Fd%3D25844%26a%3D96573%26l%3Den%26newsdep%3D25844&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-DPF-172"><span class="mw-cite-backlink"><b><a href="#cite_ref-DPF_172-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://davisphinneyfoundation.org/dpf/who-we-are/">"Who We Are"</a>. Davis Phinney Foundation. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20120111054225/http://davisphinneyfoundation.org/dpf/who-we-are/">Archived</a> from the original on 11 January 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">18 January</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Who+We+Are&amp;rft.pub=Davis+Phinney+Foundation&amp;rft_id=http%3A%2F%2Fdavisphinneyfoundation.org%2Fdpf%2Fwho-we-are%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Ali_NN-173"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ali_NN_173-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMatthews2006" class="citation journal cs1">Matthews W (April 2006). "Ali's Fighting Spirit". <i>Neurology Now</i>. <b>2</b> (2): 10–23. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F01222928-200602020-00004">10.1097/01222928-200602020-00004</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:181104230">181104230</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology+Now&amp;rft.atitle=Ali%27s+Fighting+Spirit&amp;rft.volume=2&amp;rft.issue=2&amp;rft.pages=10-23&amp;rft.date=2006-04&amp;rft_id=info%3Adoi%2F10.1097%2F01222928-200602020-00004&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A181104230%23id-name%3DS2CID&amp;rft.aulast=Matthews&amp;rft.aufirst=W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Ali_NYT-174"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ali_NYT_174-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTauber1988" class="citation news cs1">Tauber P (17 July 1988). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1988/07/17/magazine/ali-still-magic.html">"Ali: Still Magic"</a>. <i>The New York Times</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161117151827/http://www.nytimes.com/1988/07/17/magazine/ali-still-magic.html">Archived</a> from the original on 17 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2011</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Ali%3A+Still+Magic&amp;rft.date=1988-07-17&amp;rft.aulast=Tauber&amp;rft.aufirst=P&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1988%2F07%2F17%2Fmagazine%2Fali-still-magic.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Gallman2015-175"><span class="mw-cite-backlink">^ <a href="#cite_ref-Gallman2015_175-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Gallman2015_175-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFGallman2015" class="citation news cs1">Gallman S (4 November 2015). <a rel="nofollow" class="external text" href="http://www.cnn.com/2015/11/03/health/robin-williams-widow-susan-williams/index.html">"Robin Williams' widow speaks: Depression didn't kill my husband"</a>. <i>CNN</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20151104002632/http://www.cnn.com/2015/11/03/health/robin-williams-widow-susan-williams/index.html">Archived</a> from the original on 4 November 2015<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Robin+Williams%27+widow+speaks%3A+Depression+didn%27t+kill+my+husband&amp;rft.date=2015-11-04&amp;rft.aulast=Gallman&amp;rft.aufirst=S&amp;rft_id=http%3A%2F%2Fwww.cnn.com%2F2015%2F11%2F03%2Fhealth%2Frobin-williams-widow-susan-williams%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-176"><span class="mw-cite-backlink"><b><a href="#cite_ref-176">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFWilliams2016" class="citation journal cs1">Williams SS (September 2016). <a rel="nofollow" class="external text" href="http://n.neurology.org/content/87/13/1308.long">"The terrorist inside my husband's brain"</a>. <i>Neurology</i>. <b>87</b> (13): 1308–11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2FWNL.0000000000003162">10.1212/WNL.0000000000003162</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27672165">27672165</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=The+terrorist+inside+my+husband%27s+brain&amp;rft.volume=87&amp;rft.issue=13&amp;rft.pages=1308-11&amp;rft.date=2016-09&amp;rft_id=info%3Adoi%2F10.1212%2FWNL.0000000000003162&amp;rft_id=info%3Apmid%2F27672165&amp;rft.aulast=Williams&amp;rft.aufirst=SS&amp;rft_id=http%3A%2F%2Fn.neurology.org%2Fcontent%2F87%2F13%2F1308.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-177"><span class="mw-cite-backlink"><b><a href="#cite_ref-177">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRobbins2016" class="citation news cs1">Robbins R (30 September 2016). <a rel="nofollow" class="external text" href="https://www.scientificamerican.com/article/how-lewy-body-dementia-gripped-robin-williams1/">"How Lewy body dementia gripped Robin Williams"</a>. <i>Scientific American</i><span class="reference-accessdate">. Retrieved <span class="nowrap">9 April</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scientific+American&amp;rft.atitle=How+Lewy+body+dementia+gripped+Robin+Williams&amp;rft.date=2016-09-30&amp;rft.aulast=Robbins&amp;rft.aufirst=R&amp;rft_id=https%3A%2F%2Fwww.scientificamerican.com%2Farticle%2Fhow-lewy-body-dementia-gripped-robin-williams1%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-LBDA-178"><span class="mw-cite-backlink">^ <a href="#cite_ref-LBDA_178-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-LBDA_178-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20200812093153/https://www.lbda.org/content/lbda-clarifies-autopsy-report-comedian-robin-williams">"LBDA Clarifies Autopsy Report on Comedian, Robin Williams"</a>. <a href="/wiki/Lewy_Body_Dementia_Association" title="Lewy Body Dementia Association">Lewy Body Dementia Association</a>. 10 November 2014. Archived from <a rel="nofollow" class="external text" href="https://www.lbda.org/content/lbda-clarifies-autopsy-report-comedian-robin-williams">the original</a> on 12 August 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">19 April</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=LBDA+Clarifies+Autopsy+Report+on+Comedian%2C+Robin+Williams&amp;rft.pub=Lewy+Body+Dementia+Association&amp;rft.date=2014-11-10&amp;rft_id=https%3A%2F%2Fwww.lbda.org%2Fcontent%2Flbda-clarifies-autopsy-report-comedian-robin-williams&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-179"><span class="mw-cite-backlink"><b><a href="#cite_ref-179">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMcKeith2015" class="citation news cs1">McKeith IG (6 November 2015). <a rel="nofollow" class="external text" href="https://theconversation.com/robin-williams-had-dementia-with-lewy-bodies-so-what-is-it-and-why-has-it-been-eclipsed-by-alzheimers-50221">"Robin Williams had dementia with Lewy bodies – so, what is it and why has it been eclipsed by Alzheimer's?"</a>. <i>The Conversation</i>. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20161104010452/https://theconversation.com/robin-williams-had-dementia-with-lewy-bodies-so-what-is-it-and-why-has-it-been-eclipsed-by-alzheimers-50221">Archived</a> from the original on 4 November 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">6 April</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Conversation&amp;rft.atitle=Robin+Williams+had+dementia+with+Lewy+bodies+%E2%80%93+so%2C+what+is+it+and+why+has+it+been+eclipsed+by+Alzheimer%27s%3F&amp;rft.date=2015-11-06&amp;rft.aulast=McKeith&amp;rft.aufirst=IG&amp;rft_id=https%3A%2F%2Ftheconversation.com%2Frobin-williams-had-dementia-with-lewy-bodies-so-what-is-it-and-why-has-it-been-eclipsed-by-alzheimers-50221&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Poewe2017-180"><span class="mw-cite-backlink">^ <a href="#cite_ref-Poewe2017_180-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Poewe2017_180-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Poewe2017_180-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPoeweSeppiTanner2017" class="citation journal cs1">Poewe W, Seppi K, Tanner CM,  et&#160;al. (23 March 2017). "Parkinson disease". <i>Nature Reviews Disease Primers</i>. <b>3</b> (1): 17013. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrdp.2017.13">10.1038/nrdp.2017.13</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2056-676X">2056-676X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28332488">28332488</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:11605091">11605091</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Disease+Primers&amp;rft.atitle=Parkinson+disease&amp;rft.volume=3&amp;rft.issue=1&amp;rft.pages=17013&amp;rft.date=2017-03-23&amp;rft.issn=2056-676X&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A11605091%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28332488&amp;rft_id=info%3Adoi%2F10.1038%2Fnrdp.2017.13&amp;rft.aulast=Poewe&amp;rft.aufirst=W&amp;rft.au=Seppi%2C+K&amp;rft.au=Tanner%2C+CM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-181"><span class="mw-cite-backlink"><b><a href="#cite_ref-181">^</a></b></span> <span class="reference-text"> <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHeinzelBergGasserChen2019" class="citation journal cs1">Heinzel S, Berg D, Gasser T, Chen H, Yao C, Postuma RB (October 2019). "Update of the MDS research criteria for prodromal Parkinson's disease". <i>Mov Disord</i>. <b>34</b> (10): 1464–1470. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.27802">10.1002/mds.27802</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31412427">31412427</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mov+Disord&amp;rft.atitle=Update+of+the+MDS+research+criteria+for+prodromal+Parkinson%27s+disease&amp;rft.volume=34&amp;rft.issue=10&amp;rft.pages=1464-1470&amp;rft.date=2019-10&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.27802&amp;rft_id=info%3Apmid%2F31412427&amp;rft.aulast=Heinzel&amp;rft.aufirst=S&amp;rft.au=Berg%2C+D&amp;rft.au=Gasser%2C+T&amp;rft.au=Chen%2C+H&amp;rft.au=Yao%2C+C&amp;rft.au=Postuma%2C+RB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid6823561-182"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid6823561_182-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLangstonBallardTetrudIrwin1983" class="citation journal cs1">Langston JW, Ballard P, Tetrud JW, Irwin I (February 1983). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/0fa587e1e8aba5327f1de9237279c47477b9e12d">"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis"</a>. <i>Science</i>. <b>219</b> (4587): 979–80. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/1983Sci...219..979L">1983Sci...219..979L</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1126%2Fscience.6823561">10.1126/science.6823561</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/6823561">6823561</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31966839">31966839</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Chronic+Parkinsonism+in+humans+due+to+a+product+of+meperidine-analog+synthesis&amp;rft.volume=219&amp;rft.issue=4587&amp;rft.pages=979-80&amp;rft.date=1983-02&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.6823561&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31966839%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F6823561&amp;rft_id=info%3Abibcode%2F1983Sci...219..979L&amp;rft.aulast=Langston&amp;rft.aufirst=JW&amp;rft.au=Ballard%2C+P&amp;rft.au=Tetrud%2C+JW&amp;rft.au=Irwin%2C+I&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2F0fa587e1e8aba5327f1de9237279c47477b9e12d&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid19729209-183"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid19729209_183-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCicchettiDrouin-OuelletGross2009" class="citation journal cs1">Cicchetti F, Drouin-Ouellet J, Gross RE (September 2009). "Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?". <i>Trends in Pharmacological Sciences</i>. <b>30</b> (9): 475–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.tips.2009.06.005">10.1016/j.tips.2009.06.005</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/19729209">19729209</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Trends+in+Pharmacological+Sciences&amp;rft.atitle=Environmental+toxins+and+Parkinson%27s+disease%3A+what+have+we+learned+from+pesticide-induced+animal+models%3F&amp;rft.volume=30&amp;rft.issue=9&amp;rft.pages=475-83&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.tips.2009.06.005&amp;rft_id=info%3Apmid%2F19729209&amp;rft.aulast=Cicchetti&amp;rft.aufirst=F&amp;rft.au=Drouin-Ouellet%2C+J&amp;rft.au=Gross%2C+RE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18642640-184"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18642640_184-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHarveyWangHoffer2008" class="citation book cs1">Harvey BK, Wang Y, Hoffer BJ (2008). <i>Transgenic rodent models of Parkinson's disease</i>. <i><a href="/wiki/Acta_Neurochirurgica._Supplement" class="mw-redirect" title="Acta Neurochirurgica. Supplement">Acta Neurochirurgica. Supplement</a></i>. Acta Neurochirurgica Supplementum. Vol.&#160;101. pp.&#160;89–92. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F978-3-211-78205-7_15">10.1007/978-3-211-78205-7_15</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-211-78204-0" title="Special:BookSources/978-3-211-78204-0"><bdi>978-3-211-78204-0</bdi></a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2613245">2613245</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18642640">18642640</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Transgenic+rodent+models+of+Parkinson%27s+disease&amp;rft.series=Acta+Neurochirurgica+Supplementum&amp;rft.pages=89-92&amp;rft.date=2008&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2613245%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18642640&amp;rft_id=info%3Adoi%2F10.1007%2F978-3-211-78205-7_15&amp;rft.isbn=978-3-211-78204-0&amp;rft.aulast=Harvey&amp;rft.aufirst=BK&amp;rft.au=Wang%2C+Y&amp;rft.au=Hoffer%2C+BJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-185"><span class="mw-cite-backlink"><b><a href="#cite_ref-185">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBlumTorchLambeng2001" class="citation journal cs1">Blum D, Torch S, Lambeng N,  et&#160;al. (October 2001). "Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease". <i>Progress in Neurobiology</i>. <b>65</b> (2): 135–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0301-0082%2801%2900003-X">10.1016/S0301-0082(01)00003-X</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11403877">11403877</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19095092">19095092</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Progress+in+Neurobiology&amp;rft.atitle=Molecular+pathways+involved+in+the+neurotoxicity+of+6-OHDA%2C+dopamine+and+MPTP%3A+contribution+to+the+apoptotic+theory+in+Parkinson%27s+disease&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=135-72&amp;rft.date=2001-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19095092%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11403877&amp;rft_id=info%3Adoi%2F10.1016%2FS0301-0082%2801%2900003-X&amp;rft.aulast=Blum&amp;rft.aufirst=D&amp;rft.au=Torch%2C+S&amp;rft.au=Lambeng%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-186"><span class="mw-cite-backlink"><b><a href="#cite_ref-186">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHittiYangGonzalez-AlegreBaltuch2019" class="citation journal cs1">Hitti FL, Yang AI, Gonzalez-Alegre P, Baltuch GH (September 2019). "Human gene therapy approaches for the treatment of Parkinson's disease: An overview of current and completed clinical trials". <i>Parkinsonism Relat. Disord</i>. <b>66</b>: 16–24. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2019.07.018">10.1016/j.parkreldis.2019.07.018</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31324556">31324556</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:198132349">198132349</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+Relat.+Disord.&amp;rft.atitle=Human+gene+therapy+approaches+for+the+treatment+of+Parkinson%27s+disease%3A+An+overview+of+current+and+completed+clinical+trials&amp;rft.volume=66&amp;rft.pages=16-24&amp;rft.date=2019-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A198132349%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F31324556&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2019.07.018&amp;rft.aulast=Hitti&amp;rft.aufirst=FL&amp;rft.au=Yang%2C+AI&amp;rft.au=Gonzalez-Alegre%2C+P&amp;rft.au=Baltuch%2C+GH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-187"><span class="mw-cite-backlink"><b><a href="#cite_ref-187">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://asgct.org/research/news/april-2020/parkinsons-disease-awareness-month">"Parkinson's Disease: Is Gene Therapy the Answer We Have Been Looking For? | ASGCT - American Society of Gene &amp; Cell Therapy"</a>. <i>asgct.org</i><span class="reference-accessdate">. Retrieved <span class="nowrap">19 November</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=asgct.org&amp;rft.atitle=Parkinson%27s+Disease%3A+Is+Gene+Therapy+the+Answer+We+Have+Been+Looking+For%3F+%7C+ASGCT+-+American+Society+of+Gene+%26+Cell+Therapy&amp;rft_id=https%3A%2F%2Fasgct.org%2Fresearch%2Fnews%2Fapril-2020%2Fparkinsons-disease-awareness-month&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Dimond-188"><span class="mw-cite-backlink"><b><a href="#cite_ref-Dimond_188-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDimond2010" class="citation web cs1">Dimond PF (16 August 2010). <a rel="nofollow" class="external text" href="http://www.genengnews.com/analysis-and-insight/no-new-parkinson-disease-drug-expected-anytime-soon/77899336/">"No New Parkinson Disease Drug Expected Anytime Soon"</a>. <i>GEN news highlights</i>. GEN-Genetic Engineering &amp; Biotechnology News. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20101031023451/http://www.genengnews.com/analysis-and-insight/no-new-parkinson-disease-drug-expected-anytime-soon/77899336/">Archived</a> from the original on 31 October 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN+news+highlights&amp;rft.atitle=No+New+Parkinson+Disease+Drug+Expected+Anytime+Soon&amp;rft.date=2010-08-16&amp;rft.aulast=Dimond&amp;rft.aufirst=PF&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fanalysis-and-insight%2Fno-new-parkinson-disease-drug-expected-anytime-soon%2F77899336%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-189"><span class="mw-cite-backlink"><b><a href="#cite_ref-189">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVolcPoeweKutzelnigg2020" class="citation journal cs1">Volc D, Poewe W, Kutzelnigg A,  et&#160;al. (July 2020). "Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial". <i>The Lancet. Neurology</i>. <b>19</b> (7): 591–600. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1474-4422%2820%2930136-8">10.1016/S1474-4422(20)30136-8</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32562684">32562684</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:219947651">219947651</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Neurology&amp;rft.atitle=Safety+and+immunogenicity+of+the+%CE%B1-synuclein+active+immunotherapeutic+PD01A+in+patients+with+Parkinson%27s+disease%3A+a+randomised%2C+single-blinded%2C+phase+1+trial&amp;rft.volume=19&amp;rft.issue=7&amp;rft.pages=591-600&amp;rft.date=2020-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A219947651%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32562684&amp;rft_id=info%3Adoi%2F10.1016%2FS1474-4422%2820%2930136-8&amp;rft.aulast=Volc&amp;rft.aufirst=D&amp;rft.au=Poewe%2C+W&amp;rft.au=Kutzelnigg%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-NS1-190"><span class="mw-cite-backlink"><b><a href="#cite_ref-NS1_190-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation news cs1"><a rel="nofollow" class="external text" href="https://www.newscientist.com/article/mg21428682.000-worlds-first-parkinsons-vaccine-is-trialled.html">"World's first Parkinson's vaccine is trialled"</a>. <i>New Scientist</i>. London. 7 June 2012. <a rel="nofollow" class="external text" href="https://web.archive.org/web/20150423080305/http://www.newscientist.com/article/mg21428682.000-worlds-first-parkinsons-vaccine-is-trialled.html">Archived</a> from the original on 23 April 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+Scientist&amp;rft.atitle=World%27s+first+Parkinson%27s+vaccine+is+trialled&amp;rft.date=2012-06-07&amp;rft_id=https%3A%2F%2Fwww.newscientist.com%2Farticle%2Fmg21428682.000-worlds-first-parkinsons-vaccine-is-trialled.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-JAMA-191"><span class="mw-cite-backlink"><b><a href="#cite_ref-JAMA_191-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJankovicGoodmanSafirstein2018" class="citation journal cs1">Jankovic J, Goodman I, Safirstein B,  et&#160;al. (October 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6233845">"Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial"</a>. <i>JAMA Neurology</i>. <b>75</b> (10): 1206–14. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamaneurol.2018.1487">10.1001/jamaneurol.2018.1487</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6233845">6233845</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/29913017">29913017</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Neurology&amp;rft.atitle=Safety+and+Tolerability+of+Multiple+Ascending+Doses+of+PRX002%2FRG7935%2C+an+Anti-%CE%B1-Synuclein+Monoclonal+Antibody%2C+in+Patients+With+Parkinson+Disease%3A+A+Randomized+Clinical+Trial&amp;rft.volume=75&amp;rft.issue=10&amp;rft.pages=1206-14&amp;rft.date=2018-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6233845%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29913017&amp;rft_id=info%3Adoi%2F10.1001%2Fjamaneurol.2018.1487&amp;rft.aulast=Jankovic&amp;rft.aufirst=J&amp;rft.au=Goodman%2C+I&amp;rft.au=Safirstein%2C+B&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6233845&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-hench-192"><span class="mw-cite-backlink">^ <a href="#cite_ref-hench_192-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-hench_192-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHenchcliffeParmar2018" class="citation journal cs1">Henchcliffe C, Parmar M (2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6311366">"Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies"</a>. <i>Journal of Parkinson's Disease</i>. <b>8</b> (s1): S131–37. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FJPD-181488">10.3233/JPD-181488</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6311366">6311366</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30584166">30584166</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Parkinson%27s+Disease&amp;rft.atitle=Repairing+the+Brain%3A+Cell+Replacement+Using+Stem+Cell-Based+Technologies&amp;rft.volume=8&amp;rft.issue=s1&amp;rft.pages=S131-37&amp;rft.date=2018&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6311366%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30584166&amp;rft_id=info%3Adoi%2F10.3233%2FJPD-181488&amp;rft.aulast=Henchcliffe&amp;rft.aufirst=C&amp;rft.au=Parmar%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6311366&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-193"><span class="mw-cite-backlink"><b><a href="#cite_ref-193">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSchweitzerSongHerrington2020" class="citation journal cs1">Schweitzer JS, Song B, Herrington TM,  et&#160;al. (May 2020). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7288982">"Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease"</a>. <i>The New England Journal of Medicine</i>. <b>382</b> (20): 1926–32. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJMoa1915872">10.1056/NEJMoa1915872</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7288982">7288982</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32402162">32402162</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Personalized+iPSC-Derived+Dopamine+Progenitor+Cells+for+Parkinson%27s+Disease&amp;rft.volume=382&amp;rft.issue=20&amp;rft.pages=1926-32&amp;rft.date=2020-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7288982%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32402162&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa1915872&amp;rft.aulast=Schweitzer&amp;rft.aufirst=JS&amp;rft.au=Song%2C+B&amp;rft.au=Herrington%2C+TM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7288982&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20714078-194"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20714078_194-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKoch2010" class="citation journal cs1">Koch G (2010). "rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets". <i>Restorative Neurology and Neuroscience</i>. <b>28</b> (4): 561–68. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FRNN-2010-0556">10.3233/RNN-2010-0556</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20714078">20714078</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Restorative+Neurology+and+Neuroscience&amp;rft.atitle=rTMS+effects+on+levodopa+induced+dyskinesias+in+Parkinson%27s+disease+patients%3A+searching+for+effective+cortical+targets&amp;rft.volume=28&amp;rft.issue=4&amp;rft.pages=561-68&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.3233%2FRNN-2010-0556&amp;rft_id=info%3Apmid%2F20714078&amp;rft.aulast=Koch&amp;rft.aufirst=G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid20714064-195"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20714064_195-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPlatzRothwell2010" class="citation journal cs1">Platz T, Rothwell JC (2010). "Brain stimulation and brain repair – rTMS: from animal experiment to clinical trials – what do we know?". <i>Restorative Neurology and Neuroscience</i>. <b>28</b> (4): 387–98. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3233%2FRNN-2010-0570">10.3233/RNN-2010-0570</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20714064">20714064</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Restorative+Neurology+and+Neuroscience&amp;rft.atitle=Brain+stimulation+and+brain+repair+%E2%80%93+rTMS%3A+from+animal+experiment+to+clinical+trials+%E2%80%93+what+do+we+know%3F&amp;rft.volume=28&amp;rft.issue=4&amp;rft.pages=387-98&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.3233%2FRNN-2010-0570&amp;rft_id=info%3Apmid%2F20714064&amp;rft.aulast=Platz&amp;rft.aufirst=T&amp;rft.au=Rothwell%2C+JC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid16606908-196"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16606908_196-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSuchowerskyGronsethPerlmutterReich2006" class="citation journal cs1">Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ (April 2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000206363.57955.1b">"Practice Parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology"</a>. <i>Neurology</i>. <b>66</b> (7): 976–82. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1212%2F01.wnl.0000206363.57955.1b">10.1212/01.wnl.0000206363.57955.1b</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/16606908">16606908</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neurology&amp;rft.atitle=Practice+Parameter%3A+neuroprotective+strategies+and+alternative+therapies+for+Parkinson+disease+%28an+evidence-based+review%29%3A+report+of+the+Quality+Standards+Subcommittee+of+the+American+Academy+of+Neurology&amp;rft.volume=66&amp;rft.issue=7&amp;rft.pages=976-82&amp;rft.date=2006-04&amp;rft_id=info%3Adoi%2F10.1212%2F01.wnl.0000206363.57955.1b&amp;rft_id=info%3Apmid%2F16606908&amp;rft.aulast=Suchowersky&amp;rft.aufirst=O&amp;rft.au=Gronseth%2C+G&amp;rft.au=Perlmutter%2C+J&amp;rft.au=Reich%2C+S&amp;rft.au=Zesiewicz%2C+T&amp;rft.au=Weiner%2C+WJ&amp;rft_id=%2F%2Fdoi.org%2F10.1212%252F01.wnl.0000206363.57955.1b&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18374620-197"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18374620_197-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeeLamErnst2008" class="citation journal cs1">Lee MS, Lam P, Ernst E (December 2008). "Effectiveness of tai chi for Parkinson's disease: a critical review". <i>Parkinsonism &amp; Related Disorders</i>. <b>14</b> (8): 589–94. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.parkreldis.2008.02.003">10.1016/j.parkreldis.2008.02.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18374620">18374620</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Parkinsonism+%26+Related+Disorders&amp;rft.atitle=Effectiveness+of+tai+chi+for+Parkinson%27s+disease%3A+a+critical+review&amp;rft.volume=14&amp;rft.issue=8&amp;rft.pages=589-94&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.parkreldis.2008.02.003&amp;rft_id=info%3Apmid%2F18374620&amp;rft.aulast=Lee&amp;rft.aufirst=MS&amp;rft.au=Lam%2C+P&amp;rft.au=Ernst%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18973253-198"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18973253_198-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeeErnst2009" class="citation journal cs1">Lee MS, Ernst E (January 2009). "Qigong for movement disorders: A systematic review". <i>Movement Disorders</i>. <b>24</b> (2): 301–03. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.22275">10.1002/mds.22275</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18973253">18973253</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:206239252">206239252</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Qigong+for+movement+disorders%3A+A+systematic+review&amp;rft.volume=24&amp;rft.issue=2&amp;rft.pages=301-03&amp;rft.date=2009-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A206239252%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18973253&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.22275&amp;rft.aulast=Lee&amp;rft.aufirst=MS&amp;rft.au=Ernst%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18618661-199"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18618661_199-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeeShinKongErnst2008" class="citation journal cs1">Lee MS, Shin BC, Kong JC, Ernst E (August 2008). <a rel="nofollow" class="external text" href="https://semanticscholar.org/paper/b99f5e8de469d13d5a065bcd34f0d3da68d6e34e">"Effectiveness of acupuncture for Parkinson's disease: a systematic review"</a>. <i>Movement Disorders</i>. <b>23</b> (11): 1505–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fmds.21993">10.1002/mds.21993</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18618661">18618661</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24713983">24713983</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Movement+Disorders&amp;rft.atitle=Effectiveness+of+acupuncture+for+Parkinson%27s+disease%3A+a+systematic+review&amp;rft.volume=23&amp;rft.issue=11&amp;rft.pages=1505-15&amp;rft.date=2008-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24713983%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F18618661&amp;rft_id=info%3Adoi%2F10.1002%2Fmds.21993&amp;rft.aulast=Lee&amp;rft.aufirst=MS&amp;rft.au=Shin%2C+BC&amp;rft.au=Kong%2C+JC&amp;rft.au=Ernst%2C+E&amp;rft_id=https%3A%2F%2Fsemanticscholar.org%2Fpaper%2Fb99f5e8de469d13d5a065bcd34f0d3da68d6e34e&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-200"><span class="mw-cite-backlink"><b><a href="#cite_ref-200">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTremlettBauerAppel-CresswellFinlay2017" class="citation journal cs1">Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E (March 2017). "The gut microbiome in human neurological disease: A review". <i>Annals of Neurology</i>. <b>81</b> (3): 369–382. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fana.24901">10.1002/ana.24901</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28220542">28220542</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:25394413">25394413</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Neurology&amp;rft.atitle=The+gut+microbiome+in+human+neurological+disease%3A+A+review&amp;rft.volume=81&amp;rft.issue=3&amp;rft.pages=369-382&amp;rft.date=2017-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A25394413%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28220542&amp;rft_id=info%3Adoi%2F10.1002%2Fana.24901&amp;rft.aulast=Tremlett&amp;rft.aufirst=H&amp;rft.au=Bauer%2C+KC&amp;rft.au=Appel-Cresswell%2C+S&amp;rft.au=Finlay%2C+BB&amp;rft.au=Waubant%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-201"><span class="mw-cite-backlink"><b><a href="#cite_ref-201">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKlingelhoeferReichmann2017" class="citation book cs1">Klingelhoefer L, Reichmann H (2017). "The Gut and Nonmotor Symptoms in Parkinson's Disease". <i>Nonmotor Parkinson's: The Hidden Face – Management and the Hidden Face of Related Disorders</i>. <i>International Review of Neurobiology</i>. Vol.&#160;134. pp.&#160;787–809. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fbs.irn.2017.05.027">10.1016/bs.irn.2017.05.027</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0128126035" title="Special:BookSources/978-0128126035"><bdi>978-0128126035</bdi></a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/28805583">28805583</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=The+Gut+and+Nonmotor+Symptoms+in+Parkinson%27s+Disease&amp;rft.btitle=Nonmotor+Parkinson%27s%3A+The+Hidden+Face+%E2%80%93+Management+and+the+Hidden+Face+of+Related+Disorders&amp;rft.pages=787-809&amp;rft.date=2017&amp;rft_id=info%3Apmid%2F28805583&amp;rft_id=info%3Adoi%2F10.1016%2Fbs.irn.2017.05.027&amp;rft.isbn=978-0128126035&amp;rft.aulast=Klingelhoefer&amp;rft.aufirst=L&amp;rft.au=Reichmann%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-202"><span class="mw-cite-backlink"><b><a href="#cite_ref-202">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBhattacharyyaMohiteKrishnamoorthyGayen2019" class="citation journal cs1">Bhattacharyya D, Mohite GM, Krishnamoorthy J, Gayen N, Mehra S, Navalkar A,  et&#160;al. (May 2019). "Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function". <i>ACS Chemical Neuroscience</i>. <b>10</b> (5): 2229–2236. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Facschemneuro.8b00733">10.1021/acschemneuro.8b00733</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30855940">30855940</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:75136112">75136112</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ACS+Chemical+Neuroscience&amp;rft.atitle=Lipopolysaccharide+from+Gut+Microbiota+Modulates+%CE%B1-Synuclein+Aggregation+and+Alters+Its+Biological+Function&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=2229-2236&amp;rft.date=2019-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A75136112%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30855940&amp;rft_id=info%3Adoi%2F10.1021%2Facschemneuro.8b00733&amp;rft.aulast=Bhattacharyya&amp;rft.aufirst=D&amp;rft.au=Mohite%2C+GM&amp;rft.au=Krishnamoorthy%2C+J&amp;rft.au=Gayen%2C+N&amp;rft.au=Mehra%2C+S&amp;rft.au=Navalkar%2C+A&amp;rft.au=Kotler%2C+SA&amp;rft.au=Ratha%2C+BN&amp;rft.au=Ghosh%2C+A&amp;rft.au=Kumar%2C+R&amp;rft.au=Garai%2C+K&amp;rft.au=Mandal%2C+AK&amp;rft.au=Maji%2C+SK&amp;rft.au=Bhunia%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-203"><span class="mw-cite-backlink"><b><a href="#cite_ref-203">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFJenner2014" class="citation journal cs1">Jenner P (2014). "An overview of adenosine A2A receptor antagonists in Parkinson's disease". <i>International Review of Neurobiology</i>. <b>119</b>: 71–86. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FB978-0-12-801022-8.00003-9">10.1016/B978-0-12-801022-8.00003-9</a>. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0128010228" title="Special:BookSources/978-0128010228"><bdi>978-0128010228</bdi></a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2162-5514">2162-5514</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25175961">25175961</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Review+of+Neurobiology&amp;rft.atitle=An+overview+of+adenosine+A2A+receptor+antagonists+in+Parkinson%27s+disease&amp;rft.volume=119&amp;rft.pages=71-86&amp;rft.date=2014&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-801022-8.00003-9&amp;rft.issn=2162-5514&amp;rft_id=info%3Apmid%2F25175961&amp;rft.isbn=978-0128010228&amp;rft.aulast=Jenner&amp;rft.aufirst=P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-FDA2020-204"><span class="mw-cite-backlink">^ <a href="#cite_ref-FDA2020_204-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FDA2020_204-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOffice_of_the_Commissioner2020" class="citation web cs1">Office of the Commissioner (20 February 2020). <a rel="nofollow" class="external text" href="http://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease">"FDA approves new add-on drug to treat off episodes in adults with Parkinson's disease"</a>. <i>FDA</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 February</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FDA&amp;rft.atitle=FDA+approves+new+add-on+drug+to+treat+off+episodes+in+adults+with+Parkinson%27s+disease&amp;rft.date=2020-02-20&amp;rft.au=Office+of+the+Commissioner&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AParkinson%27s+disease" class="Z3988"></span></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Parkinson%27s_disease&amp;action=edit&amp;section=41" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1061125337">.mw-parser-output .sister-box{border:1px solid #aaa;padding:0;background:#f9f9f9}.mw-parser-output .sister-box>div{padding:0.75em 0;text-align:center}.mw-parser-output .sister-box>div>b{display:block}.mw-parser-output .sister-box>ul{border-top:1px solid #aaa;padding:0.75em 0;width:217px;margin:0 auto}.mw-parser-output .sister-box>ul>li{min-height:31px}.mw-parser-output .sister-logo{display:inline-block;width:31px;line-height:31px;vertical-align:middle;text-align:center}.mw-parser-output .sister-link{display:inline-block;margin-left:4px;width:182px;vertical-align:middle}.mw-parser-output .sister-bar{display:flex;justify-content:center;align-items:baseline;font-size:88%;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em 0 0;padding:0 2em}.mw-parser-output .sister-bar-header{margin:0 1em 0 0.5em;padding:0.2em 0;flex:0 0 auto;min-height:24px;line-height:22px}.mw-parser-output .sister-bar-content{display:flex;flex-flow:row wrap;flex:0 1 auto;align-items:baseline;padding:0.2em 0;column-gap:1em}.mw-parser-output .sister-bar-item{display:flex;align-items:baseline;margin:0.15em 0;min-height:24px;text-align:left}.mw-parser-output .sister-bar-logo{width:22px;line-height:22px;margin:0 0.2em;text-align:right}.mw-parser-output .sister-bar-link{margin:0 0.2em;text-align:left}@media screen and (max-width:960px){.mw-parser-output .sister-bar{display:flex;flex-flow:column wrap;font-size:88%;background-color:#fdfdfd;clear:both;margin:1em auto 0;padding:0 2em}.mw-parser-output .sister-bar-header{padding:0.2em 0;flex:0 1}.mw-parser-output .sister-bar-content{display:flex;flex-flow:row wrap;flex:1;align-items:baseline;padding:0.2em 0;border-top:1px solid #a2a9b1}.mw-parser-output .sister-bar-item{display:flex;align-items:baseline;flex:0 0 20em;min-width:20em;margin:0.15em 0;min-height:24px}}.mw-parser-output .navbox+link+.sister-bar{margin-top:-1px}.mw-parser-output .navbox+style+.sister-bar{margin-top:-1px}.mw-parser-output .portal-bar+link+.sister-bar{margin-top:-1px}.mw-parser-output .portal-bar+style+.sister-bar{margin-top:-1px}.mw-parser-output .sister-bar+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .sister-bar+.navbox-styles+.portal-bar{margin-top:-1px}</style><div role="navigation" aria-labelledby="sister-projects" class="metadata plainlinks sistersitebox plainlist sister-box mbox-small"><div><b>Parkinson's disease</b>at Wikipedia's <a href="/wiki/Wikipedia:Wikimedia_sister_projects" title="Wikipedia:Wikimedia sister projects"><span id="sister-projects">sister projects</span></a></div><ul><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/0/06/Wiktionary-logo-v2.svg/27px-Wiktionary-logo-v2.svg.png" decoding="async" width="27" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/en/thumb/0/06/Wiktionary-logo-v2.svg/41px-Wiktionary-logo-v2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/0/06/Wiktionary-logo-v2.svg/54px-Wiktionary-logo-v2.svg.png 2x" data-file-width="391" data-file-height="391" /></span><span class="sister-link"><a href="https://en.wiktionary.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="wikt:Special:Search/Parkinson&#39;s disease">Definitions</a> from Wiktionary</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/20px-Commons-logo.svg.png" decoding="async" width="20" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/40px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376" /></span><span class="sister-link"><a href="https://commons.wikimedia.org/wiki/Category:Parkinson%27s_disease" class="extiw" title="c:Category:Parkinson&#39;s disease">Media</a> from Commons</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/27px-Wikinews-logo.svg.png" decoding="async" width="27" height="15" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/41px-Wikinews-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/24/Wikinews-logo.svg/54px-Wikinews-logo.svg.png 2x" data-file-width="759" data-file-height="415" /></span><span class="sister-link"><a href="https://en.wikinews.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="n:Special:Search/Parkinson&#39;s disease">News</a> from Wikinews</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/23px-Wikiquote-logo.svg.png" decoding="async" width="23" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/35px-Wikiquote-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikiquote-logo.svg/46px-Wikiquote-logo.svg.png 2x" data-file-width="300" data-file-height="355" /></span><span class="sister-link"><a href="https://en.wikiquote.org/wiki/Parkinson%27s_disease" class="extiw" title="q:Parkinson&#39;s disease">Quotations</a> from Wikiquote</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/26px-Wikisource-logo.svg.png" decoding="async" width="26" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/39px-Wikisource-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/51px-Wikisource-logo.svg.png 2x" data-file-width="410" data-file-height="430" /></span><span class="sister-link"><a href="https://en.wikisource.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="s:Special:Search/Parkinson&#39;s disease">Texts</a> from Wikisource</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/27px-Wikibooks-logo.svg.png" decoding="async" width="27" height="27" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/41px-Wikibooks-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fa/Wikibooks-logo.svg/54px-Wikibooks-logo.svg.png 2x" data-file-width="300" data-file-height="300" /></span><span class="sister-link"><a href="https://en.wikibooks.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="b:Special:Search/Parkinson&#39;s disease">Textbooks</a> from Wikibooks</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Wikiversity_logo_2017.svg/27px-Wikiversity_logo_2017.svg.png" decoding="async" width="27" height="22" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Wikiversity_logo_2017.svg/41px-Wikiversity_logo_2017.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Wikiversity_logo_2017.svg/54px-Wikiversity_logo_2017.svg.png 2x" data-file-width="626" data-file-height="512" /></span><span class="sister-link"><a href="https://en.wikiversity.org/wiki/Special:Search/Parkinson%27s_disease" class="extiw" title="v:Special:Search/Parkinson&#39;s disease">Resources</a> from Wikiversity</span></li><li><span class="sister-logo"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Wikidata-logo.svg/27px-Wikidata-logo.svg.png" decoding="async" width="27" height="15" style="vertical-align: middle" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Wikidata-logo.svg/41px-Wikidata-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/ff/Wikidata-logo.svg/54px-Wikidata-logo.svg.png 2x" data-file-width="1050" data-file-height="590" /></span><span class="sister-link"><a href="https://www.wikidata.org/wiki/Q11085" class="extiw" title="d:Q11085">Data</a> from Wikidata</span></li></ul></div>
<ul><li><a rel="nofollow" class="external text" href="https://curlie.org/Health/Conditions_and_Diseases/Neurological_Disorders/Parkinson&#39;s_Disease/">Parkinson's Disease</a> at <a href="/wiki/Curlie" class="mw-redirect" title="Curlie">Curlie</a></li>
<li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20161202234630/http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm">Parkinson's Disease: Hope Through Research (National Institute of Neurological Disorders and Stroke)</a></li>
<li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20061109041052/http://www.wpda.org/">World Parkinson Disease Association</a></li>
<li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20081220041909/http://www.pdgene.org/">PDGENE – Database for Parkinson's Disease genetic association studies</a></li></ul>
<div class="navbox-styles nomobile"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-label="Navbox" style="width:100%; margin:0.5em 0 0.5em 0;;padding:3px"><table class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">Classification</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q11085" class="extiw" title="d:Q11085">D</a></div><div class="hlist hlist-separated" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/G20">G20</a>, <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/F02.3">F02.3</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=332">332</a></li><li><b><a href="/wiki/Online_Mendelian_Inheritance_in_Man" title="Online Mendelian Inheritance in Man">OMIM</a></b>: <a rel="nofollow" class="external text" href="https://omim.org/entry/168600">168600</a> <a rel="nofollow" class="external text" href="https://omim.org/entry/556500">556500</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D010300">D010300</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb9651.htm">9651</a></li></ul></div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">External resources</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist hlist-separated" style="text-align:left;"><ul><li><b><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></b>: <a rel="nofollow" class="external text" href="https://www.nlm.nih.gov/medlineplus/ency/article/000755.htm">000755</a></li><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/neuro/304-overview">neuro/304</a> <a rel="nofollow" class="external text" href="http://www.emedicine.com/neuro/topic635.htm#">neuro/635</a> in young<br /><a rel="nofollow" class="external text" href="http://www.emedicine.com/pmr/topic99.htm#">pmr/99</a> rehab</li><li><b><a href="/wiki/GeneReviews" title="GeneReviews">GeneReviews</a></b>: <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/books/NBK1223/">Parkinson Disease Overview</a></li></ul></div></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Mental_disorders_(Classification)" style="padding:3px"><table class="nowraplinks hlist mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Mental_disorders" title="Template:Mental disorders"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Mental_disorders" title="Template talk:Mental disorders"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Mental_disorders&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Mental_disorders_(Classification)" style="font-size:114%;margin:0 4em"><a href="/wiki/Mental_disorder" title="Mental disorder">Mental disorders</a>&#160;<small>(<a href="/wiki/Classification_of_mental_disorders" title="Classification of mental disorders">Classification</a>)</small></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Adult_personality_and_behavior" style="font-size:114%;margin:0 4em">Adult personality and behavior</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Sexual</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Ego-dystonic_sexual_orientation" title="Ego-dystonic sexual orientation">Ego-dystonic sexual orientation</a></li>
<li><a href="/wiki/Paraphilia" title="Paraphilia">Paraphilia</a>
<ul><li><a href="/wiki/Sexual_fetishism" title="Sexual fetishism">Fetishism</a></li>
<li><a href="/wiki/Voyeurism" title="Voyeurism">Voyeurism</a></li></ul></li>
<li><a href="/wiki/Sexual_maturation_disorder" title="Sexual maturation disorder">Sexual maturation disorder</a></li>
<li><a href="/wiki/Sexual_relationship_disorder" title="Sexual relationship disorder">Sexual relationship disorder</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Factitious_disorder" title="Factitious disorder">Factitious disorder</a>
<ul><li><a href="/wiki/Factitious_disorder_imposed_on_self" title="Factitious disorder imposed on self">Munchausen syndrome</a></li></ul></li>
<li><a href="/wiki/Gender_dysphoria" title="Gender dysphoria">Gender dysphoria</a></li>
<li><a href="/wiki/Intermittent_explosive_disorder" title="Intermittent explosive disorder">Intermittent explosive disorder</a></li>
<li><a href="/wiki/Excoriation_disorder" title="Excoriation disorder">Dermatillomania</a></li>
<li><a href="/wiki/Kleptomania" title="Kleptomania">Kleptomania</a></li>
<li><a href="/wiki/Pyromania" title="Pyromania">Pyromania</a></li>
<li><a href="/wiki/Trichotillomania" title="Trichotillomania">Trichotillomania</a></li>
<li><a href="/wiki/Personality_disorder" title="Personality disorder">Personality disorder</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Childhood_and_learning" style="font-size:114%;margin:0 4em"><a href="/wiki/Mental_disorders_diagnosed_in_childhood" title="Mental disorders diagnosed in childhood">Childhood and learning</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Emotional_and_behavioral_disorders" title="Emotional and behavioral disorders">Emotional and behavioral</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Attention_deficit_hyperactivity_disorder" title="Attention deficit hyperactivity disorder">ADHD</a></li>
<li><a href="/wiki/Conduct_disorder" title="Conduct disorder">Conduct disorder</a>
<ul><li><a href="/wiki/Oppositional_defiant_disorder" title="Oppositional defiant disorder">ODD</a></li></ul></li>
<li><a href="/wiki/Emotional_and_behavioral_disorders" title="Emotional and behavioral disorders">Emotional and behavioral disorders</a>
<ul><li><a href="/wiki/Separation_anxiety_disorder" title="Separation anxiety disorder">Separation anxiety disorder</a></li></ul></li>
<li><a href="/wiki/Movement_disorders" class="mw-redirect" title="Movement disorders">Movement disorders</a>
<ul><li><a href="/wiki/Stereotypic_movement_disorder" title="Stereotypic movement disorder">Stereotypic</a></li></ul></li>
<li>Social functioning
<ul><li><a href="/wiki/Disinhibited_attachment_disorder" title="Disinhibited attachment disorder">DAD</a></li>
<li><a href="/wiki/Reactive_attachment_disorder" title="Reactive attachment disorder">RAD</a></li>
<li><a href="/wiki/Selective_mutism" title="Selective mutism">Selective mutism</a></li></ul></li>
<li><a href="/wiki/Speech_disorder" title="Speech disorder">Speech</a>
<ul><li><a href="/wiki/Cluttering" title="Cluttering">Cluttering</a></li>
<li><a href="/wiki/Stuttering" title="Stuttering">Stuttering</a></li></ul></li>
<li><a href="/wiki/Tic_disorder" title="Tic disorder">Tic disorder</a>
<ul><li><a href="/wiki/Tourette_syndrome" title="Tourette syndrome">Tourette syndrome</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Intellectual_disability" title="Intellectual disability">Intellectual disability</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/X-linked_intellectual_disability" title="X-linked intellectual disability">X-linked intellectual disability</a>
<ul><li><a href="/wiki/Lujan%E2%80%93Fryns_syndrome" title="Lujan–Fryns syndrome">Lujan–Fryns syndrome</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Psychological development<br />(<a href="/wiki/Developmental_disability" title="Developmental disability">developmental disabilities</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Pervasive_developmental_disorder" title="Pervasive developmental disorder">Pervasive</a></li>
<li><a href="/wiki/Specific_developmental_disorder" title="Specific developmental disorder">Specific</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Mood_(affective)" style="font-size:114%;margin:0 4em"><a href="/wiki/Mood_disorder" title="Mood disorder">Mood</a> (affective)</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Bipolar_disorder" title="Bipolar disorder">Bipolar</a>
<ul><li><a href="/wiki/Bipolar_I_disorder" title="Bipolar I disorder">Bipolar I</a></li>
<li><a href="/wiki/Bipolar_II_disorder" title="Bipolar II disorder">Bipolar II</a></li>
<li><a href="/wiki/Bipolar_disorder_not_otherwise_specified" title="Bipolar disorder not otherwise specified">Bipolar NOS</a></li>
<li><a href="/wiki/Cyclothymia" title="Cyclothymia">Cyclothymia</a></li></ul></li>
<li><a href="/wiki/Depression_(mood)" title="Depression (mood)">Depression</a>
<ul><li><a href="/wiki/Atypical_depression" title="Atypical depression">Atypical depression</a></li>
<li><a href="/wiki/Dysthymia" title="Dysthymia">Dysthymia</a></li>
<li><a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">Major depressive disorder</a></li>
<li><a href="/wiki/Melancholic_depression" title="Melancholic depression">Melancholic depression</a></li>
<li><a href="/wiki/Seasonal_affective_disorder" title="Seasonal affective disorder">Seasonal affective disorder</a></li></ul></li>
<li><a href="/wiki/Mania" title="Mania">Mania</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible uncollapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Neurological_and_symptomatic" style="font-size:114%;margin:0 4em">Neurological and symptomatic</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Autism_spectrum" title="Autism spectrum">Autism spectrum</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Autism" title="Autism">Autism</a></li>
<li><a href="/wiki/Asperger_syndrome" title="Asperger syndrome">Asperger syndrome</a></li>
<li><a href="/wiki/High-functioning_autism" title="High-functioning autism">High-functioning autism</a></li>
<li><a href="/wiki/Pervasive_developmental_disorder_not_otherwise_specified" title="Pervasive developmental disorder not otherwise specified">PDD-NOS</a></li>
<li><a href="/wiki/Savant_syndrome" title="Savant syndrome">Savant syndrome</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dementia" title="Dementia">Dementia</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/HIV-associated_neurocognitive_disorder" title="HIV-associated neurocognitive disorder">AIDS dementia complex</a></li>
<li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's disease</a></li>
<li><a href="/wiki/Creutzfeldt%E2%80%93Jakob_disease" title="Creutzfeldt–Jakob disease">Creutzfeldt–Jakob disease</a></li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington&#39;s disease">Huntington's disease</a></li>
<li><a href="/wiki/Mild_cognitive_impairment" title="Mild cognitive impairment">Mild cognitive impairment</a></li>
<li><a class="mw-selflink selflink">Parkinson's disease</a></li>
<li><a href="/wiki/Pick%27s_disease" class="mw-redirect" title="Pick&#39;s disease">Pick's disease</a></li>
<li><a href="/wiki/Sundowning" title="Sundowning">Sundowning</a></li>
<li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li>
<li><a href="/wiki/Wandering_(dementia)" title="Wandering (dementia)">Wandering</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Delirium" title="Delirium">Delirium</a></li>
<li><a href="/wiki/Organic_brain_syndrome" title="Organic brain syndrome">Organic brain syndrome</a></li>
<li><a href="/wiki/Post-concussion_syndrome" title="Post-concussion syndrome">Post-concussion syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Neurotic,_stress-related_and_somatoform" style="font-size:114%;margin:0 4em"><a href="/wiki/Neurosis" title="Neurosis">Neurotic</a>, <a href="/wiki/Stress_(biology)" title="Stress (biology)">stress</a>-related and <a href="/wiki/Somatic_symptom_disorder" title="Somatic symptom disorder">somatoform</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Adjustment_disorder" title="Adjustment disorder">Adjustment</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Adjustment_disorder" title="Adjustment disorder">Adjustment disorder</a> with depressed mood</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anxiety_disorder" title="Anxiety disorder">Anxiety</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Phobia" title="Phobia">Phobia</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Agoraphobia" title="Agoraphobia">Agoraphobia</a></li>
<li><a href="/wiki/Social_anxiety" title="Social anxiety">Social anxiety</a></li>
<li><a href="/wiki/Social_anxiety_disorder" title="Social anxiety disorder">Social phobia</a>
<ul><li><a href="/wiki/Anthropophobia" class="mw-redirect" title="Anthropophobia">Anthropophobia</a></li>
<li><a href="/wiki/Specific_social_phobia" title="Specific social phobia">Specific social phobia</a></li></ul></li>
<li><a href="/wiki/Specific_phobia" title="Specific phobia">Specific phobia</a>
<ul><li><a href="/wiki/Claustrophobia" title="Claustrophobia">Claustrophobia</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">Generalized anxiety disorder</a></li>
<li><a href="/wiki/Obsessive%E2%80%93compulsive_disorder" title="Obsessive–compulsive disorder">OCD</a></li>
<li><a href="/wiki/Panic_attack" title="Panic attack">Panic attack</a></li>
<li><a href="/wiki/Panic_disorder" title="Panic disorder">Panic disorder</a></li>
<li><a href="/wiki/Psychological_stress" title="Psychological stress">Stress</a>
<ul><li><a href="/wiki/Acute_stress_disorder" title="Acute stress disorder">Acute stress disorder</a></li>
<li><a href="/wiki/Post-traumatic_stress_disorder" title="Post-traumatic stress disorder">PTSD</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dissociative_disorder" title="Dissociative disorder">Dissociative</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Depersonalization-derealization_disorder" title="Depersonalization-derealization disorder">Depersonalization-derealization disorder</a></li>
<li><a href="/wiki/Dissociative_identity_disorder" title="Dissociative identity disorder">Dissociative identity disorder</a></li>
<li><a href="/wiki/Fugue_state" title="Fugue state">Fugue state</a></li>
<li><a href="/wiki/Psychogenic_amnesia" title="Psychogenic amnesia">Psychogenic amnesia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Somatic_symptom_disorder" title="Somatic symptom disorder">Somatic symptom</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Body_dysmorphic_disorder" title="Body dysmorphic disorder">Body dysmorphic disorder</a></li>
<li><a href="/wiki/Conversion_disorder" title="Conversion disorder">Conversion disorder</a>
<ul><li><a href="/wiki/Ganser_syndrome" title="Ganser syndrome">Ganser syndrome</a></li>
<li><a href="/wiki/Globus_pharyngis" title="Globus pharyngis">Globus pharyngis</a></li>
<li><a href="/wiki/Psychogenic_non-epileptic_seizure" title="Psychogenic non-epileptic seizure">Psychogenic non-epileptic seizures</a></li></ul></li>
<li><a href="/wiki/False_pregnancy" title="False pregnancy">False pregnancy</a></li>
<li><a href="/wiki/Hypochondriasis" title="Hypochondriasis">Hypochondriasis</a></li>
<li><a href="/wiki/Mass_psychogenic_illness" title="Mass psychogenic illness">Mass psychogenic illness</a></li>
<li><a href="/wiki/Nosophobia" title="Nosophobia">Nosophobia</a></li>
<li><a href="/wiki/Psychogenic_pain" title="Psychogenic pain">Psychogenic pain</a></li>
<li><a href="/wiki/Somatization_disorder" title="Somatization disorder">Somatization disorder</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Physiological_and_physical_behavior" style="font-size:114%;margin:0 4em">Physiological and physical behavior</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Eating_disorder" title="Eating disorder">Eating</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">Anorexia nervosa</a></li>
<li><a href="/wiki/Bulimia_nervosa" title="Bulimia nervosa">Bulimia nervosa</a></li>
<li><a href="/wiki/Rumination_syndrome" title="Rumination syndrome">Rumination syndrome</a></li>
<li><a href="/wiki/Other_specified_feeding_or_eating_disorder" title="Other specified feeding or eating disorder">Other specified feeding or eating disorder</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nonorganic <a href="/wiki/Sleep_disorder" title="Sleep disorder">sleep</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Hypersomnia" title="Hypersomnia">Hypersomnia</a></li>
<li><a href="/wiki/Insomnia" title="Insomnia">Insomnia</a></li>
<li><a href="/wiki/Parasomnia" title="Parasomnia">Parasomnia</a>
<ul><li><a href="/wiki/Night_terror" title="Night terror">Night terror</a></li>
<li><a href="/wiki/Nightmare" title="Nightmare">Nightmare</a></li>
<li><a href="/wiki/Rapid_eye_movement_sleep_behavior_disorder" title="Rapid eye movement sleep behavior disorder">REM sleep behavior disorder</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Psychiatric_disorders_of_childbirth" title="Psychiatric disorders of childbirth">Postnatal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Postpartum_depression" title="Postpartum depression">Postpartum depression</a></li>
<li><a href="/wiki/Postpartum_psychosis" title="Postpartum psychosis">Postpartum psychosis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sexual_dysfunction" title="Sexual dysfunction">Sexual dysfunction</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sexual_dysfunction#Sexual_arousal_disorders" title="Sexual dysfunction">Arousal</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">Erectile dysfunction</a></li>
<li><a href="/wiki/Female_sexual_arousal_disorder" title="Female sexual arousal disorder">Female sexual arousal disorder</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sexual_dysfunction#Sexual_desire_disorders" title="Sexual dysfunction">Desire</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Hypersexuality" title="Hypersexuality">Hypersexuality</a></li>
<li><a href="/wiki/Hypoactive_sexual_desire_disorder" title="Hypoactive sexual desire disorder">Hypoactive sexual desire disorder</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sexual_dysfunction#Orgasm_disorders" title="Sexual dysfunction">Orgasm</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Anorgasmia" title="Anorgasmia">Anorgasmia</a></li>
<li><a href="/wiki/Delayed_ejaculation" title="Delayed ejaculation">Delayed ejaculation</a></li>
<li><a href="/wiki/Premature_ejaculation" title="Premature ejaculation">Premature ejaculation</a></li>
<li><a href="/wiki/Sexual_anhedonia" title="Sexual anhedonia">Sexual anhedonia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Sexual_dysfunction#Sexual_pain_disorders" title="Sexual dysfunction">Pain</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li>Nonorganic <a href="/wiki/Dyspareunia" title="Dyspareunia">dyspareunia</a></li>
<li>Nonorganic <a href="/wiki/Vaginismus" title="Vaginismus">vaginismus</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Psychoactive_substances,_substance_abuse_and_substance-related" style="font-size:114%;margin:0 4em"><a href="/wiki/Psychoactive_drug" title="Psychoactive drug">Psychoactive</a> substances, <a href="/wiki/Substance_abuse" title="Substance abuse">substance abuse</a> and substance-related</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Drug_overdose" title="Drug overdose">Drug overdose</a></li>
<li><a href="/wiki/Substance_intoxication" title="Substance intoxication">Intoxication</a></li>
<li><a href="/wiki/Physical_dependence" title="Physical dependence">Physical dependence</a></li>
<li><a href="/wiki/Rebound_effect" title="Rebound effect">Rebound effect</a></li>
<li><a href="/wiki/Stimulant_psychosis" title="Stimulant psychosis">Stimulant psychosis</a></li>
<li><a href="/wiki/Substance_dependence" title="Substance dependence">Substance dependence</a></li>
<li><a href="/wiki/Drug_withdrawal" title="Drug withdrawal">Withdrawal</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Schizophrenia,_schizotypal_and_delusional" style="font-size:114%;margin:0 4em"><a href="/wiki/Schizophrenia" title="Schizophrenia">Schizophrenia</a>, <a href="/wiki/Schizotypal_personality_disorder" title="Schizotypal personality disorder">schizotypal</a> and <a href="/wiki/Delusional_disorder" title="Delusional disorder">delusional</a></div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Delusional</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Delusional_disorder" title="Delusional disorder">Delusional disorder</a></li>
<li><a href="/wiki/Folie_%C3%A0_deux" title="Folie à deux">Folie à deux</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Psychosis" title="Psychosis">Psychosis</a> and<br />schizophrenia-like</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Brief_reactive_psychosis" class="mw-redirect" title="Brief reactive psychosis">Brief reactive psychosis</a></li>
<li><a href="/wiki/Schizoaffective_disorder" title="Schizoaffective disorder">Schizoaffective disorder</a></li>
<li><a href="/wiki/Schizophreniform_disorder" title="Schizophreniform disorder">Schizophreniform disorder</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Schizophrenia</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Childhood_schizophrenia" title="Childhood schizophrenia">Childhood schizophrenia</a></li>
<li><a href="/wiki/Disorganized_schizophrenia" title="Disorganized schizophrenia">Disorganized (hebephrenic) schizophrenia</a></li>
<li><a href="/wiki/Paranoid_schizophrenia" class="mw-redirect" title="Paranoid schizophrenia">Paranoid schizophrenia</a></li>
<li><a href="/wiki/Pseudoneurotic_schizophrenia" title="Pseudoneurotic schizophrenia">Pseudoneurotic schizophrenia</a></li>
<li><a href="/wiki/Simple-type_schizophrenia" title="Simple-type schizophrenia">Simple-type schizophrenia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Catatonia" title="Catatonia">Catatonia</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks mw-collapsible mw-collapsed navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Symptoms_and_uncategorized" style="font-size:114%;margin:0 4em">Symptoms and uncategorized</div></th></tr><tr><td colspan="2" class="navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Impulse-control_disorder" title="Impulse-control disorder">Impulse-control disorder</a></li>
<li><a href="/wiki/Kl%C3%BCver%E2%80%93Bucy_syndrome" title="Klüver–Bucy syndrome">Klüver–Bucy syndrome</a></li>
<li><a href="/wiki/Psychomotor_agitation" title="Psychomotor agitation">Psychomotor agitation</a></li>
<li><a href="/wiki/Stereotypy" title="Stereotypy">Stereotypy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Diseases_of_the_nervous_system,_primarily_CNS" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Central_nervous_system_disease" title="Template:Central nervous system disease"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Central_nervous_system_disease" title="Template talk:Central nervous system disease"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Central_nervous_system_disease&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Diseases_of_the_nervous_system,_primarily_CNS" style="font-size:114%;margin:0 4em">Diseases of the <a href="/wiki/Nervous_system" title="Nervous system">nervous system</a>, primarily <a href="/wiki/Central_nervous_system_disease" title="Central nervous system disease">CNS</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Inflammation" title="Inflammation">Inflammation</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Brain" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Encephalitis" title="Encephalitis">Encephalitis</a>
<ul><li><a href="/wiki/Viral_encephalitis" title="Viral encephalitis">Viral encephalitis</a></li>
<li><a href="/wiki/Herpesviral_encephalitis" title="Herpesviral encephalitis">Herpesviral encephalitis</a></li>
<li><a href="/wiki/Limbic_encephalitis" title="Limbic encephalitis">Limbic encephalitis</a></li>
<li><a href="/wiki/Encephalitis_lethargica" title="Encephalitis lethargica">Encephalitis lethargica</a></li></ul></li>
<li><a href="/wiki/Cavernous_sinus_thrombosis" title="Cavernous sinus thrombosis">Cavernous sinus thrombosis</a></li>
<li><a href="/wiki/Brain_abscess" title="Brain abscess">Brain abscess</a>
<ul><li><a href="/wiki/Amoebic_brain_abscess" title="Amoebic brain abscess">Amoebic</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Brain and <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Encephalomyelitis" title="Encephalomyelitis">Encephalomyelitis</a>
<ul><li><a href="/wiki/Acute_disseminated_encephalomyelitis" title="Acute disseminated encephalomyelitis">Acute disseminated</a></li></ul></li>
<li><a href="/wiki/Meningitis" title="Meningitis">Meningitis</a></li>
<li><a href="/wiki/Meningoencephalitis" title="Meningoencephalitis">Meningoencephalitis</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Human_brain" title="Human brain">Brain</a>/<br /><a href="/wiki/Encephalopathy" title="Encephalopathy">encephalopathy</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Extrapyramidal_system" title="Extrapyramidal system">Extrapyramidal</a> and<br /><a href="/wiki/Movement_disorders" class="mw-redirect" title="Movement disorders">movement disorders</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Basal_ganglia_disease" title="Basal ganglia disease">Basal ganglia disease</a>
<ul><li><a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a>
<ul><li><a class="mw-selflink selflink">PD</a></li>
<li><a href="/wiki/Postencephalitic_parkinsonism" class="mw-redirect" title="Postencephalitic parkinsonism">Postencephalitic</a></li>
<li><a href="/wiki/Neuroleptic_malignant_syndrome" title="Neuroleptic malignant syndrome">NMS</a></li></ul></li>
<li><a href="/wiki/Pantothenate_kinase-associated_neurodegeneration" title="Pantothenate kinase-associated neurodegeneration">PKAN</a></li>
<li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Progressive_supranuclear_palsy" title="Progressive supranuclear palsy">PSP</a></li></ul></li>
<li><a href="/wiki/Multiple_system_atrophy" title="Multiple system atrophy">Striatonigral degeneration</a></li>
<li><a href="/wiki/Hemiballismus" title="Hemiballismus">Hemiballismus</a></li>
<li><a href="/wiki/Huntington%27s_disease" title="Huntington&#39;s disease">HD</a></li>
<li><a href="/wiki/Olivopontocerebellar_atrophy" title="Olivopontocerebellar atrophy">OA</a></li></ul></li></ul>
<ul><li><a href="/wiki/Dyskinesia" title="Dyskinesia">Dyskinesia</a>
<ul><li><a href="/wiki/Dystonia" title="Dystonia">Dystonia</a>
<ul><li><a href="/wiki/Status_dystonicus" title="Status dystonicus">Status dystonicus</a></li>
<li><a href="/wiki/Spasmodic_torticollis" title="Spasmodic torticollis">Spasmodic torticollis</a></li>
<li><a href="/wiki/Meige%27s_syndrome" title="Meige&#39;s syndrome">Meige's</a></li>
<li><a href="/wiki/Blepharospasm" title="Blepharospasm">Blepharospasm</a></li></ul></li>
<li><a href="/wiki/Athetosis" title="Athetosis">Athetosis</a></li>
<li><a href="/wiki/Chorea" title="Chorea">Chorea</a>
<ul><li><a href="/wiki/Choreoathetosis" title="Choreoathetosis">Choreoathetosis</a></li></ul></li>
<li><a href="/wiki/Myoclonus" title="Myoclonus">Myoclonus</a>
<ul><li><a href="/wiki/Myoclonic_epilepsy" title="Myoclonic epilepsy">Myoclonic epilepsy</a></li></ul></li>
<li><a href="/wiki/Akathisia" title="Akathisia">Akathisia</a></li></ul></li></ul>
<ul><li><a href="/wiki/Tremor" title="Tremor">Tremor</a>
<ul><li><a href="/wiki/Essential_tremor" title="Essential tremor">Essential tremor</a></li>
<li><a href="/wiki/Intention_tremor" title="Intention tremor">Intention tremor</a></li></ul></li>
<li><a href="/wiki/Restless_legs_syndrome" title="Restless legs syndrome">Restless legs</a></li>
<li><a href="/wiki/Stiff-person_syndrome" title="Stiff-person syndrome">Stiff-person</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dementia" title="Dementia">Dementia</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Tauopathy" title="Tauopathy">Tauopathy</a>
<ul><li><a href="/wiki/Alzheimer%27s_disease" title="Alzheimer&#39;s disease">Alzheimer's</a>
<ul><li><a href="/wiki/Early-onset_Alzheimer%27s_disease" title="Early-onset Alzheimer&#39;s disease">Early-onset</a></li></ul></li>
<li><a href="/wiki/Primary_progressive_aphasia" title="Primary progressive aphasia">Primary progressive aphasia</a></li></ul></li>
<li><a href="/wiki/Frontotemporal_dementia" title="Frontotemporal dementia">Frontotemporal dementia</a>/<a href="/wiki/Frontotemporal_lobar_degeneration" title="Frontotemporal lobar degeneration">Frontotemporal lobar degeneration</a>
<ul><li><a href="/wiki/Pick%27s_disease" class="mw-redirect" title="Pick&#39;s disease">Pick's</a></li>
<li><a href="/wiki/Dementia_with_Lewy_bodies" title="Dementia with Lewy bodies">Dementia with Lewy bodies</a></li></ul></li>
<li><a href="/wiki/Posterior_cortical_atrophy" title="Posterior cortical atrophy">Posterior cortical atrophy</a></li></ul>
<ul><li><a href="/wiki/Vascular_dementia" title="Vascular dementia">Vascular dementia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Mitochondrial_disease" title="Mitochondrial disease">Mitochondrial disease</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Leigh_syndrome" title="Leigh syndrome">Leigh syndrome</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Demyelinating_disease" title="Demyelinating disease">Demyelinating</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/CNS_demyelinating_autoimmune_diseases" title="CNS demyelinating autoimmune diseases">Autoimmune</a></li>
<li><a href="/wiki/Inflammatory_demyelinating_diseases_of_the_central_nervous_system" title="Inflammatory demyelinating diseases of the central nervous system">Inflammatory</a></li>
<li><a href="/wiki/Multiple_sclerosis" title="Multiple sclerosis">Multiple sclerosis</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Demyelinating_diseases_of_CNS" title="Template:Demyelinating diseases of CNS">Template:Demyelinating diseases of CNS</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Episodic/<br /><a href="/wiki/Paroxysmal_attack" title="Paroxysmal attack">paroxysmal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Epileptic_seizure" class="mw-redirect" title="Epileptic seizure">Seizures</a> and <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Focal_seizure" title="Focal seizure">Focal</a></li>
<li><a href="/wiki/Generalized_epilepsy" title="Generalized epilepsy">Generalised</a></li>
<li><a href="/wiki/Status_epilepticus" title="Status epilepticus">Status epilepticus</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Epilepsy" class="mw-redirect" title="Template:Epilepsy">Template:Epilepsy</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Headache" title="Headache">Headache</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Migraine" title="Migraine">Migraine</a></li>
<li><a href="/wiki/Cluster_headache" title="Cluster headache">Cluster</a></li>
<li><a href="/wiki/Tension_headache" title="Tension headache">Tension</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Headache" title="Template:Headache">Template:Headache</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrovascular_disease" title="Cerebrovascular disease">Cerebrovascular</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">TIA</a></li>
<li><a href="/wiki/Stroke" title="Stroke">Stroke</a></li>
<li>For more detailed coverage, see <a href="/wiki/Template:Cerebrovascular_diseases" title="Template:Cerebrovascular diseases">Template:Cerebrovascular diseases</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Sleep_disorders" class="mw-redirect" title="Sleep disorders">Sleep disorders</a>
<ul><li>For more detailed coverage, see <a href="/wiki/Template:Sleep" title="Template:Sleep">Template:Sleep</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Cerebrospinal_fluid" title="Cerebrospinal fluid">CSF</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Intracranial_pressure" title="Intracranial pressure">Intracranial hypertension</a>
<ul><li><a href="/wiki/Hydrocephalus" title="Hydrocephalus">Hydrocephalus</a></li>
<li><a href="/wiki/Normal_pressure_hydrocephalus" title="Normal pressure hydrocephalus">Normal pressure hydrocephalus</a></li>
<li><a href="/wiki/Choroid_plexus_papilloma" title="Choroid plexus papilloma">Choroid plexus papilloma</a></li>
<li><a href="/wiki/Idiopathic_intracranial_hypertension" title="Idiopathic intracranial hypertension">Idiopathic intracranial hypertension</a></li></ul></li>
<li><a href="/wiki/Cerebral_edema" title="Cerebral edema">Cerebral edema</a></li>
<li><a href="/wiki/Spontaneous_cerebrospinal_fluid_leak" class="mw-redirect" title="Spontaneous cerebrospinal fluid leak">Intracranial hypotension</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Brain_herniation" title="Brain herniation">Brain herniation</a></li>
<li><a href="/wiki/Reye_syndrome" title="Reye syndrome">Reye syndrome</a></li>
<li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Toxic_encephalopathy" title="Toxic encephalopathy">Toxic encephalopathy</a></li>
<li><a href="/wiki/Hashimoto%27s_encephalopathy" title="Hashimoto&#39;s encephalopathy">Hashimoto's encephalopathy</a></li>
<li><a href="/wiki/Fetal_alcohol_spectrum_disorder" title="Fetal alcohol spectrum disorder">Static Encephalopathy</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Both/either</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Degenerative" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Neurodegenerative_disease" title="Neurodegenerative disease">Degenerative</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Spinocerebellar_ataxia" title="Spinocerebellar ataxia">SA</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Friedreich%27s_ataxia" title="Friedreich&#39;s ataxia">Friedreich's ataxia</a></li>
<li><a href="/wiki/Ataxia%E2%80%93telangiectasia" title="Ataxia–telangiectasia">Ataxia–telangiectasia</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Motor_neuron_disease" title="Motor neuron disease">MND</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i><a href="/wiki/Upper_motor_neuron" title="Upper motor neuron">UMN</a> only:</i>
<ul><li><a href="/wiki/Primary_lateral_sclerosis" title="Primary lateral sclerosis">Primary lateral sclerosis</a></li>
<li><a href="/wiki/Pseudobulbar_palsy" title="Pseudobulbar palsy">Pseudobulbar palsy</a></li>
<li><a href="/wiki/Hereditary_spastic_paraplegia" title="Hereditary spastic paraplegia">Hereditary spastic paraplegia</a></li></ul></li></ul>
<ul><li><i><a href="/wiki/Lower_motor_neuron" title="Lower motor neuron">LMN</a> only:</i>
<ul><li><a href="/wiki/Distal_hereditary_motor_neuronopathies" title="Distal hereditary motor neuronopathies">Distal hereditary motor neuronopathies</a></li>
<li><a href="/wiki/Spinal_muscular_atrophies" title="Spinal muscular atrophies">Spinal muscular atrophies</a>
<ul><li><a href="/wiki/Spinal_muscular_atrophy" title="Spinal muscular atrophy">SMA</a></li>
<li><a href="/wiki/Spinal_and_bulbar_muscular_atrophy" title="Spinal and bulbar muscular atrophy">SMAX1</a></li>
<li><a href="/wiki/X-linked_spinal_muscular_atrophy_type_2" title="X-linked spinal muscular atrophy type 2">SMAX2</a></li>
<li><a href="/wiki/Distal_spinal_muscular_atrophy_type_1" title="Distal spinal muscular atrophy type 1">DSMA1</a></li>
<li><a href="/wiki/Congenital_distal_spinal_muscular_atrophy" title="Congenital distal spinal muscular atrophy">Congenital DSMA</a></li>
<li>Spinal muscular atrophy with lower extremity predominance (SMALED)
<ul><li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_1" title="Spinal muscular atrophy with lower extremity predominance 1">SMALED1</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2A" title="Spinal muscular atrophy with lower extremity predominance 2A">SMALED2A</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_lower_extremity_predominance_2B" title="Spinal muscular atrophy with lower extremity predominance 2B">SMALED2B</a></li></ul></li>
<li><a href="/wiki/Pontocerebellar_hypoplasia" title="Pontocerebellar hypoplasia">SMA-PCH</a></li>
<li><a href="/wiki/Spinal_muscular_atrophy_with_progressive_myoclonic_epilepsy" title="Spinal muscular atrophy with progressive myoclonic epilepsy">SMA-PME</a></li></ul></li>
<li><a href="/wiki/Progressive_muscular_atrophy" title="Progressive muscular atrophy">Progressive muscular atrophy</a></li>
<li><a href="/wiki/Progressive_bulbar_palsy" title="Progressive bulbar palsy">Progressive bulbar palsy</a>
<ul><li><a href="/wiki/Fazio%E2%80%93Londe_disease" title="Fazio–Londe disease">Fazio–Londe</a></li>
<li><a href="/wiki/Infantile_progressive_bulbar_palsy" title="Infantile progressive bulbar palsy">Infantile progressive bulbar palsy</a></li></ul></li></ul></li></ul>
<ul><li><i>both:</i>
<ul><li><a href="/wiki/Amyotrophic_lateral_sclerosis" title="Amyotrophic lateral sclerosis">Amyotrophic lateral sclerosis</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox" aria-labelledby="Antiparkinson_agents_(N04)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1063604349"/><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Antiparkinson_agents" title="Template:Antiparkinson agents"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Antiparkinson_agents" title="Template talk:Antiparkinson agents"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Antiparkinson_agents&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Antiparkinson_agents_(N04)" style="font-size:114%;margin:0 4em"><a href="/wiki/Management_of_Parkinson%27s_disease#Medication" title="Management of Parkinson&#39;s disease">Antiparkinson agents</a> (<a href="/wiki/ATC_code_N04" title="ATC code N04">N04</a>)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dopaminergic" title="Dopaminergic">Dopaminergics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dopamine" title="Dopamine">DA</a> <a href="/wiki/Precursor_(chemistry)" title="Precursor (chemistry)">precursors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/L-DOPA" title="L-DOPA">Levodopa</a><sup>#</sup></li>
<li><a href="/wiki/Melevodopa" title="Melevodopa">Melevodopa</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Dopamine_receptor" title="Dopamine receptor">DA receptor</a> <a href="/wiki/Dopamine_agonist" title="Dopamine agonist">agonists</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><i>Ergoline:</i> <a href="/wiki/Bromocriptine" title="Bromocriptine">Bromocriptine</a></li>
<li><a href="/wiki/Cabergoline" title="Cabergoline">Cabergoline</a></li>
<li><a href="/wiki/Dihydroergocryptine" title="Dihydroergocryptine">Dihydroergocryptine</a></li>
<li><a href="/wiki/Lisuride" title="Lisuride">Lisuride</a></li>
<li><a href="/wiki/Pergolide" title="Pergolide">Pergolide</a></li></ul>
<ul><li><i>Non-ergoline:</i> <a href="/wiki/Apomorphine" title="Apomorphine">Apomorphine</a></li>
<li><a href="/wiki/Piribedil" title="Piribedil">Piribedil</a></li>
<li><a href="/wiki/Pramipexole" title="Pramipexole">Pramipexole</a></li>
<li><a href="/wiki/Ropinirole" title="Ropinirole">Ropinirole</a></li>
<li><a href="/wiki/Rotigotine" title="Rotigotine">Rotigotine</a></li>
<li><a href="/wiki/Talipexole" title="Talipexole">Talipexole</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Monoamine_oxidase_B" title="Monoamine oxidase B">MAO-B</a> <a href="/wiki/Monoamine_oxidase_inhibitor" title="Monoamine oxidase inhibitor">inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Rasagiline" title="Rasagiline">Rasagiline</a></li>
<li><a href="/wiki/Safinamide" title="Safinamide">Safinamide</a></li>
<li><a href="/wiki/Selegiline" title="Selegiline">Selegiline</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Catechol-O-methyltransferase" title="Catechol-O-methyltransferase">COMT</a> <a href="/wiki/COMT_inhibitor" class="mw-redirect" title="COMT inhibitor">inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Entacapone" title="Entacapone">Entacapone</a></li>
<li><a href="/wiki/Opicapone" title="Opicapone">Opicapone</a></li>
<li><a href="/wiki/Tolcapone" title="Tolcapone">Tolcapone</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Aromatic_L-amino_acid_decarboxylase" title="Aromatic L-amino acid decarboxylase">AAAD</a> <a href="/wiki/Aromatic_L-amino_acid_decarboxylase_inhibitor" title="Aromatic L-amino acid decarboxylase inhibitor">inhibitors</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Benserazide" title="Benserazide">Benserazide</a></li>
<li><a href="/wiki/Carbidopa" title="Carbidopa">Carbidopa</a><sup>#</sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anticholinergic" title="Anticholinergic">Anticholinergics</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Benzatropine" title="Benzatropine">Benzatropine</a></li>
<li><a href="/wiki/Biperiden" title="Biperiden">Biperiden</a><sup>#</sup></li>
<li><a href="/wiki/Bornaprine" title="Bornaprine">Bornaprine</a></li>
<li><a href="/wiki/Chlorphenoxamine" title="Chlorphenoxamine">Chlorphenoxamine</a></li>
<li><a href="/wiki/Cycrimine" title="Cycrimine">Cycrimine</a></li>
<li><a href="/wiki/Dexetimide" title="Dexetimide">Dexetimide</a></li>
<li><a href="/wiki/Diphenhydramine" title="Diphenhydramine">Diphenhydramine</a></li>
<li><a href="/wiki/Etanautine" title="Etanautine">Etanautine</a></li>
<li><a href="/wiki/Etybenzatropine" title="Etybenzatropine">Etybenzatropine</a></li>
<li><a href="/wiki/Mazaticol" title="Mazaticol">Mazaticol</a></li>
<li><a href="/wiki/Metixene" title="Metixene">Metixene</a></li>
<li><a href="/wiki/Orphenadrine" title="Orphenadrine">Orphenadrine</a></li>
<li><a href="/wiki/Phenglutarimide" title="Phenglutarimide">Phenglutarimide</a></li>
<li><a href="/wiki/Piroheptine" title="Piroheptine">Piroheptine</a></li>
<li><a href="/wiki/Procyclidine" title="Procyclidine">Procyclidine</a></li>
<li><a href="/wiki/Profenamine" title="Profenamine">Profenamine</a></li>
<li><a href="/wiki/Tigloidine" title="Tigloidine">Tigloidine</a></li>
<li><a href="/wiki/Trihexyphenidyl" title="Trihexyphenidyl">Trihexyphenidyl</a></li>
<li><a href="/wiki/Tropatepine" title="Tropatepine">Tropatepine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Others</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Amantadine" title="Amantadine">Amantadine</a></li>
<li><a href="/wiki/Budipine" title="Budipine">Budipine</a></li>
<li><a href="/wiki/Istradefylline" title="Istradefylline">Istradefylline</a></li>
<li><a href="/wiki/Xanthine" title="Xanthine">Methylxanthines</a> (e.g., <a href="/wiki/Caffeine" title="Caffeine">caffeine</a>)</li>
<li><a href="/wiki/Rimantadine" title="Rimantadine">Rimantadine</a></li></ul>
</div></td></tr><tr><td colspan="2" class="navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist">
<ul><li><sup>#</sup><a href="/wiki/WHO_Model_List_of_Essential_Medicines" title="WHO Model List of Essential Medicines">WHO-EM</a></li>
<li><sup>‡</sup><a href="/wiki/List_of_withdrawn_drugs" title="List of withdrawn drugs">Withdrawn</a> from market</li>
<li><a href="/wiki/Clinical_trial" title="Clinical trial">Clinical trials</a>:
<ul><li><sup>†</sup><a href="/wiki/Phases_of_clinical_research#Phase_III" title="Phases of clinical research">Phase III</a></li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div class="navbox-styles nomobile"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"/></div><div role="navigation" class="navbox authority-control" aria-labelledby="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q11085#identifiers&amp;#124;Edit_this_at_Wikidata" style="padding:3px"><table class="nowraplinks hlist mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q11085#identifiers&amp;#124;Edit_this_at_Wikidata" style="font-size:114%;margin:0 4em"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a> <a href="https://www.wikidata.org/wiki/Q11085#identifiers" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20" /></a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">National libraries</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><span class="uid"><a rel="nofollow" class="external text" href="http://catalogo.bne.es/uhtbin/authoritybrowse.cgi?action=display&amp;authority_id=XX528689">Spain</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://catalogue.bnf.fr/ark:/12148/cb119760133">France</a> <a rel="nofollow" class="external text" href="https://data.bnf.fr/ark:/12148/cb119760133">(data)</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://d-nb.info/gnd/4044683-9">Germany</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.loc.gov/authorities/subjects/sh85098118">United States</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="https://id.ndl.go.jp/auth/ndlna/00571142">Japan</a></span></li>
<li><span class="uid"><a rel="nofollow" class="external text" href="http://katalog.nsk.hr/F/?func=direct&amp;doc_number=000175745&amp;local_base=nsk10">Croatia</a></span></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><span class="uid"><a rel="nofollow" class="external text" href="https://catalog.archives.gov/id/10647691">National Archives (US)</a></span></li></ul>
</div></td></tr></tbody></table></div></div>